Cover
Cover | 6 Months Ended |
Jun. 30, 2021 | |
Cover [Abstract] | |
Document Type | 6-K |
Entity Registrant Name | Barclays PLC |
Amendment Flag | false |
Document Fiscal Year Focus | 2021 |
Document Fiscal Period Focus | Q2 |
Document Period End Date | Jun. 30, 2021 |
Entity Central Index Key | 0000312069 |
Current Fiscal Year End Date | --12-31 |
Condensed consolidated income s
Condensed consolidated income statement (unaudited) - GBP (£) £ in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | ||
Profit or loss [abstract] | |||
Interest and similar income | £ 5,279 | £ 6,437 | |
Interest and similar expense | (1,376) | (2,214) | |
Net interest income | 3,903 | 4,223 | |
Fee and commission income | 4,682 | 4,399 | |
Fee and commission expense | (976) | (1,090) | |
Net fee and commission income | 3,706 | 3,309 | |
Net trading income | 3,482 | 4,198 | |
Net investment income | 152 | (136) | |
Other income | 72 | 27 | |
Total income | 11,315 | 11,621 | |
Credit impairment releases/(charges) | 742 | (3,738) | |
Net operating income | 12,057 | 7,883 | |
Staff costs | (4,334) | (4,053) | |
Infrastructure, administration and general expenses | (2,798) | (2,510) | |
Litigation and conduct | (99) | (30) | |
Total operating expenses | (7,231) | (6,593) | |
Share of post-tax results of associates and joint ventures | 154 | (31) | |
Profit on disposal of subsidiaries, associates and joint ventures | (1) | 13 | |
Profit before tax | 4,979 | 1,272 | [1] |
Tax charge | (759) | (113) | |
Profit after tax | 4,220 | 1,159 | |
Attributable to: | |||
Equity holders of the parent | 3,812 | 695 | |
Other equity instrument holders | 389 | 427 | |
Total equity holders of the parent | 4,201 | 1,122 | |
Non-controlling interests | 19 | 37 | |
Profit after tax | £ 4,220 | £ 1,159 | |
Earnings per share | |||
Basic earnings per ordinary share (in GBP per share) | £ 0.222 | £ 0.040 | |
Diluted earnings per ordinary share (in GBP per share) | £ 0.217 | £ 0.039 | |
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. |
Condensed consolidated statemen
Condensed consolidated statement of comprehensive income (unaudited) - GBP (£) £ in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | ||
Statement of comprehensive income [abstract] | |||
Profit after tax | £ 4,220 | £ 1,159 | |
Other comprehensive income/(loss) that may be recycled to profit or loss: | |||
Currency translation reserve | [1] | (495) | 1,220 |
Fair value through other comprehensive income reserve | [1] | (365) | 137 |
Cash flow hedging reserve | [1] | (911) | 912 |
Other | [1] | 0 | (6) |
Other comprehensive income that may be recycled to profit | [1] | (1,771) | 2,263 |
Other comprehensive (loss)/income not recycled to profit or loss: | |||
Retirement benefit remeasurements | [1] | 103 | 645 |
Fair value through other comprehensive income reserve | [1] | 115 | (515) |
Own credit | [1] | (47) | 496 |
Other comprehensive income not recycled to profit | [1] | 171 | 626 |
Other comprehensive income for the period | (1,600) | 2,889 | |
Total comprehensive income for the period | 2,620 | 4,048 | |
Attributable to: | |||
Equity holders of the parent | 2,601 | 4,011 | |
Non-controlling interests | 19 | 37 | |
Total comprehensive income for the period | £ 2,620 | £ 4,048 | |
[1] | Reported net of tax. |
Condensed consolidated balance
Condensed consolidated balance sheet (unaudited) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Assets | ||
Cash and balances at central banks | £ 216,963 | £ 191,127 |
Cash collateral and settlement balances | 111,921 | 101,367 |
Loans and advances at amortised cost | 348,549 | 342,632 |
Reverse repurchase agreements and other similar secured lending | 4,459 | 9,031 |
Trading portfolio assets | 147,239 | 127,950 |
Financial assets at fair value through the income statement | 194,421 | 175,151 |
Derivative financial instruments | 256,636 | 302,446 |
Financial assets at fair value through other comprehensive income | 73,260 | 78,688 |
Investments in associates and joint ventures | 907 | 781 |
Goodwill and intangible assets | 8,196 | 7,948 |
Property, plant and equipment | 3,581 | 4,036 |
Current tax assets | 228 | 477 |
Deferred tax assets | 3,771 | 3,444 |
Retirement benefit assets | 2,701 | 1,814 |
Other assets | 3,501 | 2,622 |
Total assets | 1,376,333 | 1,349,514 |
Liabilities | ||
Deposits at amortised cost | 500,895 | 481,036 |
Cash collateral and settlement balances | 101,923 | 85,423 |
Repurchase agreements and other similar secured borrowing | 20,005 | 14,174 |
Debt securities in issue | 90,733 | 75,796 |
Subordinated Liabilities | 12,839 | 16,341 |
Trading portfolio liabilities | 56,986 | 47,405 |
Financial liabilities designated at fair value | 264,164 | 249,765 |
Derivative financial instruments | 247,034 | 300,775 |
Current tax liabilities | 592 | 645 |
Deferred tax liabilities | 8 | 15 |
Retirement benefit liabilities | 338 | 291 |
Other liabilities | 10,928 | 8,662 |
Provisions | 1,772 | 2,304 |
Total liabilities | 1,308,217 | 1,282,632 |
Equity | ||
Called up share capital and share premium | 4,568 | 4,637 |
Other reserves | 2,856 | 4,461 |
Retained earnings | 48,461 | 45,527 |
Shareholders' equity attributable to ordinary shareholders of the parent | 55,885 | 54,625 |
Other equity instruments | 11,167 | 11,172 |
Total equity excluding non-controlling interests | 67,052 | 65,797 |
Non-controlling interests | 1,064 | 1,085 |
Total equity | 68,116 | 66,882 |
Total equity and liabilities | £ 1,376,333 | £ 1,349,514 |
Condensed consolidated statem_2
Condensed consolidated statement of changes in equity (unaudited) - GBP (£) £ in Millions | Total | Total | Total share capital and share premium | [1] | Other equity instruments | Other reserves | [1] | Retained earnings | Non-controlling interests | [2] | |||
Beginning Balance, equity at Dec. 31, 2019 | £ 65,660 | £ 64,429 | £ 4,594 | £ 10,871 | [1] | £ 4,760 | £ 44,204 | £ 1,231 | |||||
Profit after tax | 1,159 | 1,122 | 427 | [1] | 695 | 37 | |||||||
Currency translation movements | 1,220 | [3] | 1,220 | 1,220 | |||||||||
Fair value through other comprehensive income reserve | (378) | (378) | (378) | ||||||||||
Cash flow hedges | 912 | [3] | 912 | 912 | |||||||||
Retirement benefit remeasurements | 645 | [3] | 645 | 645 | |||||||||
Own credit | 496 | [3] | 496 | 496 | |||||||||
Other | (6) | [3] | (6) | (6) | |||||||||
Total comprehensive income for the period | 4,048 | 4,011 | 427 | [1] | 2,250 | 1,334 | 37 | ||||||
Equity settled share schemes | 629 | 629 | 26 | 603 | |||||||||
Other equity instruments coupon paid | (427) | (427) | (427) | [1] | |||||||||
Vesting of employee share schemes | (341) | (341) | (14) | (327) | |||||||||
Dividends paid | (37) | (37) | |||||||||||
Other movements | 9 | 3 | 3 | 6 | |||||||||
Ending Balance, equity at Jun. 30, 2020 | 69,541 | 68,304 | 4,620 | 10,871 | [1] | 6,996 | 45,817 | 1,237 | |||||
Beginning Balance, equity at Dec. 31, 2019 | 65,660 | 64,429 | 4,594 | 10,871 | [1] | 4,760 | 44,204 | 1,231 | |||||
Other movements | (10) | ||||||||||||
Ending Balance, equity at Dec. 31, 2020 | 66,882 | 65,797 | 4,637 | 11,172 | [1] | 4,461 | 45,527 | 1,085 | |||||
Beginning Balance, equity at Jun. 30, 2020 | 69,541 | 68,304 | 4,620 | 10,871 | [1] | 6,996 | 45,817 | 1,237 | |||||
Profit after tax | 1,302 | 1,261 | 430 | [1] | 831 | 41 | |||||||
Currency translation movements | (1,693) | (1,693) | (1,693) | ||||||||||
Fair value through other comprehensive income reserve | 570 | 570 | 570 | ||||||||||
Cash flow hedges | (339) | (339) | (339) | ||||||||||
Retirement benefit remeasurements | (756) | (756) | (756) | ||||||||||
Own credit | (1,077) | (1,077) | (1,077) | ||||||||||
Other | 11 | 11 | 11 | ||||||||||
Total comprehensive income for the period | (1,982) | (2,023) | 430 | [1] | (2,539) | 86 | 41 | ||||||
Equity settled share schemes | (283) | (283) | 17 | (300) | |||||||||
Issue and exchange of other equity instruments | 98 | 256 | 311 | [1] | (55) | (158) | |||||||
Other equity instruments coupon paid | (430) | (430) | (430) | [1] | |||||||||
Vesting of employee share schemes | (16) | (16) | 4 | (20) | |||||||||
Dividends paid | (42) | (42) | |||||||||||
Other movements | (4) | (11) | (10) | [1] | (1) | 7 | |||||||
Ending Balance, equity at Dec. 31, 2020 | 66,882 | 65,797 | 4,637 | 11,172 | [1] | 4,461 | 45,527 | 1,085 | |||||
Profit after tax | 4,220 | 4,201 | 389 | [1] | 3,812 | 19 | |||||||
Currency translation movements | (495) | [3] | (495) | (495) | |||||||||
Fair value through other comprehensive income reserve | (250) | (250) | (250) | ||||||||||
Cash flow hedges | (911) | [3] | (911) | (911) | |||||||||
Retirement benefit remeasurements | 103 | [3] | 103 | 103 | |||||||||
Own credit | (47) | [3] | (47) | (47) | |||||||||
Other | [3] | 0 | |||||||||||
Total comprehensive income for the period | 2,620 | 2,601 | 389 | [1] | (1,703) | 3,915 | 19 | ||||||
Equity settled share schemes | 314 | 314 | 25 | 289 | |||||||||
Other equity instruments coupon paid | (389) | (389) | (389) | [1] | |||||||||
Vesting of employee share schemes | (393) | (393) | 4 | (397) | |||||||||
Dividends paid | (189) | (173) | (173) | (16) | |||||||||
Repurchase of shares | (700) | (700) | (94) | 94 | (700) | ||||||||
Other movements | (29) | (5) | (5) | [1] | (24) | ||||||||
Ending Balance, equity at Jun. 30, 2021 | £ 68,116 | £ 67,052 | £ 4,568 | £ 11,167 | [1] | £ 2,856 | £ 48,461 | £ 1,064 | |||||
[1] | Details of share capital, other equity instruments and other reserves are shown on pages 84 to 85. | ||||||||||||
[2] | 2 Details of non-controlling interests are shown on page 73. | ||||||||||||
[3] | Reported net of tax. |
Condensed consolidated cash flo
Condensed consolidated cash flow statement (unaudited) - GBP (£) £ in Millions | 6 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | [1] | ||
Reconciliation of profit before tax to net cash flows from operating activities: | ||||
Profit before tax | £ 4,979 | £ 1,272 | ||
Adjustment for non-cash items | [2] | 6,900 | (1,431) | |
Net increase in loans and advances at amortised cost | [2] | 432 | (12,868) | |
Net increase in deposits at amortised cost | 19,859 | 51,126 | ||
Net increase in debt securities in issue | 13,041 | 24,183 | ||
Changes in other operating assets and liabilities | [3] | (5,559) | (6,770) | |
Corporate income tax paid | (712) | (351) | ||
Net cash from operating activities | 38,940 | 55,161 | ||
Net cash from investing activities | [2] | (3,389) | (17,844) | |
Net cash from financing activities | (2,562) | 3,133 | ||
Effect of exchange rates on cash and cash equivalents | (5,535) | 7,814 | ||
Net increase/(decrease) in cash and cash equivalents | 27,454 | 48,264 | ||
Cash and cash equivalents at beginning of the period | [3] | 210,142 | 166,613 | |
Cash and cash equivalents at end of period | [3] | £ 237,596 | £ 214,877 | |
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. | |||
[2] | Movements in cash and cash equivalents relating to debt securities at amortised cost were previously shown within loans and advances at amortised cost in operating activities. These debt securities holdings are now considered to be part of the investing activity performed by the Group following a change in accounting policy and have been presented within investing activities in H121. Comparatives have been restated. The effect of this change was to reclassify £6,245m of net cash outflows from operating activities to investing activities in H120. | |||
[3] | Cash and cash equivalents have been restated to exclude cash collateral and settlement balances, with the exception of balances that the Group holds at central banks related to payment schemes. The effect of this change decreased cash and cash equivalents by £28,301m as at 30 June 2020 and £16,774m as at 31 December 2019. As a result, net cash from operating activities decreased by £11,527m in H120, representing the net increase in the cash collateral and settlement balances line item in this period. |
Condensed consolidated cash f_2
Condensed consolidated cash flow statement (unaudited) (Parenthetical) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended | |
Jun. 30, 2020 | Dec. 31, 2019 | ||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Increase (decrease) in cash and cash equivalents | [1] | £ (48,264) | |
Cash flows from (used in) operating activities | [1] | (55,161) | |
Net cash from investing activities | [1],[2] | (17,844) | |
Increase (decrease) due to corrections of prior period errors | |||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Increase (decrease) in cash and cash equivalents | 28,301 | £ 16,774 | |
Cash flows from (used in) operating activities | (11,527) | ||
Increase (decrease) due to changes in accounting policy | |||
Condensed Cash Flow Statements, Captions [Line Items] | |||
Cash flows from (used in) operating activities | 6,245 | ||
Net cash from investing activities | £ 6,245 | ||
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. | ||
[2] | Movements in cash and cash equivalents relating to debt securities at amortised cost were previously shown within loans and advances at amortised cost in operating activities. These debt securities holdings are now considered to be part of the investing activity performed by the Group following a change in accounting policy and have been presented within investing activities in H121. Comparatives have been restated. The effect of this change was to reclassify £6,245m of net cash outflows from operating activities to investing activities in H120. |
Basis of preparation
Basis of preparation | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of initial application of standards or interpretations [abstract] | |
Basis of preparation | Basis of preparation These condensed consolidated interim financial statements for the six months ended 30 June 2021 have been prepared in accordance with the Disclosure and Transparency Rules (DTR) of the UK’s Financial Conduct Authority (FCA) and IAS 34, Interim Financial Reporting, as published by the International Accounting Standards Board (IASB) and adopted by the UK. The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2020. The annual financial statements for the year ended 31 December 2020 were prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and in accordance with International Financial Reporting Standards (IFRS) and interpretations (IFRICs) as issued by the IASB and adopted pursuant to Regulation (EC) No 1606/2002 as it applies in the European Union as well as adopted by the UK. UK adopted IFRS and EU adopted IFRS are currently the same and were the same as at 31 December 2020. The accounting policies and methods of computation used in these condensed consolidated interim financial statements are the same as those used in the Barclays PLC Annual Report 2020. 1. Going concern The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent company have the resources to continue in business for a period of at least 12 months from approval of the interim financial statements. In making this assessment, the Directors have considered a wide range of information relating to present and future conditions and includes a review of a working capital report (WCR). The WCR is used by the Directors to assess the future performance of the business and that it has the resources in place that are required to meet its ongoing regulatory requirements. The WCR also includes an assessment of the impact of internally generated stress testing scenarios on the liquidity and capital requirement forecasts. The stress tests used were based upon an assessment of reasonably possible downside economic scenarios that the Group could experience. The WCR indicated that the Group had sufficient capital in place to support its future business requirements and remained above its regulatory minimum requirements in the internal stress scenarios. 2. Other disclosures The Credit risk disclosures on pages 28 to 46 form part of these interim financial statements. |
Segmental reporting
Segmental reporting | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of operating segments [abstract] | |
Segmental reporting | Segmental reporting Analysis of results by business Barclays Barclays Head Barclays Half year ended 30.06.21 £m £m £m £m Total income 3,199 8,218 (102) 11,315 Credit impairment releases 443 293 6 742 Net operating income/(expenses) 3,642 8,511 (96) 12,057 Operating expenses (2,114) (4,606) (412) (7,132) Litigation and conduct (22) (84) 7 (99) Total operating expenses (2,136) (4,690) (405) (7,231) Other net income 1 — 22 131 153 Profit/(loss) before tax 1,506 3,843 (370) 4,979 As at 30.06.21 £bn £bn £bn £bn Total assets 311.2 1,046.8 18.3 1,376.3 Barclays Barclays Head Barclays Half year ended 30.06.20 £m £m £m £m Total income 3,171 8,654 (204) 11,621 Credit impairment charges (1,064) (2,619) (55) (3,738) Net operating income/(expenses) 2,107 6,035 (259) 7,883 Operating expenses (2,041) (4,405) (117) (6,563) Litigation and conduct (11) (11) (8) (30) Total operating expenses (2,052) (4,416) (125) (6,593) Other net income/(expenses) 1 13 10 (41) (18) Profit/(loss) before tax 68 1,629 (425) 1,272 As at 31.12.20 £bn £bn £bn £bn Total assets 289.1 1,041.8 18.6 1,349.5 1 Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates and joint ventures and gains on acquisitions. Split of income by geographic region 1 Half year ended 30.06.21 Half year ended 30.06.20 £m £m United Kingdom 5,895 5,989 Europe 1,222 1,199 Americas 3,608 3,776 Africa and Middle East 20 20 Asia 570 637 Total 11,315 11,621 1 The geographical analysis is based on the location of the office where the transactions are recorded. |
Net fee and commission income
Net fee and commission income | 6 Months Ended |
Jun. 30, 2021 | |
Fee and commission income (expense) [abstract] | |
Net fee and commission income | Net fee and commission income Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from Contracts with Customers: Barclays UK Barclays International Head Office Total Half year ended 30.06.21 £m £m £m £m Fee type Transactional 408 1,181 — 1,589 Advisory 83 459 1 543 Brokerage and execution 109 553 — 662 Underwriting and syndication — 1,715 — 1,715 Other 35 73 3 111 Total revenue from contracts with customers 635 3,981 4 4,620 Other non-contract fee income — 62 — 62 Fee and commission income 635 4,043 4 4,682 Fee and commission expense (108) (861) (7) (976) Net fee and commission income 527 3,182 (3) 3,706 Barclays UK Barclays International Head Office Total Half year ended 30.06.20 £m £m £m £m Fee type Transactional 386 1,157 — 1,543 Advisory 79 306 1 386 Brokerage and execution 102 685 — 787 Underwriting and syndication — 1,468 — 1,468 Other 38 115 2 155 Total revenue from contracts with customers 605 3,731 3 4,339 Other non-contract fee income — 60 — 60 Fee and commission income 605 3,791 3 4,399 Fee and commission expense (148) (940) (2) (1,090) Net fee and commission income 457 2,851 1 3,309 Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees. These include interchange and merchant fee income generated from credit and bank card usage. Advisory fees are generated from wealth management services and investment banking advisory services related to mergers, acquisitions and financial restructurings. Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter markets and assisting clients in clearing transactions. Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement and administration of a loan syndication. These include commitment fees to provide loan financing. |
Staff costs
Staff costs | 6 Months Ended |
Jun. 30, 2021 | |
Classes of employee benefits expense [abstract] | |
Staff costs | Staff costs Half year ended 30.06.21 Half year ended 30.06.20 Compensation costs £m £m Upfront bonus charge 824 476 Deferred bonus charge 262 269 Other incentives 6 4 Performance costs 1,092 749 Salaries 2,117 2,153 Social security costs 336 317 Post-retirement benefits 275 268 Other compensation costs 223 254 Total compensation costs 4,043 3,741 Other resourcing costs Outsourcing 171 175 Redundancy and restructuring 23 39 Temporary staff costs 55 58 Other 42 40 Total other resourcing costs 291 312 Total staff costs 4,334 4,053 Barclays Group compensation costs as a % of total income 35.7 32.2 No material awards have yet been granted in relation to the 2021 bonus pool as decisions regarding incentive awards are not taken by the Remuneration Committee until the performance for the full year can be assessed. The current year bonus charge for the first six months represents an accrual for estimated costs in accordance with accounting requirements. One of the primary considerations when evaluating the accrual is Group and business level returns, aligning colleague and shareholder interests. The Group has entered into physically settled forward contracts to hedge the settlement of certain share-based payment schemes. The present value of the fixed forward price to be paid under these outstanding contracts is £158m and has been recorded in retained earnings. |
Infrastructure, administration
Infrastructure, administration and general expenses | 6 Months Ended |
Jun. 30, 2021 | |
Expenses by nature [abstract] | |
Infrastructure, administration and general expenses | Infrastructure, administration and general expenses Half year ended 30.06.21 Half year ended 30.06.20 Infrastructure costs £m £m Property and equipment 709 757 Depreciation and amortisation 832 751 Lease payments 20 26 Impairment of property, equipment and intangible assets 304 32 Total infrastructure costs 1,865 1,566 Administration and general expenses Consultancy, legal and professional fees 262 270 Marketing and advertising 163 158 Other administration and general expenses 508 516 Total administration and general expenses 933 944 Total infrastructure, administration and general expenses 2,798 2,510 |
Tax
Tax | 6 Months Ended |
Jun. 30, 2021 | |
Major components of tax expense (income) [abstract] | |
Tax | Tax The tax charge for H121 was £759m (H120: £113m), representing an effective tax rate of 15.2% (H120: 8.9%). The effective tax rate for H121 includes a benefit recognised as a result of the increase in the UK corporation tax rate and absent this benefit the tax charge would have been £1,151m and the effective tax rate would have been 23.1%. The H120 effective tax rate included a benefit recognised for re-measurement of the Group’s UK deferred tax assets as a result of UK corporation tax previously being maintained at a rate of 19%. Included in the H121 tax charge is a credit of £104m (H120: £112m) in respect of payments made on AT1 instruments that are classified as equity for accounting purposes. In its Budget held in March 2021, the UK Government announced that the UK rate of corporation tax will increase from 19% to 25% from 1 April 2023. This legislative change has been enacted, resulting in the Group’s UK deferred tax assets increasing by £223m with a tax benefit in the income statement of £392m and a tax charge within other comprehensive income of £169m. The UK Government also announced that it will undertake a review of the additional 8% banking surcharge during 2021. The Budget Report issued on 3 March 2021 outlines that “the government will set out how it intends to ensure that the combined rate of tax on banks’ profits does not increase substantially from its current level”. Any subsequent reduction in the banking surcharge arising from the Government’s review would result in a tax charge in the income statement and tax credit within the other comprehensive income upon enactment as the Group’s UK deferred tax assets are again re-measured and decreased, the timing of which is uncertain but is expected to occur in H122. In the USA, the Biden administration published in April 2021 The Made In America Tax Plan, which proposes an increase in the US federal corporate income tax rate. This would result in a re-measurement to increase the Group’s US deferred tax assets upon enactment, the timing of which is uncertain. In addition, revisions to international elements of the US tax regime are being considered that could affect the Group’s US tax position in future. The G7 finance ministers published a communiqué on 5 June 2021 which sets out high level political agreement on global tax reform, including the implementation of a global minimum tax rate. The Group will continue to monitor developments and assess the potential impact of associated future legislative changes. As at 30.06.21 As at 31.12.20 Deferred tax assets and liabilities £m £m USA 1,908 2,049 UK 1,380 886 Other territories 483 509 Deferred tax assets 3,771 3,444 Deferred tax liabilities (8) (15) Analysis of deferred tax assets Temporary differences 2,972 2,709 Tax losses 799 735 Deferred tax assets 3,771 3,444 |
Non-controlling interests
Non-controlling interests | 6 Months Ended |
Jun. 30, 2021 | |
Non-controlling interests [Abstract] | |
Non-controlling interests | Non-controlling interests Profit attributable to Equity attributable to Half year ended 30.06.21 Half year ended 30.06.20 As at 30.06.21 As at 31.12.20 £m £m £m £m Barclays Bank PLC issued: - Preference shares 13 28 529 529 - Upper T2 instruments 3 9 533 533 Other non-controlling interests 3 — 2 23 Total 19 37 1,064 1,085 |
Earnings per share
Earnings per share | 6 Months Ended |
Jun. 30, 2021 | |
Earnings per share [abstract] | |
Earnings per share | Earnings per share Half year ended 30.06.21 Half year ended 30.06.20 £m £m Profit attributable to ordinary equity holders of the parent 3,812 695 m m Basic weighted average number of shares in issue 17,140 17,294 Number of potential ordinary shares 467 319 Diluted weighted average number of shares 17,607 17,613 p p Basic earnings per ordinary share 22.2 4.0 Diluted earnings per ordinary share 21.7 3.9 |
Dividends on ordinary shares
Dividends on ordinary shares | 6 Months Ended |
Jun. 30, 2021 | |
Dividends on ordinary shares [Abstract] | |
Dividends on ordinary shares | Dividends on ordinary shares A half year dividend for 2021 of 2.0p (H120: 0p) per ordinary share will be paid on 17 September 2021 to shareholders on the register on 13 August 2021. Half year ended 30.06.21 Half year ended 30.06.20 Per share Total Per share Total Dividends paid during the period p £m p £m Full year dividend paid during period 1.0 173 — — For qualifying US and Canadian resident ADR holders, the half year dividend of 2.0p per ordinary share becomes 8.0p per ADS (representing 4 shares). The ADR depositary will post the half year dividend on 17 September 2021 to ADR holders on the record at close of business on 13 August 2021. The Directors have confirmed their intention to initiate a share buyback of up to £500m after the balance sheet date. The share buyback is expected to commence in the third quarter of 2021. The financial statements for the six months ended 30 June 2021 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are repurchased by the Company. |
Derivative financial instrument
Derivative financial instruments | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of nature and extent of risks arising from financial instruments [abstract] | |
Derivative financial instruments | Derivative financial instruments Contract notional amount Fair value Assets Liabilities As at 30.06.21 £m £m £m Foreign exchange derivatives 5,654,026 66,963 (64,194) Interest rate derivatives 37,888,009 134,734 (123,436) Credit derivatives 920,030 5,469 (5,960) Equity and stock index and commodity derivatives 1,541,007 48,530 (52,444) Derivative assets/(liabilities) held for trading 46,003,072 255,696 (246,034) Derivatives in hedge accounting relationships Derivatives designated as cash flow hedges 91,278 806 — Derivatives designated as fair value hedges 107,879 128 (993) Derivatives designated as hedges of net investments 1,595 6 (7) Derivative assets/(liabilities) designated in hedge accounting relationships 200,752 940 (1,000) Total recognised derivative assets/(liabilities) 46,203,824 256,636 (247,034) As at 31.12.20 Foreign exchange derivatives 5,554,037 84,739 (84,381) Interest rate derivatives 35,257,371 172,144 (162,402) Credit derivatives 847,845 4,605 (5,004) Equity and stock index and commodity derivatives 1,510,718 40,392 (48,008) Derivative assets/(liabilities) held for trading 43,169,971 301,880 (299,795) Derivatives in hedge accounting relationships Derivatives designated as cash flow hedges 74,437 386 — Derivatives designated as fair value hedges 114,556 155 (980) Derivatives designated as hedges of net investments 791 25 — Derivative assets/(liabilities) designated in hedge accounting relationships 189,784 566 (980) Total recognised derivative assets/(liabilities) 43,359,755 302,446 (300,775) The IFRS netting posted against derivative assets was £33bn including £4bn of cash collateral netted (December 2020: £44bn including £5bn cash collateral netted) and £31bn for liabilities including £5bn of cash collateral netted (December 2020: £42bn including £7bn of cash collateral netted). Derivative asset exposures would be £230bn (December 2020: £276bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for which the Group holds cash collateral of £36bn (December 2020: £43bn). Similarly, derivative liabilities would be £225bn (December 2020: £276bn) lower reflecting counterparty netting and cash collateral placed of £31bn (December 2020: £43bn). In addition, non-cash collateral of £5bn (December 2020: £5bn) was held in respect of derivative assets and £3bn (December 2020: £4bn) was placed in respect of derivative liabilities. Collateral amounts are limited to net on balance sheet exposure so as to not include over-collateralisation. |
Fair value of financial instrum
Fair value of financial instruments | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of fair value measurement of assets [abstract] | |
Fair value of financial instruments | Fair value of financial instruments This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual Report 2020 which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the accounting policies adopted or the valuation methodologies used. Valuation The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification: Valuation technique using Quoted market prices Observable inputs Significant unobservable inputs (Level 1) (Level 2) (Level 3) Total As at 30.06.21 £m £m £m £m Trading portfolio assets 73,405 71,282 2,552 147,239 Financial assets at fair value through the income statement 1,229 185,415 7,777 194,421 Derivative financial instruments 11,643 241,336 3,657 256,636 Financial assets at fair value through other comprehensive income 21,375 51,837 48 73,260 Investment property — — 8 8 Total assets 107,652 549,870 14,042 671,564 Trading portfolio liabilities (30,911) (26,058) (17) (56,986) Financial liabilities designated at fair value (142) (263,710) (312) (264,164) Derivative financial instruments (11,227) (230,207) (5,600) (247,034) Total liabilities (42,280) (519,975) (5,929) (568,184) As at 31.12.20 Trading portfolio assets 60,671 65,416 1,863 127,950 Financial assets at fair value through the income statement 4,503 162,142 8,506 175,151 Derivative financial instruments 9,155 288,822 4,469 302,446 Financial assets at fair value through other comprehensive income 19,792 58,743 153 78,688 Investment property — — 10 10 Total assets 94,121 575,123 15,001 684,245 Trading portfolio liabilities (24,391) (22,986) (28) (47,405) Financial liabilities designated at fair value (159) (249,251) (355) (249,765) Derivative financial instruments (8,762) (285,774) (6,239) (300,775) Total liabilities (33,312) (558,011) (6,622) (597,945) The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type: As at 30.06.21 As at 31.12.20 Assets Liabilities Assets Liabilities £m £m £m £m Interest rate derivatives 916 (1,269) 1,613 (1,615) Foreign exchange derivatives 151 (129) 144 (143) Credit derivatives 100 (364) 196 (351) Equity derivatives 2,490 (3,838) 2,498 (4,112) Commodity derivatives — — 18 (18) Corporate debt 981 (38) 698 (3) Reverse repurchase and repurchase agreements — (161) — (174) Non-asset backed loans 6,338 — 6,394 — Asset backed securities 562 — 767 (24) Equity cash products 402 — 542 — Private equity investments 979 (16) 873 (14) Other 1 1,123 (114) 1,258 (168) Total 14,042 (5,929) 15,001 (6,622) 1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. Assets and liabilities reclassified between Level 1 and Level 2 During the period, there were no material transfers between Level 1 and Level 2 (period ended 31 December 2020: no material transfers between Level 1 and Level 2). Level 3 movement analysis The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the period. Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant. Level 3 movement analysis Total gains and losses in the period recognised in the income statement Total gains or losses recognised in OCI Transfers As at 01.01.21 Purchases Sales Issues Settle-ments Trading income Other income In Out As at 30.06.21 £m £m £m £m £m £m £m £m £m £m £m Corporate debt 151 305 (87) — — 25 — — 40 (11) 423 Non-asset backed loans 709 620 (131) — (84) 13 — — 124 (106) 1,145 Asset backed securities 686 112 (294) — — (10) — — 43 (48) 489 Equity cash products 214 13 (17) — — 32 — — 29 (9) 262 Other 103 21 — — (51) (1) — — 162 (1) 233 Trading portfolio assets 1,863 1,071 (529) — (135) 59 — — 398 (175) 2,552 Non-asset backed loans 5,580 698 (299) — (687) (119) — — 69 (48) 5,194 Equity cash products 326 160 (194) — — (171) 18 — 1 — 140 Private equity investments 874 106 (9) — (8) (5) 92 — — (71) 979 Other 1,726 2,291 (2,389) — (162) (19) 1 — 16 — 1,464 Financial assets at fair value through the income statement 8,506 3,255 (2,891) — (857) (314) 111 — 86 (119) 7,777 Non-asset backed loans 106 — — — — — — — — (106) — Asset backed securities 47 4 — — (5) — — 2 — — 48 Assets at fair value through other comprehensive income 153 4 — — (5) — — 2 — (106) 48 Investment property 10 — (2) — — — — — — — 8 — — Trading portfolio liabilities (28) (3) 14 — — (7) — — — 7 (17) Financial liabilities designated at fair value (355) — — — 98 7 (2) — (78) 18 (312) Interest rate derivatives (2) 9 — — 33 (121) 4 — 21 (297) (353) Foreign exchange derivatives 1 — — — 58 (6) — — 3 (34) 22 Credit derivatives (155) (117) 2 — (5) 12 (1) — 1 (1) (264) Equity derivatives (1,614) (315) (1) — (32) (221) (1) — 28 808 (1,348) Net derivative financial instruments 1 (1,770) (423) 1 — 54 (336) 2 — 53 476 (1,943) Total 8,379 3,904 (3,407) — (845) (591) 111 2 459 101 8,113 1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,657m and derivative financial liabilities were £5,600m. Level 3 movement analysis As at 01.01.20 Purchases Sales Issues Settle- Total gains and losses in the period recognised in the income statement Total gains or losses recognised in OCI Transfers As at 30.06.20 Trading income Other income In Out £m £m £m £m £m £m £m £m £m £m £m Corporate debt 120 25 — — — (26) — — 4 (17) 106 Non-asset backed loans 974 1,926 (740) — (4) (111) — — 97 (320) 1,822 Asset backed securities 656 249 (224) — (76) (12) — — 41 (11) 623 Equity cash products 392 2 (4) — — (67) — — 28 (4) 347 Other 122 48 — — — 2 — — 8 — 180 Trading portfolio assets 2,264 2,250 (968) — (80) (214) — — 178 (352) 3,078 Non-asset backed loans 5,494 1,050 (270) — (410) 381 — — — (58) 6,187 Equity cash products 835 14 — — — (22) (28) — — — 799 Private equity investments 900 19 (6) — (2) 2 (44) — 23 (12) 880 Other 1,271 1,870 (2,017) — (18) (8) 64 — 24 — 1,186 Financial assets at fair value through the income statement 8,500 2,953 (2,293) — (430) 353 (8) — 47 (70) 9,052 Non-asset backed loans 343 79 — — (157) — — (3) — — 262 Asset backed securities 86 — (1) — — 1 — (1) — — 85 Assets at fair value through other comprehensive income 429 79 (1) — (157) 1 — (4) — — 347 Investment property 13 — (1) — — — (2) — 2 (2) 10 Trading portfolio liabilities — — — — — — — — — — — Financial liabilities designated at fair value (362) — 1 (3) — (10) 2 — (22) 25 (369) Interest rate derivatives (206) 18 — — 10 268 1 — 300 (10) 381 Foreign exchange derivatives (7) — — — (12) 89 — — 5 (8) 67 Credit derivatives 198 (258) 11 — (376) 151 1 — 2 8 (263) Equity derivatives (819) (448) (1) — 17 (90) — — (5) (23) (1,369) Net derivative financial instruments 1 (834) (688) 10 — (361) 418 2 — 302 (33) (1,184) Total 10,010 4,594 (3,252) (3) (1,028) 548 (6) (4) 507 (432) 10,934 1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £7,748m and derivative financial liabilities were £8,932m. Unrealised gains and losses on Level 3 financial assets and liabilities The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and liabilities held at the period end. Half year ended 30.06.21 Half year ended 30.06.20 Income statement Other compre hensive income Total Income statement Other compre hensive income Total Trading income Other income Trading income Other income £m £m £m £m £m £m £m £m Trading portfolio assets 35 — — 35 (177) — — (177) Financial assets at fair value through the income statement (201) 114 — (87) 397 (53) — 344 Financial assets at fair value through other comprehensive income — — — — — — (2) (2) Investment properties — — — — — (2) — (2) Trading portfolio liabilities (6) — — (6) — — — — Financial liabilities designated at fair value 7 — — 7 (16) (1) — (17) Net derivative financial instruments (367) — — (367) 248 — — 248 Non-current assets/liabilities held for sale — — — — — — — — Total (532) 114 — (418) 452 (56) (2) 394 Valuation techniques and sensitivity analysis Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative models. Current year valuation and sensitivity methodologies are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2020. Sensitivity analysis of valuations using unobservable inputs As at 30.06.21 As at 31.12.20 Favourable changes Unfavourable changes Favourable changes Unfavourable changes Income statement Equity Income statement Equity Income statement Equity Income statement Equity £m £m £m £m £m £m £m £m Interest rate derivatives 52 — (83) — 82 — (123) — Foreign exchange derivatives 6 — (10) — 6 — (11) — Credit derivatives 53 — (44) — 55 — (44) — Equity derivatives 185 — (193) — 174 — (179) — Commodity derivatives 2 — (2) — 2 — (2) — Corporate debt 22 — (16) — 16 — (14) — Non-asset backed loans 202 — (310) — 190 3 (409) (3) Equity cash products 130 — (119) — 158 — (141) — Private equity investments 223 — (198) — 199 — (227) — Other 1 18 — (18) — 21 — (21) — Total 893 — (993) — 903 3 (1,171) (3) 1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact of using alternative models, would be to increase fair values by up to £893m (December 2020: £906m) or to decrease fair values by up to £993m (December 2020: £1,174m) with substantially all the potential effect impacting profit and loss rather than reserves. Significant unobservable inputs The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level 3 are consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2020. Fair value adjustments Key balance sheet valuation adjustments are quantified below: As at 30.06.21 As at 31.12.20 £m £m Exit price adjustments derived from market bid-offer spreads (500) (493) Uncollateralised derivative funding (80) (115) Derivative credit valuation adjustments (210) (268) Derivative debit valuation adjustments 91 113 • Exit price adjustments derived from market bid-offer spreads increased by £7m to £500m • Uncollateralised derivative funding decreased by £35m to £80m as a result of tightening input funding spreads • Derivative credit valuation adjustments decreased by £58m to £210m as a result of tightening input counterparty credit spreads • Derivative debit valuation adjustments decreased by £22m to £91m as a result of tightening input Barclays Bank PLC credit spreads Portfolio exemption The Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of financial assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at the measurement date. Unrecognised gains as a result of the use of valuation models using unobservable inputs The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, is £126m (December 2020: £116m) for financial instruments measured at fair value and £240m (December 2020: £247m) for financial instruments carried at amortised cost. There are additions of £32m (December 2020: £27m) and amortisation and releases of £22m (December 2020: £24m) for financial instruments measured at fair value and additions of £nil (December 2020: £6m) and amortisation and releases of £7m (December 2020: £14m) for financial instruments carried at amortised cost. Third party credit enhancements Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the Federal Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and other banks pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9 fair value option includes this third party credit enhancement. The on balance sheet value of these brokered certificates of deposit amounted to £1,241m (December 2020: £1,494m). Comparison of carrying amounts and fair values for assets and liabilities not held at fair value Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2020. The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s balance sheet. As at 30.06.21 As at 31.12.20 Carrying amount Fair value Carrying amount Fair value Financial assets £m £m £m £m Loans and advances at amortised cost 348,549 347,733 342,632 340,516 Reverse repurchase agreements and other similar secured lending 4,459 4,459 9,031 9,031 Financial liabilities Deposits at amortised cost (500,895) (500,933) (481,036) (481,106) Repurchase agreements and other similar secured borrowing (20,005) (20,005) (14,174) (14,174) Debt securities in issue (90,733) (92,746) (75,796) (77,813) Subordinated liabilities (12,839) (13,434) (16,341) (16,918) |
Loans and advances and deposits
Loans and advances and deposits at amortised cost | 6 Months Ended |
Jun. 30, 2021 | |
Loans and advances and deposits at amortised cost [Abstract] | |
Loans and advances and deposits at amortised cost | Loans and advances and deposits at amortised cost As at 30.06.21 As at 31.12.20 £m £m Loans and advances at amortised cost to banks 11,032 8,900 Loans and advances at amortised cost to customers 309,194 309,927 Debt securities at amortised cost 28,323 23,805 Total loans and advances at amortised cost 348,549 342,632 Deposits at amortised cost from banks 17,165 17,343 Deposits at amortised cost from customers 483,730 463,693 Total deposits at amortised cost 500,895 481,036 |
Goodwill and intangible assets
Goodwill and intangible assets | 6 Months Ended |
Jun. 30, 2021 | |
Intangible assets and goodwill [abstract] | |
Goodwill and intangible assets | Goodwill and intangible assets Goodwill and intangible assets are allocated to business operations according to business segments as follows: As at 30.06.21 As at 31.12.20 Goodwill Intangibles Total Goodwill Intangibles Total £m £m £m £m £m £m Barclays UK 3,560 1,570 5,130 3,560 1,618 5,178 Barclays International 286 2,735 3,021 289 2,435 2,724 Head Office 42 3 45 42 4 46 Total 3,888 4,308 8,196 3,891 4,057 7,948 |
Subordinated liabilities
Subordinated liabilities | 6 Months Ended |
Jun. 30, 2021 | |
Subordinated liabilities [abstract] | |
Subordinated liabilities | Subordinated liabilities Half year ended 30.06.21 Year ended 31.12.20 £m £m Opening balance as at 1 January 16,341 18,156 Issuances 1,734 1,438 Redemptions (4,534) (3,464) Other (702) 211 Closing balance 12,839 16,341 Issuances of £1,734m comprise £855m EUR 1.125% Fixed Rate Resetting Subordinated Callable Notes and £724m USD 3.811% Fixed Rate Resetting Subordinated Callable Notes, both issued externally by Barclays PLC and £82m ZAR Floating Rate Notes and £73m USD Floating Rate Notes issued externally by Barclays subsidiaries. Redemptions of £4,534m comprise £1,961m GBP 10% Fixed Rate Subordinated Notes, £1,339m EUR 6% Fixed Rate Subordinated Notes, £1,075m USD 10.179% Fixed Rate Subordinated Notes and £86m EUR Subordinated Floating Rate Notes, issued externally by Barclays Bank PLC and £73m USD Floating Rate Notes issued externally by a Barclays subsidiary. Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments. |
Provisions
Provisions | 6 Months Ended |
Jun. 30, 2021 | |
Provisions [abstract] | |
Provisions | Provisions As at 30.06.21 As at 31.12.20 £m £m Customer redress 449 497 Legal, competition and regulatory matters 223 268 Redundancy and restructuring 88 158 Undrawn contractually committed facilities and guarantees 713 1,064 Onerous contracts 14 28 Sundry provisions 285 289 Total 1,772 2,304 |
Retirement benefits
Retirement benefits | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of defined benefit plans [abstract] | |
Disclosure of retirement benefits | Retirement benefits As at 30 June 2021, the Group’s IAS 19 pension surplus across all schemes was £2.4bn (December 2020: £1.5bn). The UK Retirement Fund (UKRF), which is the Group’s main scheme, had an IAS 19 pension surplus of £2.6bn (December 2020: £1.8bn). The movement for the UKRF was driven by payment of deficit reduction contributions, and an increase in the discount rate, partially offset by higher than expected long-term price inflation. UKRF funding valuations |
Called up share capital
Called up share capital | 6 Months Ended |
Jun. 30, 2021 | |
Equity [abstract] | |
Called up share capital | Called up share capital Ordinary share capital Share premium Total share capital and share premium Half year ended 30.06.21 £m £m £m Opening balance as at 1 January 4,340 297 4,637 Issue of shares under employee share schemes 3 22 25 Repurchase of shares (94) — (94) Closing balance 4,249 319 4,568 |
Other equity instruments
Other equity instruments | 6 Months Ended |
Jun. 30, 2021 | |
Miscellaneous components of equity [abstract] | |
Other equity instruments | Other equity instruments Half year ended 30.06.21 Year ended 31.12.20 £m £m Opening balance as at 1 January 11,172 10,871 Issuances — 1,142 Redemptions — (831) Securities held by the Group (5) (10) Closing balance 11,167 11,172 Other equity instruments of £11,167m (December 2020: £11,172m) include AT1 securities issued by Barclays PLC. There have been no issuances or redemptions in the period. The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option of Barclays PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1 securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA. All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the fully loaded CET1 ratio of the Group fall below 7%. |
Other reserves
Other reserves | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of reserves within equity [abstract] | |
Other reserves | Other reserves As at 30.06.21 As at 31.12.20 £m £m Currency translation reserve 2,376 2,871 Fair value through other comprehensive income reserve (245) 5 Cash flow hedging reserve 664 1,575 Own credit reserve (1,001) (954) Other reserves and treasury shares 1,062 964 Total 2,856 4,461 Currency translation reserve The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net investment in foreign operations, net of the effects of hedging. As at 30 June 2021, there was a credit balance of £2,376m (December 2020: £2,871m credit) in the currency translation reserve. The £495m debit movement principally reflects the strengthening of GBP against USD and EUR during the period. Fair value through other comprehensive income reserve The fair value through other comprehensive income reserve represents the unrealised change in the fair value through other comprehensive income investments since initial recognition. As at 30 June 2021, there was a debit balance of £245m (December 2020: £5m credit) in the fair value through other comprehensive income reserve. The loss of £250m is principally driven by a loss of £325m from the decrease in fair value of bonds due to increasing bond yields and £199m of net gains transferred to the income statement. This is partially offset by a gain of £114m due to an increase in the Absa Group Limited share price and a tax credit of £168m. £8m release in impairment was also noted during the period. Cash flow hedging reserve The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss. As at 30 June 2021, there was a credit balance of £664m (December 2020: £1,575m credit) in the cash flow hedging reserve. The decrease of £911m principally reflects a £902m decrease in the fair value of interest rate swaps held for hedging purposes as major interest rate forward curves increased and £287m of gains transferred to the income statement. This is partially offset by a tax credit of £282m. Own credit reserve The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve are not recycled to profit or loss in future periods. As at 30 June 2021, there was a debit balance of £1,001m (December 2020: £954m debit) in the own credit reserve. The movement of £47m principally reflects a £266m loss from the tightening of Barclays’ funding spreads. This is partially offset by other activity of £100m and a tax credit of £115m. Other reserves and treasury shares Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays PLC shares held principally in relation to the Group’s various share schemes. As at 30 June 2021, there was a credit balance of £1,062m (December 2020: £964m credit) in other reserves and treasury shares. This is driven by an increase of £94m due to the repurchase of 377m shares as part of the £0.7bn share buyback and a £4m increase due to a reduction in treasury shares held in relation to employee share schemes. |
Contingent liabilities and comm
Contingent liabilities and commitments | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of contingent liabilities [abstract] | |
Contingent liabilities and commitments | Contingent liabilities and commitments As at 30.06.21 As at 31.12.20 Contingent liabilities £m £m Guarantees and letters of credit pledged as collateral security 13,519 15,665 Performance guarantees, acceptances and endorsements 5,679 5,944 Total 19,198 21,609 Commitments Documentary credits and other short-term trade related transactions 1,017 1,086 Standby facilities, credit lines and other commitments 345,281 331,963 Total 346,298 333,049 In addition to the above, Note 21, Legal, competition and regulatory matters details out further contingent liabilities where it is not practicable to disclose an estimate of the potential financial effect on Barclays. |
Legal, competition and regulato
Legal, competition and regulatory matters | 6 Months Ended |
Jun. 30, 2021 | |
Legal, competition and regulatory matters [Abstract] | |
Legal, competition and regulatory matters | Legal, competition and regulatory mattersThe Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision, or both, depending on the relevant facts and circumstances. The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in accordance with the relevant accounting policies applicable to Note 15, Provisions. We have not disclosed an estimate of the potential financial impact or effect on the Group of contingent liabilities where it is not currently practicable to do so. Various matters detailed in this note seek damages of an unspecified amount. While certain matters specify the damages claimed, such claimed amounts do not necessarily reflect the Group’s potential financial exposure in respect of those matters. Matters are ordered under headings corresponding to the financial statements in which they are disclosed. 1. Barclays PLC and Barclays Bank PLC Investigations into certain advisory services agreements and related civil action FCA proceedings In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements). The Financial Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to Barclays PLC’s capital raisings in June and November 2008 (the Capital Raisings) and therefore should have been disclosed in the announcements or public documents relating to the Capital Raisings. In 2013, the FCA issued warning notices (the Notices) finding that Barclays PLC and Barclays Bank PLC acted recklessly and in breach of certain disclosure-related listing rules, and that Barclays PLC was also in breach of Listing Principle 3. The financial penalty provided in the Notices is £50m. Barclays PLC and Barclays Bank PLC continue to contest the findings. Following the conclusion of the Serious Fraud Office (SFO) proceedings against certain former Barclays executives resulting in their acquittals, the FCA proceedings, which were stayed, have resumed. Civil action In 2021, the High Court of Justice (High Court) dismissed a claim brought by PCP Capital Partners LLP and PCP International Finance Limited (PCP) against Barclays Bank PLC for fraudulent misrepresentation and deceit, arising from certain statements made by Barclays Bank PLC to PCP relating to the November 2008 capital raising. PCP’s application to appeal the High Court’s decision has also been refused which concludes these proceedings. Investigations into LIBOR and other benchmarks and related civil actions Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial benchmarks, such as LIBOR. The SFO closed its investigation with no action to be taken against the Group. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to the alleged manipulation of LIBOR and/or other benchmarks. USD LIBOR civil actions The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially similar and allege, among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial institutions individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities Exchange Act of 1934 and various state laws by manipulating USD LIBOR rates. Putative class actions and individual actions seek unspecified damages with the exception of three lawsuits, in which the plaintiffs are seeking a combined total of approximately $100m in actual damages and additional punitive damages against all defendants, including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. Barclays Bank PLC has previously settled certain claims. Two class action settlements where Barclays Bank PLC has respectively paid $7.1m and $20m, have received final court approval. Barclays Bank PLC also settled a further matter for $7.5m, paid in June 2021. Sterling LIBOR civil actions In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel banks alleging, among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust Act, CEA and RICO, were consolidated. The defendants’ motion to dismiss the claims was granted in 2018. The plaintiffs have appealed the dismissal. Japanese Yen LIBOR civil actions In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks by a lead plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s Euroyen Tokyo Interbank Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation of the Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed the plaintiff’s antitrust claims, and, in 2020, the court dismissed the plaintiff’s remaining CEA claims. The plaintiff has appealed the lower court’s dismissal of such claims. In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs filed an amended complaint in 2020, and the defendants have filed a motion to dismiss. SIBOR/SOR civil action In 2016, a putative class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants, alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR). In 2018, the court dismissed all claims against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs’ appeal of the dismissal of their claims was granted in March 2021 and the matter has been remanded to the lower court for further proceedings. ICE LIBOR civil actions In 2019, several putative class actions were filed in the SDNY against a panel of banks, including Barclays PLC, Barclays Bank PLC, BCI, other financial institution defendants and Intercontinental Exchange Inc. and certain of its affiliates (ICE), asserting antitrust claims that defendants manipulated USD LIBOR through defendants’ submissions to ICE. These actions have been consolidated. The defendants’ motion to dismiss was granted in 2020. The plaintiffs have appealed the dismissal. In August 2020, an ICE LIBOR-related action was filed by a group of individual plaintiffs in the US District Court for the Northern District of California on behalf of individual borrowers and consumers of loans and credit cards with variable interest rates linked to USD ICE LIBOR. Plaintiffs have filed motions seeking, among other things, preliminary and permanent injunctions to enjoin the defendants from continuing to set LIBOR or enforce any financial instrument that relies in whole or in part on USD LIBOR. Non-US benchmarks civil actions Legal proceedings (which include the claims referred to below in ‘Local authority civil actions concerning LIBOR’) have been brought or threatened against Barclays Bank PLC (and, in certain cases, Barclays Bank UK PLC) in the UK in connection with alleged manipulation of LIBOR, EURIBOR and other benchmarks. Proceedings have also been brought in a number of other jurisdictions in Europe and Israel. Additional proceedings in other jurisdictions may be brought in the future. Credit Default Swap civil action In July 2021, the New Mexico Attorney General, on behalf of the New Mexico State Investment Council, filed an antitrust class action in the US District Court for the District of New Mexico against Barclays PLC, Barclays Bank PLC, BCI and other financial institutions. The plaintiff alleges that the defendants conspired to manipulate the benchmark price used to value Credit Default Swap (CDS) contracts at settlement (i.e. the CDS final auction price). The plaintiff alleges violations of the Antitrust Act and the CEA, and unjust enrichment under state law. Foreign Exchange investigations and related civil actions In 2015, the Group reached settlements totalling approximately $2.38bn with various US federal and state authorities and the FCA in relation to investigations into certain sales and trading practices in the Foreign Exchange market. The Group continues to provide relevant information to certain authorities. The European Commission is one of a number of authorities still conducting an investigation into certain trading practices in Foreign Exchange markets. The European Commission announced two settlements in May 2019 and the Group paid penalties totalling approximately €210m. In June 2019, the Swiss Competition Commission announced two settlements and the Group paid penalties totalling approximately CHF 27m. The financial impact of the ongoing matters is not expected to be material to the Group’s operating results, cash flows or financial position. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to alleged manipulation of Foreign Exchange markets. FX opt out civil action In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign Exchange markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs who opted out of the Consolidated FX Action filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants. Some of the plaintiff’s claims were dismissed in 2020. Retail basis civil action In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf of a proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The SDNY has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court subsequently dismissed all Retail Basis Claims against the Group and all other defendants. The plaintiffs have filed an amended complaint. Non-US FX civil actions Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays Execution Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK, a number of other jurisdictions in Europe, Israel and Australia and additional proceedings may be brought in the future. These include two purported class actions filed against Barclays PLC, Barclays Bank PLC, BX, BCI and other financial institutions in the UK Competition Appeal Tribunal in 2019 following the settlements with the European Commission described above. Also in 2019, a separate claim was filed in the UK in the High Court by various banks and asset management firms against Barclays Bank PLC and other financial institutions alleging breaches of European and UK competition laws related to FX trading. Metals investigations and related civil actions Barclays Bank PLC previously provided information to the US Department of Justice (DoJ), the US Commodity Futures Trading Commission and other authorities in connection with investigations into metals and metals-based financial instruments. A number of US civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd. manipulated the prices of gold and gold derivative contracts in violation of the Antitrust Act and other federal laws. This consolidated putative class action remains pending. A separate US civil complaint by a proposed class of plaintiffs against a number of banks, including Barclays Bank PLC, BCI and BX, alleging manipulation of the price of silver in violation of the CEA, the Antitrust Act and state antitrust and consumer protection laws, has been dismissed as against the Barclays entities. The plaintiffs have the option to seek the court’s permission to appeal. Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc. and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices. US residential mortgage related civil actions There are various pending civil actions relating to US Residential Mortgage-Backed Securities (RMBS), including four actions arising from unresolved repurchase requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level representations and warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in 2007. The unresolved repurchase requests had an original principal balance of approximately $2.1bn. The Trustees have also alleged that the relevant R&Ws may have been breached with respect to a greater (but unspecified) amount of loans than previously stated in the unresolved repurchase requests. These repurchase actions are ongoing. In one repurchase action, the New York Court of Appeals held that claims related to certain R&Ws are time-barred. Barclays Bank PLC has reached a settlement to resolve two of the repurchase actions, which is subject to final court approval. The financial impact of the settlement is not expected to be material to the Group’s operating results, cash flows or financial position. The remaining two repurchase actions are pending. In 2020, a civil litigation claim was filed in the New Mexico First Judicial District Court by the State of New Mexico against six banks, including BCI, on behalf of two New Mexico state pension funds and the New Mexico State Investment Council relating to legacy RMBS purchases. As to BCI, the complaint alleges that the funds purchased approximately $22m in RMBS underwritten by BCI. The plaintiffs have asserted claims under New Mexico state law, which provides for the ability to claim treble damages and civil penalties. Government and agency securities civil actions and related matters Certain governmental authorities have conducted investigations into activities relating to the trading of certain government and agency securities in various markets. The Group provided information in cooperation with such investigations. Civil actions have also been filed on the basis of similar allegations, as described below. Treasury auction securities civil actions Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial institutions under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to boycott such trading platforms. The court dismissed the consolidated action in March 2021. The plaintiffs have filed an amended complaint, which the defendants have moved to dismiss. In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging that defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA and state common law. Supranational, Sovereign and Agency bonds civil actions Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC, BCI, BX, Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital Canada, Inc. and other financial institutions alleging that the defendants conspired to fix prices and restrain competition in the market for US dollar-denominated Supranational, Sovereign and Agency bonds. In one of the actions filed in the SDNY, the court granted the defendants’ motions to dismiss the plaintiffs’ complaint. The dismissal was affirmed on appeal. The plaintiffs have voluntarily dismissed the other SDNY action. In the Federal Court of Canada action, the plaintiffs reached settlements with a small number of banks in 2020 (not including Barclays Capital Canada, Inc.), but the plaintiffs have not commenced the class certification process and the action remains at an early stage. Variable Rate Demand Obligations civil actions Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have been filed by private plaintiffs on behalf of the states of Illinois and California. Three putative class action complaints, two of which have been consolidated, have been filed in the SDNY (the third complaint was filed in June 2021). In the consolidated SDNY class action, certain of the plaintiff’s claims were dismissed in November 2020. In the California action, the plaintiffs’ claims were dismissed in June 2021. The plaintiffs may appeal. Government bond civil actions In a putative class action filed in the SDNY in 2019, plaintiffs alleged that BCI and certain other bond dealers conspired to fix the prices of US Government sponsored entity bonds in violation of US antitrust law. BCI agreed to a settlement of $87m, which received final court approval in 2020. Separately, various entities in Louisiana, including the Louisiana Attorney General and the City of Baton Rouge, have commenced litigation against Barclays Bank PLC and other financial institutions making similar allegations as the SDNY class action plaintiffs. The parties have reached a settlement to resolve these matters. The financial impact of the settlement is not expected to be material to the Group’s operating results, cash flows or financial position. In 2018, a separate putative class action against various financial institutions including Barclays PLC, Barclays Bank PLC, BCI, Barclays Bank Mexico, S.A., and certain other subsidiaries of the Group was consolidated in the SDNY. The plaintiffs asserted antitrust and state law claims arising out of an alleged conspiracy to fix the prices of Mexican Government bonds. Barclays PLC has settled the claim for $5.7m, which is subject to final court approval. Odd-lot corporate bonds antitrust class action In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The complaint alleges a conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. Plaintiffs demand unspecified money damages. The defendants have filed a motion to dismiss. Interest rate swap and credit default swap US civil actions Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate swaps (IRS) are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The complaints allege the defendants conspired to prevent the development of exchanges for IRS and demand unspecified money damages. In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including Barclays PLC, Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an IRS platform. In 2017, Tera Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct alleged in the IRS cases also caused the plaintiff to suffer harm with respect to the Credit Default Swaps market. In 2018 and 2019, respectively, the court dismissed certain claims in both cases for unjust enrichment and tortious interference but denied motions to dismiss the federal and state antitrust claims, which remain pending. BDC Finance L.L.C. In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York (NY Supreme Court), demanding damages of $298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of total return swaps governed by an ISDA Master Agreement (the Agreement). Following a trial, the court ruled in 2018 that Barclays Bank PLC was not a defaulting party, which was affirmed on appeal. In April 2021, the trial court entered judgement in favour of Barclays Bank PLC for $3.3m and as yet to be determined legal fees and costs, BDC has appealed. In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings, L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays Bank PLC’s conduct relating to the Agreement, asserting claims for violation of the Connecticut Unfair Trade Practices Act and tortious interference with business and prospective business relations. This case is currently stayed. Civil actions in respect of the US Anti-Terrorism Act There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District Court in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-denominated transactions for the Iranian Government and various Iranian banks, which in turn funded acts of terrorism that injured or killed plaintiffs or plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and mental anguish under the provisions of the US Anti-Terrorism Act, which allow for the trebling of any proven damages. The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. Plaintiffs have appealed in one action. The remaining actions are stayed pending decisions on the appeal. Out of the two actions in the SDNY, the court also granted the defendants’ motion to dismiss one action. The remaining action is stayed pending any appeal in the former case. Shareholder derivative action In November 2020, a purported Barclays shareholder filed a putative derivative action in New York state court against BCI and a number of current and former members of the Board of Directors of Barclays PLC and senior executives or employees of the Group. The shareholder filed the claim on behalf of nominal defendant Barclays PLC, alleging that the individual defendants harmed the company through breaches of their duties, including under the Companies Act 2006. The plaintiff seeks damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of these alleged breaches. An amended complaint was filed in April 2021, which BCI and certain other defendants have moved to dismiss. Derivative transactions civil action In July 2021, Vestia (a Dutch housing association) issued a claim against Barclays Bank PLC in the UK in the High Court in relation to a series of derivative transactions entered into with Barclays Bank PLC between 2008 and 2012. The claim has not been served on Barclays. Skilled person review and associated matters In August 2020, the FCA granted an application by Clydesdale Financial Services Limited (CFS), which trades as Barclays Partner Finance and houses Barclays’ point-of-sale finance business, for a validation order with respect to certain loans to customers brokered by Azure Services Limited (ASL), a timeshare operator, which did not, at the point of sale, hold the necessary broker licence. As a condition to the validation order, the FCA required CFS to undertake a skilled person review of the assessment of affordability processes for the loans brokered by ASL (ASL Loans) as well as CFS’ policies and procedures for assessing affordability and oversight of brokers more generally, and dictated a remediation methodology in the event that ASL Loans did not pass the affordability test. CFS has voluntarily agreed to remediate the ASL Loans, which is expected to amount to £37m, in accordance with the FCA’s methodology. The remaining scope of the skilled person review is ongoing and the skilled person is expected to report in the fourth quarter of 2021. It is not currently possible to predict the outcome of the skilled person review and/or whether remediation activity will be undertaken or required in relation to other parts of CFS’ loan portfolio and the scope of, and methodology for, any such remediation. 2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC Investigation into UK cards’ affordability The FCA is investigating certain aspects of the affordability assessment processes used by Barclays Bank UK PLC and Barclays Bank PLC for credit card applications made to Barclays’ UK credit card business. Barclays is providing information in cooperation with the investigation. HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have retrospective effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect to attribute an amount of approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s decision has been appealed to the First Tier Tribunal (Tax Chamber). Local authority civil actions concerning LIBOR Following settlement by Barclays Bank PLC of various governmental investigations concerning certain benchmark interest rate submissions referred to above in ‘Investigations into LIBOR and other benchmarks and related civil actions’, in the UK, certain local authorities have brought claims against Barclays Bank PLC and Barclays Bank UK PLC asserting that they entered into loans in reliance on misrepresentations made by Barclays Bank PLC in respect of its conduct in relation to LIBOR. Barclays Bank PLC and Barclays Bank UK PLC were successful in their applications to strike out the claims. One local authority has obtained permission to pursue an appeal against this decision, while the claims brought by the other local authorities have been settled on terms such that the parties have agreed not to pursue these claims and to bear their own costs. 3. Barclays PLC Alternative trading systems Barclays PLC has been named as a defendant in a claim brought in the UK in the High Court by various shareholders regarding Barclays PLC’s share price based on the allegations contained within a complaint by the New York State Attorney General (NYAG) in 2014. The NYAG complaint was filed against Barclays PLC and BCI in the NY Supreme Court alleging, among other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX, BCI’s SEC-registered alternative trading system. Such claim was settled in 2016, as previously disclosed. This new shareholder claim is seeking unquantified damages. General The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other overseas jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary course of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection, consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual property, money laundering, financial crime, employment, environmental and other statutory and common law issues. The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities in which the Group is or has been engaged. The Group is cooperating with the relevant authorities and keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis. At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material adverse effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters (including formerly active matters or those matters arising after the date of this note) will not be material to Barclays PLC’s |
Related party transactions
Related party transactions | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of transactions between related parties [abstract] | |
Related party transactions | Related party transactionsRelated party transactions in the half year ended 30 June 2021 were similar in nature to those disclosed in the Barclays PLC Annual Report 2020. No related party transactions that have taken place in the half year ended 30 June 2021 have materially affected the financial position or the performance of the Group during this period. |
Interest rate benchmark reform
Interest rate benchmark reform | 6 Months Ended |
Jun. 30, 2021 | |
Interest rate benchmark reform [Abstract] | |
Interest rate benchmark reform | Interest rate benchmark reform Following the financial crisis, the reform and replacement of benchmark interest rates such as LIBOR has become a priority for global regulators. The FCA and other global regulators have instructed market participants to prepare for the cessation of LIBOR after the end of 2021, and to adopt RFRs. While it is expected that most reforms affecting the Group will be completed by the end of 2021, consultations and regulatory changes are in progress and as certain US Dollar tenors will continue to be published up to mid-2023, significant remediation efforts will continue beyond the end of 2021. How the Group is managing the transition to alternative benchmark rates Barclays has established a Group-wide LIBOR Transition Programme, further detail on the transition programme is available in the Barclays PLC Annual Report 2020 (page 367). In March 2021, the FCA announced the dates that panel bank submissions for all LIBOR settings will cease, after which representative LIBOR rates will no longer be available, these are: immediately after 31 December 2021, in the case of all sterling, euro, Swiss franc and Japanese yen settings, and the 1-week and 2-month US dollar settings; and immediately after 30 June 2023, in the case of the remaining US dollar settings. Throughout 2021, the FCA will consult with market participants to require continued publication on a ‘synthetic’ basis for some sterling LIBOR settings and, for 1 additional year, some Japanese yen LIBOR settings. Approaches to transition exposure expiring post the expected end dates for LIBOR vary by product and nature of counterparty. The transition we are undertaking is at the request of the regulators, in line with their expectations and according to the regulatory endorsed timetable. The rates to which clients and customers are being transitioned are endorsed by the regulators. We are making disclosures as part of the transition to clarify the rate to be applied and the potential risks inherent in the transition. Barclays is actively engaging with counterparties to transition or include appropriate fallback provisions and transition mechanisms in its floating rate assets and liabilities with maturities after 2021, when most IBORs are expected to cease to be published, or will be published on a non-representative basis for a limited time. Barclays is working with central clearing counterparties where the transition of cleared derivative contracts will follow a market-wide, standardised approach to reform. Barclays is working to the UK Risk Free Rate Working Group (RFRWG) target of completion of active conversion of, and/or addition of robust fallbacks to legacy GBP LIBOR contracts, where viable by the end of Q321. Additionally, plans are in place to address non-GBP and other official sector industry milestones and targets. Progress made during H121 Building on the progress made in 2020, the Group has delivered further alternative RFR product capabilities and alternatives to LIBOR across loans, bonds and derivatives. Client outreach is progressing to plan and we have continued to engage actively with customers and counterparties to transition or include the appropriate fallback provisions. The Group has in place detailed plans, processes and procedures to support the transition of the remainder during 2021. Barclays has adhered to the ISDA IBOR Fallbacks Protocol for its major derivative dealing entities and we continue to track progress and engage with clients on their own adherence. Following the progress made during 2020, the Group continues to deliver technology and business process changes in preparation for LIBOR cessation and transitions to RFRs that will be necessary during 2021 and beyond in line with official sector expectations and milestones. The Group met the Q121 UK RFRWG milestone to cease initiation of GBP LIBOR linked loans, securitisations or linear derivatives and the Q221 milestones to cease initiation of new non-linear derivatives, exchange traded futures and Bank Of Japan milestone to cease issuance of JPY LIBOR linked loans and bonds. The Group has put in place controls so that any exceptions or exemptions are approved, and is taking a similar approach to forthcoming cessation milestones. |
Barclays PLC parent company bal
Barclays PLC parent company balance sheet | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of subsidiaries [abstract] | |
Barclays PLC parent company balance sheet | Barclays PLC parent company balance sheet As at 30.06.21 As at 31.12.20 Assets £m £m Investment in subsidiaries 58,828 58,886 Loans and advances to subsidiaries 23,295 24,710 Financial assets at fair value through the income statement 21,046 17,521 Derivative financial instruments 2 7 Other assets 19 65 Total assets 103,190 101,189 Liabilities Deposits at amortised cost 476 482 Cash collateral and settlement balances — — Debt securities in issue 26,663 28,428 Subordinated liabilities 9,170 7,724 Financial liabilities designated at fair value 12,130 9,507 Other liabilities 135 176 Total liabilities 48,574 46,317 Equity Called up share capital 4,249 4,340 Share premium account 319 297 Other equity instruments 11,169 11,169 Other reserves 488 394 Retained earnings 38,391 38,672 Total equity 54,616 54,872 Total liabilities and equity 103,190 101,189 Investment in subsidiaries The investment in subsidiaries of £58,828m (December 2020: £58,886m) predominantly relates to investments in Barclays Bank PLC and Barclays Bank UK PLC, as well as holdings of their AT1 securities of £10,995m (December 2020: £10,995m). Barclays PLC considers the carrying value of its investment in subsidiaries to be fully recoverable. Financial assets and liabilities designated at fair value Financial liabilities designated at fair value of £12,130m (December 2020: £9,507m) comprises material issuances during the period of €750m Floating Notes, $1,000m Fixed Rate Resetting Senior Callable Notes, 600m AUD Fixed-to-Floating and Floating Rate Debt Instruments, and 77,000m JPY Fixed Rate Resetting Senior Callable Notes. The proceeds raised through these transactions were used to invest in subsidiaries of Barclays PLC which are included within the financial assets designated at fair value through the income statement balance of £21,046m (December 2020: £17,521m). Loans and advances to subsidiaries During the period, loans and advances to subsidiaries decreased by £1,415m to £23,295m (December 2020: £24,710m). The decrease was driven by the maturity of £2,200m senior loans to Barclays Bank PLC and a foreign exchange impact of £500m due to appreciation of GBP against major currencies (although the negative FX impact is offset across the balance sheet liabilities). There was also a £700m decrease in relation to the share buyback which took place in Q1 2020. This decrease was partially offset by £1,600m of new issuances of dated subordinated notes by Barclays Bank PLC to Barclays PLC and £776m dividend receipts from Barclays Bank PLC and Barclays Execution Services Limited. Subordinated liabilities and debt securities in issue During H121, Barclays PLC issued €1,000m and $1,000m of Fixed Rate Resetting Subordinated Callable Notes, which is included within the subordinated liabilities balance of £9,170m (December 2020: £7,724m). Debt securities in issue of £26,663m (December 2020: £28,428m) have reduced in the year due to the £2,200m maturity of senior issuances, offset in part by new issuances of €1,250m. Other equity instruments Other equity instruments comprises AT1 securities issued by Barclays PLC. There have been no new issuances or redemptions during the period. Other reserves As at 30 June 2021, there was a balance of £488m (December 2020: £394m) in other reserves. The increase is due to the repurchase of shares as part of the share buyback. Management of internal investments, loans and advances Barclays PLC retains the discretion to manage the nature of its internal investments in subsidiaries according to their regulatory and business needs. Barclays PLC may invest capital and funding into Barclays Bank PLC, Barclays Bank UK PLC and other Group subsidiaries such as Barclays Execution Services Limited and the US Intermediate Holding Company (IHC). |
Credit Risk
Credit Risk | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of credit risk exposure [abstract] | |
Credit Risk | Loans and advances at amortised cost by stage The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio by stage allocation and business segment as at 30 June 2021. Also included are off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio by stage allocation as at 30 June 2021. Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as ECL is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision. Gross exposure Impairment allowance Net exposure Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 30.06.21 £m £m £m £m £m £m £m £m £m Barclays UK 158,587 23,576 2,715 184,878 313 1,035 944 2,292 182,586 Barclays International 23,286 2,886 1,760 27,932 575 781 1,004 2,360 25,572 Head Office 4,003 502 760 5,265 3 39 358 400 4,865 Total Barclays Group retail 185,876 26,964 5,235 218,075 891 1,855 2,306 5,052 213,023 Barclays UK 36,069 1,727 1,081 38,877 63 49 89 201 38,676 Barclays International 82,515 13,617 1,425 97,557 231 329 673 1,233 96,324 Head Office 522 3 32 557 — — 31 31 526 Total Barclays Group wholesale 1 119,106 15,347 2,538 136,991 294 378 793 1,465 135,526 Total loans and advances at amortised cost 304,982 42,311 7,773 355,066 1,185 2,233 3,099 6,517 348,549 Off-balance sheet loan commitments and financial guarantee contracts 2 298,150 45,696 664 344,510 228 436 49 713 343,797 Total 3 603,132 88,007 8,437 699,576 1,413 2,669 3,148 7,230 692,346 As at 30.06.21 Half year ended 30.06.21 Coverage ratio Loan impairment release and loan loss rate Stage 1 Stage 2 Stage 3 Total Loan impairment release Loan loss rate % % % % £m bps Barclays UK 0.2 4.4 34.8 1.2 (259) — Barclays International 2.5 27.1 57.0 8.4 (19) — Head Office 0.1 7.8 47.1 7.6 (6) — Total Barclays Group retail 0.5 6.9 44.0 2.3 (284) — Barclays UK 0.2 2.8 8.2 0.5 (23) — Barclays International 0.3 2.4 47.2 1.3 (75) — Head Office — — 96.9 5.6 — — Total Barclays Group wholesale 1 0.2 2.5 31.2 1.1 (98) — Total loans and advances at amortised cost 0.4 5.3 39.9 1.8 (382) — Off-balance sheet loan commitments and financial guarantee contracts 2 0.1 1.0 7.4 0.2 (343) Other financial assets subject to impairment 3 (17) Total 0.2 3.0 37.3 1.0 (742) 1 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £7,796m of balances reported as wholesale loans on page 30 in the Loans and advances at amortised cost by product disclosure. 2 Excludes loan commitments and financial guarantees of £21bn carried at fair value. 3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn and impairment allowance of £114m. This comprises £9m ECL on £185.8bn Stage 1 assets, £3m on £58m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £102m on £109m Stage 3 other assets. Gross exposure Impairment allowance Net exposure Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 31.12.20 £m £m £m £m £m £m £m £m £m Barclays UK 153,250 23,896 2,732 179,878 332 1,509 1,147 2,988 176,890 Barclays International 1 21,048 5,500 1,992 28,540 396 1,329 1,205 2,930 25,610 Head Office 4,267 720 844 5,831 4 51 380 435 5,396 Total Barclays Group retail 178,565 30,116 5,568 214,249 732 2,889 2,732 6,353 207,896 Barclays UK 31,918 4,325 1,126 37,369 13 129 116 258 37,111 Barclays International 1 79,911 16,565 2,270 98,746 288 546 859 1,693 97,053 Head Office 570 — 33 603 — — 31 31 572 Total Barclays Group wholesale 2 112,399 20,890 3,429 136,718 301 675 1,006 1,982 134,736 Total loans and advances at amortised cost 290,964 51,006 8,997 350,967 1,033 3,564 3,738 8,335 342,632 Off-balance sheet loan commitments and financial guarantee contracts 3 289,939 52,891 2,330 345,160 256 758 50 1,064 344,096 Total 4 580,903 103,897 11,327 696,127 1,289 4,322 3,788 9,399 686,728 As at 31.12.20 Year ended 31.12.20 Coverage ratio Loan impairment charge and loan loss rate 5 Stage 1 Stage 2 Stage 3 Total Loan impairment charge Loan loss rate % % % % £m bps Barclays UK 0.2 6.3 42.0 1.7 1,070 59 Barclays International 1 1.9 24.2 60.5 10.3 1,680 589 Head Office 0.1 7.1 45.0 7.5 91 156 Total Barclays Group retail 0.4 9.6 49.1 3.0 2,841 133 Barclays UK — 3.0 10.3 0.7 154 41 Barclays International 1 0.4 3.3 37.8 1.7 914 93 Head Office — — 93.9 5.1 — — Total Barclays Group wholesale 2 0.3 3.2 29.3 1.4 1,068 78 Total loans and advances at amortised cost 0.4 7.0 41.5 2.4 3,909 111 Off-balance sheet loan commitments and financial guarantee contracts 3 0.1 1.4 2.1 0.3 776 Other financial assets subject to impairment 4 153 Total 5 0.2 4.2 33.4 1.4 4,838 1 Private Banking have refined the methodology to classify £5bn of their exposure between Wholesale and Retail during the year. 2 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £7,551m of balances reported as wholesale loans on page 30 in the Loans and advances at amortised cost by product disclosure. 3 Excludes loan commitments and financial guarantees of £9.5bn carried at fair value. 4 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn and impairment allowance of £165m. This comprises £11m ECL on £175.7bn Stage 1 assets, £9m on £4.4bn Stage 2 fair value through other comprehensive income assets,other assets and cash collateral and settlement balances and £145m on £154m Stage 3 other assets. 5 The loan loss rate is 138 bps after applying the total impairment charge of £4,838m. Loans and advances at amortised cost by product The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification. Stage 2 As at 30.06.21 Stage 1 Not past due <=30 days past due >30 days past due Total Stage 3 Total Gross exposure £m £m £m £m £m £m £m Home loans 144,103 17,991 1,666 823 20,480 2,235 166,818 Credit cards, unsecured loans and other retail lending 34,537 5,642 300 209 6,151 2,773 43,461 Wholesale loans 126,342 14,760 529 391 15,680 2,765 144,787 Total 304,982 38,393 2,495 1,423 42,311 7,773 355,066 Impairment allowance Home loans 15 56 6 7 69 389 473 Credit cards, unsecured loans and other retail lending 834 1,547 100 120 1,767 1,852 4,453 Wholesale loans 336 381 5 11 397 858 1,591 Total 1,185 1,984 111 138 2,233 3,099 6,517 Net exposure Home loans 144,088 17,935 1,660 816 20,411 1,846 166,345 Credit cards, unsecured loans and other retail lending 33,703 4,095 200 89 4,384 921 39,008 Wholesale loans 126,006 14,379 524 380 15,283 1,907 143,196 Total 303,797 36,409 2,384 1,285 40,078 4,674 348,549 Coverage ratio % % % % % % % Home loans — 0.3 0.4 0.9 0.3 17.4 0.3 Credit cards, unsecured loans and other retail lending 2.4 27.4 33.3 57.4 28.7 66.8 10.2 Wholesale loans 0.3 2.6 0.9 2.8 2.5 31.0 1.1 Total 0.4 5.2 4.4 9.7 5.3 39.9 1.8 As at 31.12.20 Gross exposure £m £m £m £m £m £m £m Home loans 138,639 16,651 1,785 876 19,312 2,234 160,185 Credit cards, unsecured loans and other retail lending 33,021 9,470 544 306 10,320 3,172 46,513 Wholesale loans 119,304 19,501 1,097 776 21,374 3,591 144,269 Total 290,964 45,622 3,426 1,958 51,006 8,997 350,967 Impairment allowance Home Loans 33 57 13 14 84 421 538 Credit cards, unsecured loans and other retail lending 680 2,382 180 207 2,769 2,251 5,700 Wholesale Loans 320 650 50 11 711 1,066 2,097 Total 1,033 3,089 243 232 3,564 3,738 8,335 Net exposure Home loans 138,606 16,594 1,772 862 19,228 1,813 159,647 Credit cards, unsecured loans and other retail lending 32,341 7,088 364 99 7,551 921 40,813 Wholesale loans 118,984 18,851 1,047 765 20,663 2,525 142,172 Total 289,931 42,533 3,183 1,726 47,442 5,259 342,632 Coverage ratio % % % % % % % Home loans — 0.3 0.7 1.6 0.4 18.8 0.3 Credit cards, unsecured loans and other retail lending 2.1 25.2 33.1 67.6 26.8 71.0 12.3 Wholesale loans 0.3 3.3 4.6 1.4 3.3 29.7 1.5 Total 0.4 6.8 7.1 11.8 7.0 41.5 2.4 Loans and advances at amortised cost by selected sectors The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance, with gross exposure and stage allocation for selected industry sectors within the wholesale loans portfolio. The industry sectors have been selected based upon the level of management focus they have received following the onset of the COVID-19 pandemic. The gross loans and advances to selected sectors have decreased over the year driven by repayments and lower drawdowns. The reduction in provisions is informed by the improved macroeconomic outlook used in the Q221 scenario refresh, partially offset by management judgments to reflect the risk of uncertainty still prevailing within these sectors. The wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against systemic losses. An additional £0.1bn (December 2020: £0.1bn) impairment allowance has been applied to the undrawn exposures not included in the table below. Gross exposure Impairment allowance Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 30.06.21 £m £m £m £m £m £m £m £m Air travel 305 322 21 648 3 13 18 34 Hospitality and leisure 4,019 1,907 298 6,224 48 68 49 165 Oil and gas 1,877 465 234 2,576 14 12 128 154 Retail 4,089 962 148 5,199 63 30 44 137 Shipping 485 220 12 717 5 35 — 40 Transportation 1,768 161 102 2,031 20 4 37 61 Total 12,543 4,037 815 17,395 153 162 276 591 Total of Wholesale exposures 10 % 26 % 29 % 12 % 45 % 41 % 32 % 37 % Gross exposure Impairment allowance Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 31.12.20 £m £m £m £m £m £m £m £m Air travel 367 525 56 948 9 27 23 59 Hospitality and leisure 4,440 2,387 313 7,140 53 115 61 229 Oil and gas 1,754 854 465 3,073 31 27 140 198 Retail 3,907 1,153 283 5,343 78 51 108 237 Shipping 308 389 12 709 2 30 1 33 Transportation 1,148 253 125 1,526 19 10 57 86 Total 11,924 5,561 1,254 18,739 192 260 390 842 Total of Wholesale exposures 10 % 26 % 35 % 13 % 60 % 37 % 37 % 40 % The coverage ratio for selected sectors has decreased from 4.5% as at 31 December 2020 to 3.4% as at 30 June 2021. Exposure to UK commercial real estate of £9.4bn, excluding government backed schemes, was in line with 31 December 2020 (£10.0bn). Coverage decreased from 0.98% to 0.61% in the period. Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An explanation of the terms 12-month ECL, lifetime ECL and credit-impaired is included in the Barclays PLC Annual Report 2020 on page 296. Transfers between stages in the table have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 6-month period. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL Home loans £m £m £m £m £m £m £m £m As at 1 January 2021 138,639 33 19,312 84 2,234 421 160,185 538 Transfers from Stage 1 to Stage 2 (6,369) (2) 6,369 2 — — — — Transfers from Stage 2 to Stage 1 3,615 21 (3,615) (21) — — — — Transfers to Stage 3 (160) — (337) (7) 497 7 — — Transfers from Stage 3 21 — 119 3 (140) (3) — — Business activity in the year 19,231 2 380 1 — — 19,611 3 Changes to models used for calculation 1 — — — (4) — 38 — 34 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (4,670) (38) (667) 13 (124) (54) (5,461) (79) Final repayments (6,204) (1) (1,081) (2) (220) (8) (7,505) (11) Disposals — — — — — — — — Write-offs 2 — — — — (12) (12) (12) (12) As at 30 June 2021 3 144,103 15 20,480 69 2,235 389 166,818 473 Credit cards, unsecured loans and other retail lending As at 1 January 2021 33,021 680 10,320 2,769 3,172 2,251 46,513 5,700 Transfers from Stage 1 to Stage 2 (1,590) (72) 1,590 72 — — — — Transfers from Stage 2 to Stage 1 4,376 1,080 (4,376) (1,080) — — — — Transfers to Stage 3 (264) (12) (572) (282) 836 294 — — Transfers from Stage 3 30 25 38 14 (68) (39) — — Business activity in the year 3,855 50 58 14 31 8 3,944 72 Changes to models used for calculation 1 — (5) — (33) — 14 — (24) Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 4 (3,134) (866) (808) 310 (123) 282 (4,065) (274) Final repayments (1,757) (46) (99) (17) (140) (50) (1,996) (113) Disposals 5 — — — — (101) (74) (101) (74) Write-offs 2 — — — — (834) (834) (834) (834) As at 30 June 2021 3 34,537 834 6,151 1,767 2,773 1,852 43,461 4,453 1 Changes to models used for calculation include a £34m movement in Home loans, £24m in Credit cards, unsecured loans and other retail lending and £36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. 2 In H121, gross write-offs amounted to £1,001m (H120: £953m) and post write-off recoveries amounted to £31m (H120: £15m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £970m (H120: £938m). 3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn (December 2020: £180.3bn) and impairment allowance of £114m (December 2020: £165m). This comprises £9m ECL (December 2020: £11m) on £185.8bn stage 1 assets (December 2020: £175.7bn), £3m (December 2020: £9m) on £58m stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 2020: £4.4bn) and £102m (December 2020: £145m) on £109m stage 3 other assets (December 2020: £154m). 4 Transfers and risk parameter changes include a £0.3bn net release in ECL arising from a reclassification of £2.2bn gross loans and advances from Stage 2 to Stage 1 in Credit cards, unsecured loans and other retail lending. The reclassification followed a review of back-testing of results which indicated that accuracy of origination probability of default characteristics require management adjustments to correct and was first established in Q220. 5 The £101m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relates to debt sales undertaken during the year. The £1.7bn disposal reported within Wholesale loans includes a sale of £0.7bn debt securities as part of Group Treasury Operations and a £1.0bn sale of Barclays Asset Finance. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL Wholesale loans £m £m £m £m £m £m £m £m As at 1 January 2021 119,304 320 21,374 711 3,591 1,066 144,269 2,097 Transfers from Stage 1 to Stage 2 (4,636) (12) 4,636 12 — — — — Transfers from Stage 2 to Stage 1 8,410 188 (8,410) (188) — — — — Transfers to Stage 3 (249) (2) (226) (17) 475 19 — — Transfers from Stage 3 515 14 376 13 (891) (27) — — Business activity in the year 23,266 35 1,181 30 191 22 24,638 87 Changes to models used for calculation 1 — (7) — (29) — — — (36) Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 81 (153) (47) (37) (185) (1) (151) (191) Final repayments (18,854) (39) (3,042) (95) (203) (33) (22,099) (167) Disposals 2 (1,495) (8) (162) (3) (58) (33) (1,715) (44) Write-offs 3 — — — — (155) (155) (155) (155) As at 30 June 2021 4 126,342 336 15,680 397 2,765 858 144,787 1,591 Reconciliation of ECL movement to impairment charge/(release) for the period £m Home loans (53) Credit cards, unsecured loans and other retail lending (339) Wholesale loans (307) ECL movement excluding assets derecognised due to disposals and write-offs (699) Recoveries and reimbursements 5 185 Exchange and other adjustments 6 132 Impairment charge on loan commitments and other financial guarantees (343) Impairment charge on other financial assets 4 (17) Income statement release for the period (742) 1 Changes to models used for calculation include a £34m movement in Home Loans, £24m in Credit cards, unsecured loans and other retail lending and £36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. 2 The £101m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relates to debt sales undertaken during the year. The £1.7bn disposal reported within Wholesale loans includes a sale of £0.7bn debt securities as part of Group Treasury Operations and a £1.0bn sale of Barclays Asset Finance. 3 In H121, gross write-offs amounted to £1,001m (H120: £953m) and post write-off recoveries amounted to £31m (H120: £15m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £970m (H120: £938m). 4 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn (December 2020: £180.3bn) and impairment allowance of £114m (December 2020: £165m). This comprises £9m ECL (December 2020: £11m) on £185.8bn stage 1 assets (December 2020: £175.7bn), £3m (December 2020: £9m) on £58m stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 2020: £4.4bn) and £102m (December 2020: £145m) on £109m stage 3 other assets (December 2020: £154m). 5 Recoveries and reimbursements includes a net loss in relation to reimbursements from financial guarantee contracts held with third parties of £216m (H120 gain: £279m) and post write off recoveries of £31m (H120: £15m). 6 Includes foreign exchange and interest and fees in suspense. Loan commitments and financial guarantees Stage 1 Stage 2 Stage 3 Total Gross ECL Gross ECL Gross ECL Gross ECL Home loans £m £m £m £m £m £m £m £m As at 1 January 2021 11,861 — 516 — 5 — 12,382 — Net transfers between stages (74) — 71 — 3 — — — Business activity in the year 6,287 — 1 — — — 6,288 — Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (7,397) — (17) — (2) — (7,416) — Limit management and final repayments (238) — (22) — (3) — (263) — As at 30 June 2021 10,439 — 549 — 3 — 10,991 — Credit cards, unsecured loans and other retail lending As at 1 January 2021 114,371 55 12,117 305 229 23 126,717 383 Net transfers between stages 5,784 217 (6,081) (212) 297 (5) — — Business activity in the year 3,378 1 32 1 1 1 3,411 3 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (1,005) (215) 114 63 (248) 4 (1,139) (148) Limit management and final repayments (4,941) (4) (398) (5) (57) (3) (5,396) (12) As at 30 June 2021 117,587 54 5,784 152 222 20 123,593 226 Wholesale loans As at 1 January 2021 163,707 201 40,258 453 2,096 27 206,061 681 Net transfers between stages 682 116 504 (112) (1,186) (4) — — Business activity in the year 37,211 28 2,915 89 12 9 40,138 126 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 1,603 (146) 680 (63) (28) 2 2,255 (207) Limit management and final repayments (33,079) (25) (4,994) (83) (455) (5) (38,528) (113) As at 30 June 2021 170,124 174 39,363 284 439 29 209,926 487 Management adjustments to models for impairment Management adjustments to impairment models are made in the ordinary course of business in order to reflect changes in policy or correct model performance issues identified through model monitoring. These adjustments remain in place until they are incorporated into future model development and are then retired. In addition, they may also be made in response to circumstances or uncertainty at the period end and this is particularly true of the ongoing COVID-19 pandemic. Total management adjustments to impairment allowance are presented by product below. Overview of management adjustments to models for impairment allowance 1 As at 30.06.21 As at 31.12.20 Management adjustments to impairment allowances Proportion of total impairment allowances Management adjustments to impairment allowances Proportion of total impairment allowances £m % £m % Home loans 83 17.5 131 24.3 Credit cards, unsecured loans and other retail lending 1,145 24.5 1,234 20.3 Wholesale loans 643 30.9 23 0.8 Total 1,871 25.9 1,388 14.8 Management adjustments to models for impairment allowance 1 Impairment allowance pre management adjustments 2 Economic uncertainty adjustments Other adjustments Total impairment allowance As at 30.06.21 £m £m £m £m Home loans 390 41 42 473 Credit cards, unsecured loans and other retail lending 3,534 1,398 (253) 4,679 Wholesale loans 1,435 651 (8) 2,078 Total 5,359 2,090 (219) 7,230 As at 31.12.20 Home loans 407 21 110 538 Credit cards, unsecured loans and other retail lending 4,849 1,625 (391) 6,083 Wholesale loans 2,755 421 (398) 2,778 Total 8,011 2,067 (679) 9,399 1 Positive values reflect an increase in impairment allowance. 2 Includes £4.3bn (December 2020: £6.8bn) of modelled ECL, £0.8bn (December 2020: £0.9bn) of individually assessed impairments and £0.3bn (December 2020: £0.3bn) ECL from non-modelled exposures. Economic uncertainty adjustments The COVID-19 pandemic has impacted the global economy since early 2020 and macroeconomic forecasts indicate longer-term impacts that will result in higher unemployment levels and customer and client stress. However, to date, little real credit deterioration has occurred, largely as a result of government and other support measures. Observed 30-day arrears rates have reduced in US cards 1.6% (December 2020: 2.5%; December 2019: 2.7%) and in UK cards 1.4% (December 2020: 1.7%; December 2019: 1.7%) due to payment holidays granted to customers impacted by COVID-19 which reduced the delinquency entrance rate and overall flow through delinquency. However, uncertainty remains as government and other support measures taper down as to whether these schemes have either averted or delayed credit losses. In order to address this uncertainty, adjustments to the modelled provisions were made in 2020. COVID-19 related economic uncertainty adjustments of £2.1bn (December 2020: £2.1bn) continue to be recognised, specifically to address whether support measures have averted or delayed credit losses. However, within this, the approach has been refined and uncertainty is now captured in two distinct ways: firstly, the identification of specific customers and clients who may be more vulnerable to the withdrawal of relief and secondly, macroeconomic and risk parameter uncertainties which are applied at a portfolio level. A summary of the adjustments is provided below: • A £1.2bn adjustment has been applied to customers and clients considered potentially vulnerable to the withdrawal of government and other support schemes. In US consumer card portfolios, the populations identified are those who have higher potential risk indicators and in the UK we have specifically considered the impact of furlough schemes ending (equivalent to UK unemployment increasing to 7.2%). In wholesale portfolios, the populations identified are specific clients who may exhibit greater cross default risk between COVID-19 and other financing exposures, including clients with Bounce Back Loans in Business Banking, and those corporate sectors deemed more vulnerable to the economic impacts of COVID-19. This adjustment is split between credit cards and unsecured loans, £0.9bn, and wholesale loans, £0.3bn • Expert judgement has been used to adjust the probability of default at portfolio level to pre-COVID-19 levels to reflect the impact of temporary support measures on underlying customer and client behaviour. Following a refinement to methodology, this has reduced to £0.5bn from £0.7bn in December 2020. A £(0.1)bn PMA to recognise government guarantees remains in place • Macroeconomic variables which may be temporarily influenced by support measures have been adjusted at a portfolio level enabling the model to consume the economic stress. This is reduced to £0.5bn from £1.2bn at December 2020 as management judgements have been refined towards potentially vulnerable customers and clients as the pandemic evolves Other adjustments Home loans: The low average LTV nature of the UK Home Loans portfolio means that modelled ECL estimates are low in all but the most severe economic scenarios. An adjustment is held to maintain an appropriate level of ECL. Credit cards, unsecured loans and other retail lending: This materially relates to a net release in ECL due to reclassification of loans and advances from Stage 2 to Stage 1 in credit cards and unsecured loans. The reclassification followed a review of back-testing of results which indicated that the accuracy of origination probability of default characteristics requires management adjustments to correct and was first established in Q220. Wholesale loans: Represents the net of adjustments for Business Banking and Investment Bank for model inaccuracies informed by back-testing. An adjustment to offset modelled ECL output in the Investment Bank to limit excessive ECL sensitivity to the macroeconomic variable for Federal Tax Receipts in place at December 2020 is materially reduced due to the Q221 scenario refresh. Measurement uncertainty The Group uses a five-scenario model to calculate ECL. An external consensus forecast is assembled from key sources, including HM Treasury (short and medium-term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House Prices), which forms the Baseline scenario. In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are derived, with associated probability weightings. The adverse scenarios are calibrated to a broadly similar severity to Barclays’ internal stress tests and stress scenarios provided by regulators whilst also considering IFRS 9 specific sensitivities and non-linearity. Downside 2 is benchmarked to the Bank of England’s stress scenarios and to the most severe scenario from Moody’s inventory, but is not designed to be the same. The favourable scenarios are calibrated to reflect upside risks to the Baseline scenario to the extent that is broadly consistent with recent favourable benchmark scenarios. All scenarios are regenerated at a minimum semi-annually. The scenarios include eight economic variables, (GDP, unemployment, House Price Index (HPI) and base rates, in both the UK and US markets), and expanded variables using statistical models based on historical correlations. The upside and downside shocks are designed to evolve over a five Macroeconomic indicators were refreshed in Q221, with key drivers for the baseline scenario more optimistic than Q420, resulting in a net ECL provision release. In the Baseline scenario, UK GDP returns to the pre-pandemic level by mid-2022 with peak UK unemployment of just over 6% in Q421. In the Upside 2 scenario, effective fiscal stimulus measures, including public investments in infrastructure and skills, provide a boost to demand and confidence, which in turn leads to economic activity in almost all advanced economies returning to the pre-COVID-19 pandemic levels by the end of 2021. Unemployment levels decline back below 5% by H222 in the UK, and below 4% by early 2022 in the US. In the Downside 2 scenario supply and distribution issues slow the vaccination process and the emergence of new virus variants that are not susceptible to the existing vaccines fuels the outbreak again resulting in full national lockdowns in Q321. This leads to significant falls in GDP in Q321 and UK and US unemployment reaching c.10% and 12% respectively. Although the macroeconomic outlook has improved, the Group’s view on uncertainty remains unchanged, believing potential credit deterioration could be seen once government support is removed, particularly in vulnerable areas of the portfolio. In response, economic uncertainty PMAs remained relatively stable at c.£2.1bn. For further details see page 35. Limited defaults have been observed to date in response to the COVID-19 pandemic, partly as a result of government and bank support measures. However, such support measures are scheduled to taper down from Q321 bringing with it uncertainty. Despite improvement in macroeconomic variables in the period, unemployment remains at elevated levels but portfolios are yet to respond, and may not do so until support measures fall away. The methodology for estimating probability weights for each of the scenarios involves a comparison of the distribution of key historical UK and US macroeconomic variables against the forecast paths of the 5 scenarios. The range of forecast paths generated in the calculation of the weights at 30 June 2021 is slightly narrower than 31 December 2020 due to lower levels of uncertainty. The Upside 2 and Downside 2 scenarios are therefore nearer the tails of the distribution than previously resulting in lower weights. See page 40 for probability weightings used at H121. The tables below show the key consensus macroeconomic variables used in the scenarios (3-year annual paths), the probability weights applied to each scenario and the macroeconomic variables by scenario using ‘specific bases’ i.e. the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios and the lowest unemployment for upside scenarios. The 5-year average table provides additional transparency. Baseline average macroeconomic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 4.9 5.6 2.3 UK unemployment 2 5.8 5.7 5.1 UK HPI 3 (0.5) 0.3 3.1 UK bank rate 0.1 0.2 0.4 US GDP 1 5.7 3.9 1.6 US unemployment 4 5.6 4.5 4.4 US HPI 5 3.9 3.5 3.5 US federal funds rate 0.3 0.3 0.7 As at 31.12.20 UK GDP 1 6.3 3.3 2.6 UK unemployment 2 6.7 6.4 5.8 UK HPI 3 2.4 2.3 5.0 UK bank rate — (0.1) — US GDP 1 3.9 3.1 2.9 US unemployment 4 6.9 5.7 5.6 US HPI 5 2.8 4.7 4.7 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Downside 2 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 (1.7) 2.0 5.2 UK unemployment 2 7.3 8.2 6.6 UK HPI 3 (5.8) (5.8) 0.2 UK bank rate 0.1 — — US GDP 1 1.5 1.4 2.0 US unemployment 4 8.7 11.0 9.3 US HPI 5 (4.9) (3.0) 1.1 US federal funds rate 0.3 0.3 0.3 As at 31.12.20 UK GDP 1 (3.9) 6.5 2.6 UK unemployment 2 8.0 9.3 7.8 UK HPI 3 (13.6) (10.8) 0.5 UK bank rate (0.2) (0.2) (0.1) US GDP 1 (2.4) 3.6 2.1 US un |
Segmental reporting (Tables)
Segmental reporting (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of operating segments [abstract] | |
Analysis of results by business | Analysis of results by business Barclays Barclays Head Barclays Half year ended 30.06.21 £m £m £m £m Total income 3,199 8,218 (102) 11,315 Credit impairment releases 443 293 6 742 Net operating income/(expenses) 3,642 8,511 (96) 12,057 Operating expenses (2,114) (4,606) (412) (7,132) Litigation and conduct (22) (84) 7 (99) Total operating expenses (2,136) (4,690) (405) (7,231) Other net income 1 — 22 131 153 Profit/(loss) before tax 1,506 3,843 (370) 4,979 As at 30.06.21 £bn £bn £bn £bn Total assets 311.2 1,046.8 18.3 1,376.3 Barclays Barclays Head Barclays Half year ended 30.06.20 £m £m £m £m Total income 3,171 8,654 (204) 11,621 Credit impairment charges (1,064) (2,619) (55) (3,738) Net operating income/(expenses) 2,107 6,035 (259) 7,883 Operating expenses (2,041) (4,405) (117) (6,563) Litigation and conduct (11) (11) (8) (30) Total operating expenses (2,052) (4,416) (125) (6,593) Other net income/(expenses) 1 13 10 (41) (18) Profit/(loss) before tax 68 1,629 (425) 1,272 As at 31.12.20 £bn £bn £bn £bn Total assets 289.1 1,041.8 18.6 1,349.5 1 Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates and joint ventures and gains on acquisitions. |
Split of income by geographic region | Split of income by geographic region 1 Half year ended 30.06.21 Half year ended 30.06.20 £m £m United Kingdom 5,895 5,989 Europe 1,222 1,199 Americas 3,608 3,776 Africa and Middle East 20 20 Asia 570 637 Total 11,315 11,621 1 The geographical analysis is based on the location of the office where the transactions are recorded. |
Net fee and commission income (
Net fee and commission income (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Fee and commission income (expense) [abstract] | |
Total fees in scope of IFRS 15 Revenues from Contracts with Customers | Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from Contracts with Customers: Barclays UK Barclays International Head Office Total Half year ended 30.06.21 £m £m £m £m Fee type Transactional 408 1,181 — 1,589 Advisory 83 459 1 543 Brokerage and execution 109 553 — 662 Underwriting and syndication — 1,715 — 1,715 Other 35 73 3 111 Total revenue from contracts with customers 635 3,981 4 4,620 Other non-contract fee income — 62 — 62 Fee and commission income 635 4,043 4 4,682 Fee and commission expense (108) (861) (7) (976) Net fee and commission income 527 3,182 (3) 3,706 Barclays UK Barclays International Head Office Total Half year ended 30.06.20 £m £m £m £m Fee type Transactional 386 1,157 — 1,543 Advisory 79 306 1 386 Brokerage and execution 102 685 — 787 Underwriting and syndication — 1,468 — 1,468 Other 38 115 2 155 Total revenue from contracts with customers 605 3,731 3 4,339 Other non-contract fee income — 60 — 60 Fee and commission income 605 3,791 3 4,399 Fee and commission expense (148) (940) (2) (1,090) Net fee and commission income 457 2,851 1 3,309 |
Staff costs (Tables)
Staff costs (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Classes of employee benefits expense [abstract] | |
Staff costs | Half year ended 30.06.21 Half year ended 30.06.20 Compensation costs £m £m Upfront bonus charge 824 476 Deferred bonus charge 262 269 Other incentives 6 4 Performance costs 1,092 749 Salaries 2,117 2,153 Social security costs 336 317 Post-retirement benefits 275 268 Other compensation costs 223 254 Total compensation costs 4,043 3,741 Other resourcing costs Outsourcing 171 175 Redundancy and restructuring 23 39 Temporary staff costs 55 58 Other 42 40 Total other resourcing costs 291 312 Total staff costs 4,334 4,053 Barclays Group compensation costs as a % of total income 35.7 32.2 |
Infrastructure, administratio_2
Infrastructure, administration and general expenses (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Expenses by nature [abstract] | |
Infrastructure, administration and general expenses | Half year ended 30.06.21 Half year ended 30.06.20 Infrastructure costs £m £m Property and equipment 709 757 Depreciation and amortisation 832 751 Lease payments 20 26 Impairment of property, equipment and intangible assets 304 32 Total infrastructure costs 1,865 1,566 Administration and general expenses Consultancy, legal and professional fees 262 270 Marketing and advertising 163 158 Other administration and general expenses 508 516 Total administration and general expenses 933 944 Total infrastructure, administration and general expenses 2,798 2,510 |
Tax (Tables)
Tax (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Major components of tax expense (income) [abstract] | |
Disclosure of deferred taxes | As at 30.06.21 As at 31.12.20 Deferred tax assets and liabilities £m £m USA 1,908 2,049 UK 1,380 886 Other territories 483 509 Deferred tax assets 3,771 3,444 Deferred tax liabilities (8) (15) Analysis of deferred tax assets Temporary differences 2,972 2,709 Tax losses 799 735 Deferred tax assets 3,771 3,444 |
Non-controlling interests (Tabl
Non-controlling interests (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Non-controlling interests [Abstract] | |
Non-controlling interest, by group | Profit attributable to Equity attributable to Half year ended 30.06.21 Half year ended 30.06.20 As at 30.06.21 As at 31.12.20 £m £m £m £m Barclays Bank PLC issued: - Preference shares 13 28 529 529 - Upper T2 instruments 3 9 533 533 Other non-controlling interests 3 — 2 23 Total 19 37 1,064 1,085 |
Earnings per share (Tables)
Earnings per share (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Earnings per share [abstract] | |
Earnings per share | Half year ended 30.06.21 Half year ended 30.06.20 £m £m Profit attributable to ordinary equity holders of the parent 3,812 695 m m Basic weighted average number of shares in issue 17,140 17,294 Number of potential ordinary shares 467 319 Diluted weighted average number of shares 17,607 17,613 p p Basic earnings per ordinary share 22.2 4.0 Diluted earnings per ordinary share 21.7 3.9 |
Dividends on ordinary shares (T
Dividends on ordinary shares (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Dividends on ordinary shares [Abstract] | |
Dividends on ordinary shares | Half year ended 30.06.21 Half year ended 30.06.20 Per share Total Per share Total Dividends paid during the period p £m p £m Full year dividend paid during period 1.0 173 — — |
Derivative financial instrume_2
Derivative financial instruments (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of nature and extent of risks arising from financial instruments [abstract] | |
Total recognised derivative assets/(liabilities) | Contract notional amount Fair value Assets Liabilities As at 30.06.21 £m £m £m Foreign exchange derivatives 5,654,026 66,963 (64,194) Interest rate derivatives 37,888,009 134,734 (123,436) Credit derivatives 920,030 5,469 (5,960) Equity and stock index and commodity derivatives 1,541,007 48,530 (52,444) Derivative assets/(liabilities) held for trading 46,003,072 255,696 (246,034) Derivatives in hedge accounting relationships Derivatives designated as cash flow hedges 91,278 806 — Derivatives designated as fair value hedges 107,879 128 (993) Derivatives designated as hedges of net investments 1,595 6 (7) Derivative assets/(liabilities) designated in hedge accounting relationships 200,752 940 (1,000) Total recognised derivative assets/(liabilities) 46,203,824 256,636 (247,034) As at 31.12.20 Foreign exchange derivatives 5,554,037 84,739 (84,381) Interest rate derivatives 35,257,371 172,144 (162,402) Credit derivatives 847,845 4,605 (5,004) Equity and stock index and commodity derivatives 1,510,718 40,392 (48,008) Derivative assets/(liabilities) held for trading 43,169,971 301,880 (299,795) Derivatives in hedge accounting relationships Derivatives designated as cash flow hedges 74,437 386 — Derivatives designated as fair value hedges 114,556 155 (980) Derivatives designated as hedges of net investments 791 25 — Derivative assets/(liabilities) designated in hedge accounting relationships 189,784 566 (980) Total recognised derivative assets/(liabilities) 43,359,755 302,446 (300,775) |
Fair value of financial instr_2
Fair value of financial instruments (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of fair value measurement of assets [abstract] | |
Assets and liabilities held at fair value disaggregated by valuation technique (fair value hierarchy) | The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification: Valuation technique using Quoted market prices Observable inputs Significant unobservable inputs (Level 1) (Level 2) (Level 3) Total As at 30.06.21 £m £m £m £m Trading portfolio assets 73,405 71,282 2,552 147,239 Financial assets at fair value through the income statement 1,229 185,415 7,777 194,421 Derivative financial instruments 11,643 241,336 3,657 256,636 Financial assets at fair value through other comprehensive income 21,375 51,837 48 73,260 Investment property — — 8 8 Total assets 107,652 549,870 14,042 671,564 Trading portfolio liabilities (30,911) (26,058) (17) (56,986) Financial liabilities designated at fair value (142) (263,710) (312) (264,164) Derivative financial instruments (11,227) (230,207) (5,600) (247,034) Total liabilities (42,280) (519,975) (5,929) (568,184) As at 31.12.20 Trading portfolio assets 60,671 65,416 1,863 127,950 Financial assets at fair value through the income statement 4,503 162,142 8,506 175,151 Derivative financial instruments 9,155 288,822 4,469 302,446 Financial assets at fair value through other comprehensive income 19,792 58,743 153 78,688 Investment property — — 10 10 Total assets 94,121 575,123 15,001 684,245 Trading portfolio liabilities (24,391) (22,986) (28) (47,405) Financial liabilities designated at fair value (159) (249,251) (355) (249,765) Derivative financial instruments (8,762) (285,774) (6,239) (300,775) Total liabilities (33,312) (558,011) (6,622) (597,945) The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type: As at 30.06.21 As at 31.12.20 Assets Liabilities Assets Liabilities £m £m £m £m Interest rate derivatives 916 (1,269) 1,613 (1,615) Foreign exchange derivatives 151 (129) 144 (143) Credit derivatives 100 (364) 196 (351) Equity derivatives 2,490 (3,838) 2,498 (4,112) Commodity derivatives — — 18 (18) Corporate debt 981 (38) 698 (3) Reverse repurchase and repurchase agreements — (161) — (174) Non-asset backed loans 6,338 — 6,394 — Asset backed securities 562 — 767 (24) Equity cash products 402 — 542 — Private equity investments 979 (16) 873 (14) Other 1 1,123 (114) 1,258 (168) Total 14,042 (5,929) 15,001 (6,622) 1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. |
Analysis of movements in Level 3 assets and liabilities | The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the period. Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant. Level 3 movement analysis Total gains and losses in the period recognised in the income statement Total gains or losses recognised in OCI Transfers As at 01.01.21 Purchases Sales Issues Settle-ments Trading income Other income In Out As at 30.06.21 £m £m £m £m £m £m £m £m £m £m £m Corporate debt 151 305 (87) — — 25 — — 40 (11) 423 Non-asset backed loans 709 620 (131) — (84) 13 — — 124 (106) 1,145 Asset backed securities 686 112 (294) — — (10) — — 43 (48) 489 Equity cash products 214 13 (17) — — 32 — — 29 (9) 262 Other 103 21 — — (51) (1) — — 162 (1) 233 Trading portfolio assets 1,863 1,071 (529) — (135) 59 — — 398 (175) 2,552 Non-asset backed loans 5,580 698 (299) — (687) (119) — — 69 (48) 5,194 Equity cash products 326 160 (194) — — (171) 18 — 1 — 140 Private equity investments 874 106 (9) — (8) (5) 92 — — (71) 979 Other 1,726 2,291 (2,389) — (162) (19) 1 — 16 — 1,464 Financial assets at fair value through the income statement 8,506 3,255 (2,891) — (857) (314) 111 — 86 (119) 7,777 Non-asset backed loans 106 — — — — — — — — (106) — Asset backed securities 47 4 — — (5) — — 2 — — 48 Assets at fair value through other comprehensive income 153 4 — — (5) — — 2 — (106) 48 Investment property 10 — (2) — — — — — — — 8 — — Trading portfolio liabilities (28) (3) 14 — — (7) — — — 7 (17) Financial liabilities designated at fair value (355) — — — 98 7 (2) — (78) 18 (312) Interest rate derivatives (2) 9 — — 33 (121) 4 — 21 (297) (353) Foreign exchange derivatives 1 — — — 58 (6) — — 3 (34) 22 Credit derivatives (155) (117) 2 — (5) 12 (1) — 1 (1) (264) Equity derivatives (1,614) (315) (1) — (32) (221) (1) — 28 808 (1,348) Net derivative financial instruments 1 (1,770) (423) 1 — 54 (336) 2 — 53 476 (1,943) Total 8,379 3,904 (3,407) — (845) (591) 111 2 459 101 8,113 1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,657m and derivative financial liabilities were £5,600m. Level 3 movement analysis As at 01.01.20 Purchases Sales Issues Settle- Total gains and losses in the period recognised in the income statement Total gains or losses recognised in OCI Transfers As at 30.06.20 Trading income Other income In Out £m £m £m £m £m £m £m £m £m £m £m Corporate debt 120 25 — — — (26) — — 4 (17) 106 Non-asset backed loans 974 1,926 (740) — (4) (111) — — 97 (320) 1,822 Asset backed securities 656 249 (224) — (76) (12) — — 41 (11) 623 Equity cash products 392 2 (4) — — (67) — — 28 (4) 347 Other 122 48 — — — 2 — — 8 — 180 Trading portfolio assets 2,264 2,250 (968) — (80) (214) — — 178 (352) 3,078 Non-asset backed loans 5,494 1,050 (270) — (410) 381 — — — (58) 6,187 Equity cash products 835 14 — — — (22) (28) — — — 799 Private equity investments 900 19 (6) — (2) 2 (44) — 23 (12) 880 Other 1,271 1,870 (2,017) — (18) (8) 64 — 24 — 1,186 Financial assets at fair value through the income statement 8,500 2,953 (2,293) — (430) 353 (8) — 47 (70) 9,052 Non-asset backed loans 343 79 — — (157) — — (3) — — 262 Asset backed securities 86 — (1) — — 1 — (1) — — 85 Assets at fair value through other comprehensive income 429 79 (1) — (157) 1 — (4) — — 347 Investment property 13 — (1) — — — (2) — 2 (2) 10 Trading portfolio liabilities — — — — — — — — — — — Financial liabilities designated at fair value (362) — 1 (3) — (10) 2 — (22) 25 (369) Interest rate derivatives (206) 18 — — 10 268 1 — 300 (10) 381 Foreign exchange derivatives (7) — — — (12) 89 — — 5 (8) 67 Credit derivatives 198 (258) 11 — (376) 151 1 — 2 8 (263) Equity derivatives (819) (448) (1) — 17 (90) — — (5) (23) (1,369) Net derivative financial instruments 1 (834) (688) 10 — (361) 418 2 — 302 (33) (1,184) Total 10,010 4,594 (3,252) (3) (1,028) 548 (6) (4) 507 (432) 10,934 1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £7,748m and derivative financial liabilities were £8,932m. |
Unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and liabilities held at the period end. Half year ended 30.06.21 Half year ended 30.06.20 Income statement Other compre hensive income Total Income statement Other compre hensive income Total Trading income Other income Trading income Other income £m £m £m £m £m £m £m £m Trading portfolio assets 35 — — 35 (177) — — (177) Financial assets at fair value through the income statement (201) 114 — (87) 397 (53) — 344 Financial assets at fair value through other comprehensive income — — — — — — (2) (2) Investment properties — — — — — (2) — (2) Trading portfolio liabilities (6) — — (6) — — — — Financial liabilities designated at fair value 7 — — 7 (16) (1) — (17) Net derivative financial instruments (367) — — (367) 248 — — 248 Non-current assets/liabilities held for sale — — — — — — — — Total (532) 114 — (418) 452 (56) (2) 394 |
Sensitivity analysis of valuations using unobservable inputs | Sensitivity analysis of valuations using unobservable inputs As at 30.06.21 As at 31.12.20 Favourable changes Unfavourable changes Favourable changes Unfavourable changes Income statement Equity Income statement Equity Income statement Equity Income statement Equity £m £m £m £m £m £m £m £m Interest rate derivatives 52 — (83) — 82 — (123) — Foreign exchange derivatives 6 — (10) — 6 — (11) — Credit derivatives 53 — (44) — 55 — (44) — Equity derivatives 185 — (193) — 174 — (179) — Commodity derivatives 2 — (2) — 2 — (2) — Corporate debt 22 — (16) — 16 — (14) — Non-asset backed loans 202 — (310) — 190 3 (409) (3) Equity cash products 130 — (119) — 158 — (141) — Private equity investments 223 — (198) — 199 — (227) — Other 1 18 — (18) — 21 — (21) — Total 893 — (993) — 903 3 (1,171) (3) 1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. |
Fair value adjustments | Key balance sheet valuation adjustments are quantified below: As at 30.06.21 As at 31.12.20 £m £m Exit price adjustments derived from market bid-offer spreads (500) (493) Uncollateralised derivative funding (80) (115) Derivative credit valuation adjustments (210) (268) Derivative debit valuation adjustments 91 113 |
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value | The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s balance sheet. As at 30.06.21 As at 31.12.20 Carrying amount Fair value Carrying amount Fair value Financial assets £m £m £m £m Loans and advances at amortised cost 348,549 347,733 342,632 340,516 Reverse repurchase agreements and other similar secured lending 4,459 4,459 9,031 9,031 Financial liabilities Deposits at amortised cost (500,895) (500,933) (481,036) (481,106) Repurchase agreements and other similar secured borrowing (20,005) (20,005) (14,174) (14,174) Debt securities in issue (90,733) (92,746) (75,796) (77,813) Subordinated liabilities (12,839) (13,434) (16,341) (16,918) |
Loans and advances and deposi_2
Loans and advances and deposits at amortised cost (Table) | 6 Months Ended |
Jun. 30, 2021 | |
Loans and advances and deposits at amortised cost [Abstract] | |
Loans and advances and deposits at amortised cost | As at 30.06.21 As at 31.12.20 £m £m Loans and advances at amortised cost to banks 11,032 8,900 Loans and advances at amortised cost to customers 309,194 309,927 Debt securities at amortised cost 28,323 23,805 Total loans and advances at amortised cost 348,549 342,632 Deposits at amortised cost from banks 17,165 17,343 Deposits at amortised cost from customers 483,730 463,693 Total deposits at amortised cost 500,895 481,036 |
Goodwill and intangible assets
Goodwill and intangible assets (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Intangible assets and goodwill [abstract] | |
Disclosure of goodwill and intangible assets | Goodwill and intangible assets are allocated to business operations according to business segments as follows: As at 30.06.21 As at 31.12.20 Goodwill Intangibles Total Goodwill Intangibles Total £m £m £m £m £m £m Barclays UK 3,560 1,570 5,130 3,560 1,618 5,178 Barclays International 286 2,735 3,021 289 2,435 2,724 Head Office 42 3 45 42 4 46 Total 3,888 4,308 8,196 3,891 4,057 7,948 |
Subordinated liabilities (Table
Subordinated liabilities (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Subordinated liabilities [abstract] | |
Subordinated liabilities | Half year ended 30.06.21 Year ended 31.12.20 £m £m Opening balance as at 1 January 16,341 18,156 Issuances 1,734 1,438 Redemptions (4,534) (3,464) Other (702) 211 Closing balance 12,839 16,341 |
Provisions (Tables)
Provisions (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Provisions [abstract] | |
Provisions | As at 30.06.21 As at 31.12.20 £m £m Customer redress 449 497 Legal, competition and regulatory matters 223 268 Redundancy and restructuring 88 158 Undrawn contractually committed facilities and guarantees 713 1,064 Onerous contracts 14 28 Sundry provisions 285 289 Total 1,772 2,304 |
Called up share capital (Tables
Called up share capital (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Equity [abstract] | |
Called up share capital | Ordinary share capital Share premium Total share capital and share premium Half year ended 30.06.21 £m £m £m Opening balance as at 1 January 4,340 297 4,637 Issue of shares under employee share schemes 3 22 25 Repurchase of shares (94) — (94) Closing balance 4,249 319 4,568 |
Other equity instruments (Table
Other equity instruments (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Miscellaneous components of equity [abstract] | |
Other equity instruments | Half year ended 30.06.21 Year ended 31.12.20 £m £m Opening balance as at 1 January 11,172 10,871 Issuances — 1,142 Redemptions — (831) Securities held by the Group (5) (10) Closing balance 11,167 11,172 |
Other reserves (Tables)
Other reserves (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of reserves within equity [abstract] | |
Other reserves | As at 30.06.21 As at 31.12.20 £m £m Currency translation reserve 2,376 2,871 Fair value through other comprehensive income reserve (245) 5 Cash flow hedging reserve 664 1,575 Own credit reserve (1,001) (954) Other reserves and treasury shares 1,062 964 Total 2,856 4,461 |
Contingent liabilities and co_2
Contingent liabilities and commitments (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of contingent liabilities [abstract] | |
Contingent liabilities and commitments | As at 30.06.21 As at 31.12.20 Contingent liabilities £m £m Guarantees and letters of credit pledged as collateral security 13,519 15,665 Performance guarantees, acceptances and endorsements 5,679 5,944 Total 19,198 21,609 Commitments Documentary credits and other short-term trade related transactions 1,017 1,086 Standby facilities, credit lines and other commitments 345,281 331,963 Total 346,298 333,049 |
Barclays PLC parent company b_2
Barclays PLC parent company balance sheet (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of subsidiaries [abstract] | |
Barclays PLC parent company balance sheet | As at 30.06.21 As at 31.12.20 Assets £m £m Investment in subsidiaries 58,828 58,886 Loans and advances to subsidiaries 23,295 24,710 Financial assets at fair value through the income statement 21,046 17,521 Derivative financial instruments 2 7 Other assets 19 65 Total assets 103,190 101,189 Liabilities Deposits at amortised cost 476 482 Cash collateral and settlement balances — — Debt securities in issue 26,663 28,428 Subordinated liabilities 9,170 7,724 Financial liabilities designated at fair value 12,130 9,507 Other liabilities 135 176 Total liabilities 48,574 46,317 Equity Called up share capital 4,249 4,340 Share premium account 319 297 Other equity instruments 11,169 11,169 Other reserves 488 394 Retained earnings 38,391 38,672 Total equity 54,616 54,872 Total liabilities and equity 103,190 101,189 |
Credit Risk (Tables)
Credit Risk (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure of credit risk exposure [abstract] | |
Disclosure of provision matrix | The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio by stage allocation and business segment as at 30 June 2021. Also included are off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio by stage allocation as at 30 June 2021. Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as ECL is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision. Gross exposure Impairment allowance Net exposure Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 30.06.21 £m £m £m £m £m £m £m £m £m Barclays UK 158,587 23,576 2,715 184,878 313 1,035 944 2,292 182,586 Barclays International 23,286 2,886 1,760 27,932 575 781 1,004 2,360 25,572 Head Office 4,003 502 760 5,265 3 39 358 400 4,865 Total Barclays Group retail 185,876 26,964 5,235 218,075 891 1,855 2,306 5,052 213,023 Barclays UK 36,069 1,727 1,081 38,877 63 49 89 201 38,676 Barclays International 82,515 13,617 1,425 97,557 231 329 673 1,233 96,324 Head Office 522 3 32 557 — — 31 31 526 Total Barclays Group wholesale 1 119,106 15,347 2,538 136,991 294 378 793 1,465 135,526 Total loans and advances at amortised cost 304,982 42,311 7,773 355,066 1,185 2,233 3,099 6,517 348,549 Off-balance sheet loan commitments and financial guarantee contracts 2 298,150 45,696 664 344,510 228 436 49 713 343,797 Total 3 603,132 88,007 8,437 699,576 1,413 2,669 3,148 7,230 692,346 As at 30.06.21 Half year ended 30.06.21 Coverage ratio Loan impairment release and loan loss rate Stage 1 Stage 2 Stage 3 Total Loan impairment release Loan loss rate % % % % £m bps Barclays UK 0.2 4.4 34.8 1.2 (259) — Barclays International 2.5 27.1 57.0 8.4 (19) — Head Office 0.1 7.8 47.1 7.6 (6) — Total Barclays Group retail 0.5 6.9 44.0 2.3 (284) — Barclays UK 0.2 2.8 8.2 0.5 (23) — Barclays International 0.3 2.4 47.2 1.3 (75) — Head Office — — 96.9 5.6 — — Total Barclays Group wholesale 1 0.2 2.5 31.2 1.1 (98) — Total loans and advances at amortised cost 0.4 5.3 39.9 1.8 (382) — Off-balance sheet loan commitments and financial guarantee contracts 2 0.1 1.0 7.4 0.2 (343) Other financial assets subject to impairment 3 (17) Total 0.2 3.0 37.3 1.0 (742) 1 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £7,796m of balances reported as wholesale loans on page 30 in the Loans and advances at amortised cost by product disclosure. 2 Excludes loan commitments and financial guarantees of £21bn carried at fair value. 3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn and impairment allowance of £114m. This comprises £9m ECL on £185.8bn Stage 1 assets, £3m on £58m Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £102m on £109m Stage 3 other assets. Gross exposure Impairment allowance Net exposure Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 31.12.20 £m £m £m £m £m £m £m £m £m Barclays UK 153,250 23,896 2,732 179,878 332 1,509 1,147 2,988 176,890 Barclays International 1 21,048 5,500 1,992 28,540 396 1,329 1,205 2,930 25,610 Head Office 4,267 720 844 5,831 4 51 380 435 5,396 Total Barclays Group retail 178,565 30,116 5,568 214,249 732 2,889 2,732 6,353 207,896 Barclays UK 31,918 4,325 1,126 37,369 13 129 116 258 37,111 Barclays International 1 79,911 16,565 2,270 98,746 288 546 859 1,693 97,053 Head Office 570 — 33 603 — — 31 31 572 Total Barclays Group wholesale 2 112,399 20,890 3,429 136,718 301 675 1,006 1,982 134,736 Total loans and advances at amortised cost 290,964 51,006 8,997 350,967 1,033 3,564 3,738 8,335 342,632 Off-balance sheet loan commitments and financial guarantee contracts 3 289,939 52,891 2,330 345,160 256 758 50 1,064 344,096 Total 4 580,903 103,897 11,327 696,127 1,289 4,322 3,788 9,399 686,728 As at 31.12.20 Year ended 31.12.20 Coverage ratio Loan impairment charge and loan loss rate 5 Stage 1 Stage 2 Stage 3 Total Loan impairment charge Loan loss rate % % % % £m bps Barclays UK 0.2 6.3 42.0 1.7 1,070 59 Barclays International 1 1.9 24.2 60.5 10.3 1,680 589 Head Office 0.1 7.1 45.0 7.5 91 156 Total Barclays Group retail 0.4 9.6 49.1 3.0 2,841 133 Barclays UK — 3.0 10.3 0.7 154 41 Barclays International 1 0.4 3.3 37.8 1.7 914 93 Head Office — — 93.9 5.1 — — Total Barclays Group wholesale 2 0.3 3.2 29.3 1.4 1,068 78 Total loans and advances at amortised cost 0.4 7.0 41.5 2.4 3,909 111 Off-balance sheet loan commitments and financial guarantee contracts 3 0.1 1.4 2.1 0.3 776 Other financial assets subject to impairment 4 153 Total 5 0.2 4.2 33.4 1.4 4,838 1 Private Banking have refined the methodology to classify £5bn of their exposure between Wholesale and Retail during the year. 2 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £7,551m of balances reported as wholesale loans on page 30 in the Loans and advances at amortised cost by product disclosure. 3 Excludes loan commitments and financial guarantees of £9.5bn carried at fair value. 4 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn and impairment allowance of £165m. This comprises £11m ECL on £175.7bn Stage 1 assets, £9m on £4.4bn Stage 2 fair value through other comprehensive income assets,other assets and cash collateral and settlement balances and £145m on £154m Stage 3 other assets. 5 The loan loss rate is 138 bps after applying the total impairment charge of £4,838m. Loans and advances at amortised cost by product The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification. Stage 2 As at 30.06.21 Stage 1 Not past due <=30 days past due >30 days past due Total Stage 3 Total Gross exposure £m £m £m £m £m £m £m Home loans 144,103 17,991 1,666 823 20,480 2,235 166,818 Credit cards, unsecured loans and other retail lending 34,537 5,642 300 209 6,151 2,773 43,461 Wholesale loans 126,342 14,760 529 391 15,680 2,765 144,787 Total 304,982 38,393 2,495 1,423 42,311 7,773 355,066 Impairment allowance Home loans 15 56 6 7 69 389 473 Credit cards, unsecured loans and other retail lending 834 1,547 100 120 1,767 1,852 4,453 Wholesale loans 336 381 5 11 397 858 1,591 Total 1,185 1,984 111 138 2,233 3,099 6,517 Net exposure Home loans 144,088 17,935 1,660 816 20,411 1,846 166,345 Credit cards, unsecured loans and other retail lending 33,703 4,095 200 89 4,384 921 39,008 Wholesale loans 126,006 14,379 524 380 15,283 1,907 143,196 Total 303,797 36,409 2,384 1,285 40,078 4,674 348,549 Coverage ratio % % % % % % % Home loans — 0.3 0.4 0.9 0.3 17.4 0.3 Credit cards, unsecured loans and other retail lending 2.4 27.4 33.3 57.4 28.7 66.8 10.2 Wholesale loans 0.3 2.6 0.9 2.8 2.5 31.0 1.1 Total 0.4 5.2 4.4 9.7 5.3 39.9 1.8 As at 31.12.20 Gross exposure £m £m £m £m £m £m £m Home loans 138,639 16,651 1,785 876 19,312 2,234 160,185 Credit cards, unsecured loans and other retail lending 33,021 9,470 544 306 10,320 3,172 46,513 Wholesale loans 119,304 19,501 1,097 776 21,374 3,591 144,269 Total 290,964 45,622 3,426 1,958 51,006 8,997 350,967 Impairment allowance Home Loans 33 57 13 14 84 421 538 Credit cards, unsecured loans and other retail lending 680 2,382 180 207 2,769 2,251 5,700 Wholesale Loans 320 650 50 11 711 1,066 2,097 Total 1,033 3,089 243 232 3,564 3,738 8,335 Net exposure Home loans 138,606 16,594 1,772 862 19,228 1,813 159,647 Credit cards, unsecured loans and other retail lending 32,341 7,088 364 99 7,551 921 40,813 Wholesale loans 118,984 18,851 1,047 765 20,663 2,525 142,172 Total 289,931 42,533 3,183 1,726 47,442 5,259 342,632 Coverage ratio % % % % % % % Home loans — 0.3 0.7 1.6 0.4 18.8 0.3 Credit cards, unsecured loans and other retail lending 2.1 25.2 33.1 67.6 26.8 71.0 12.3 Wholesale loans 0.3 3.3 4.6 1.4 3.3 29.7 1.5 Total 0.4 6.8 7.1 11.8 7.0 41.5 2.4 Loans and advances at amortised cost by selected sectors The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance, with gross exposure and stage allocation for selected industry sectors within the wholesale loans portfolio. The industry sectors have been selected based upon the level of management focus they have received following the onset of the COVID-19 pandemic. The gross loans and advances to selected sectors have decreased over the year driven by repayments and lower drawdowns. The reduction in provisions is informed by the improved macroeconomic outlook used in the Q221 scenario refresh, partially offset by management judgments to reflect the risk of uncertainty still prevailing within these sectors. The wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against systemic losses. An additional £0.1bn (December 2020: £0.1bn) impairment allowance has been applied to the undrawn exposures not included in the table below. Gross exposure Impairment allowance Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 30.06.21 £m £m £m £m £m £m £m £m Air travel 305 322 21 648 3 13 18 34 Hospitality and leisure 4,019 1,907 298 6,224 48 68 49 165 Oil and gas 1,877 465 234 2,576 14 12 128 154 Retail 4,089 962 148 5,199 63 30 44 137 Shipping 485 220 12 717 5 35 — 40 Transportation 1,768 161 102 2,031 20 4 37 61 Total 12,543 4,037 815 17,395 153 162 276 591 Total of Wholesale exposures 10 % 26 % 29 % 12 % 45 % 41 % 32 % 37 % Gross exposure Impairment allowance Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 31.12.20 £m £m £m £m £m £m £m £m Air travel 367 525 56 948 9 27 23 59 Hospitality and leisure 4,440 2,387 313 7,140 53 115 61 229 Oil and gas 1,754 854 465 3,073 31 27 140 198 Retail 3,907 1,153 283 5,343 78 51 108 237 Shipping 308 389 12 709 2 30 1 33 Transportation 1,148 253 125 1,526 19 10 57 86 Total 11,924 5,561 1,254 18,739 192 260 390 842 Total of Wholesale exposures 10 % 26 % 35 % 13 % 60 % 37 % 37 % 40 % |
Disclosure of credit risk | The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An explanation of the terms 12-month ECL, lifetime ECL and credit-impaired is included in the Barclays PLC Annual Report 2020 on page 296. Transfers between stages in the table have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 6-month period. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL Home loans £m £m £m £m £m £m £m £m As at 1 January 2021 138,639 33 19,312 84 2,234 421 160,185 538 Transfers from Stage 1 to Stage 2 (6,369) (2) 6,369 2 — — — — Transfers from Stage 2 to Stage 1 3,615 21 (3,615) (21) — — — — Transfers to Stage 3 (160) — (337) (7) 497 7 — — Transfers from Stage 3 21 — 119 3 (140) (3) — — Business activity in the year 19,231 2 380 1 — — 19,611 3 Changes to models used for calculation 1 — — — (4) — 38 — 34 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (4,670) (38) (667) 13 (124) (54) (5,461) (79) Final repayments (6,204) (1) (1,081) (2) (220) (8) (7,505) (11) Disposals — — — — — — — — Write-offs 2 — — — — (12) (12) (12) (12) As at 30 June 2021 3 144,103 15 20,480 69 2,235 389 166,818 473 Credit cards, unsecured loans and other retail lending As at 1 January 2021 33,021 680 10,320 2,769 3,172 2,251 46,513 5,700 Transfers from Stage 1 to Stage 2 (1,590) (72) 1,590 72 — — — — Transfers from Stage 2 to Stage 1 4,376 1,080 (4,376) (1,080) — — — — Transfers to Stage 3 (264) (12) (572) (282) 836 294 — — Transfers from Stage 3 30 25 38 14 (68) (39) — — Business activity in the year 3,855 50 58 14 31 8 3,944 72 Changes to models used for calculation 1 — (5) — (33) — 14 — (24) Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 4 (3,134) (866) (808) 310 (123) 282 (4,065) (274) Final repayments (1,757) (46) (99) (17) (140) (50) (1,996) (113) Disposals 5 — — — — (101) (74) (101) (74) Write-offs 2 — — — — (834) (834) (834) (834) As at 30 June 2021 3 34,537 834 6,151 1,767 2,773 1,852 43,461 4,453 1 Changes to models used for calculation include a £34m movement in Home loans, £24m in Credit cards, unsecured loans and other retail lending and £36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. 2 In H121, gross write-offs amounted to £1,001m (H120: £953m) and post write-off recoveries amounted to £31m (H120: £15m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £970m (H120: £938m). 3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn (December 2020: £180.3bn) and impairment allowance of £114m (December 2020: £165m). This comprises £9m ECL (December 2020: £11m) on £185.8bn stage 1 assets (December 2020: £175.7bn), £3m (December 2020: £9m) on £58m stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 2020: £4.4bn) and £102m (December 2020: £145m) on £109m stage 3 other assets (December 2020: £154m). 4 Transfers and risk parameter changes include a £0.3bn net release in ECL arising from a reclassification of £2.2bn gross loans and advances from Stage 2 to Stage 1 in Credit cards, unsecured loans and other retail lending. The reclassification followed a review of back-testing of results which indicated that accuracy of origination probability of default characteristics require management adjustments to correct and was first established in Q220. 5 The £101m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relates to debt sales undertaken during the year. The £1.7bn disposal reported within Wholesale loans includes a sale of £0.7bn debt securities as part of Group Treasury Operations and a £1.0bn sale of Barclays Asset Finance. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL Wholesale loans £m £m £m £m £m £m £m £m As at 1 January 2021 119,304 320 21,374 711 3,591 1,066 144,269 2,097 Transfers from Stage 1 to Stage 2 (4,636) (12) 4,636 12 — — — — Transfers from Stage 2 to Stage 1 8,410 188 (8,410) (188) — — — — Transfers to Stage 3 (249) (2) (226) (17) 475 19 — — Transfers from Stage 3 515 14 376 13 (891) (27) — — Business activity in the year 23,266 35 1,181 30 191 22 24,638 87 Changes to models used for calculation 1 — (7) — (29) — — — (36) Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 81 (153) (47) (37) (185) (1) (151) (191) Final repayments (18,854) (39) (3,042) (95) (203) (33) (22,099) (167) Disposals 2 (1,495) (8) (162) (3) (58) (33) (1,715) (44) Write-offs 3 — — — — (155) (155) (155) (155) As at 30 June 2021 4 126,342 336 15,680 397 2,765 858 144,787 1,591 Reconciliation of ECL movement to impairment charge/(release) for the period £m Home loans (53) Credit cards, unsecured loans and other retail lending (339) Wholesale loans (307) ECL movement excluding assets derecognised due to disposals and write-offs (699) Recoveries and reimbursements 5 185 Exchange and other adjustments 6 132 Impairment charge on loan commitments and other financial guarantees (343) Impairment charge on other financial assets 4 (17) Income statement release for the period (742) 1 Changes to models used for calculation include a £34m movement in Home Loans, £24m in Credit cards, unsecured loans and other retail lending and £36m in Wholesale loans. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. 2 The £101m disposals reported within Credit cards, unsecured loans and other retail lending portfolio relates to debt sales undertaken during the year. The £1.7bn disposal reported within Wholesale loans includes a sale of £0.7bn debt securities as part of Group Treasury Operations and a £1.0bn sale of Barclays Asset Finance. 3 In H121, gross write-offs amounted to £1,001m (H120: £953m) and post write-off recoveries amounted to £31m (H120: £15m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £970m (H120: £938m). 4 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £186.0bn (December 2020: £180.3bn) and impairment allowance of £114m (December 2020: £165m). This comprises £9m ECL (December 2020: £11m) on £185.8bn stage 1 assets (December 2020: £175.7bn), £3m (December 2020: £9m) on £58m stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 2020: £4.4bn) and £102m (December 2020: £145m) on £109m stage 3 other assets (December 2020: £154m). 5 Recoveries and reimbursements includes a net loss in relation to reimbursements from financial guarantee contracts held with third parties of £216m (H120 gain: £279m) and post write off recoveries of £31m (H120: £15m). 6 Includes foreign exchange and interest and fees in suspense. Loan commitments and financial guarantees Stage 1 Stage 2 Stage 3 Total Gross ECL Gross ECL Gross ECL Gross ECL Home loans £m £m £m £m £m £m £m £m As at 1 January 2021 11,861 — 516 — 5 — 12,382 — Net transfers between stages (74) — 71 — 3 — — — Business activity in the year 6,287 — 1 — — — 6,288 — Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (7,397) — (17) — (2) — (7,416) — Limit management and final repayments (238) — (22) — (3) — (263) — As at 30 June 2021 10,439 — 549 — 3 — 10,991 — Credit cards, unsecured loans and other retail lending As at 1 January 2021 114,371 55 12,117 305 229 23 126,717 383 Net transfers between stages 5,784 217 (6,081) (212) 297 (5) — — Business activity in the year 3,378 1 32 1 1 1 3,411 3 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes (1,005) (215) 114 63 (248) 4 (1,139) (148) Limit management and final repayments (4,941) (4) (398) (5) (57) (3) (5,396) (12) As at 30 June 2021 117,587 54 5,784 152 222 20 123,593 226 Wholesale loans As at 1 January 2021 163,707 201 40,258 453 2,096 27 206,061 681 Net transfers between stages 682 116 504 (112) (1,186) (4) — — Business activity in the year 37,211 28 2,915 89 12 9 40,138 126 Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes 1,603 (146) 680 (63) (28) 2 2,255 (207) Limit management and final repayments (33,079) (25) (4,994) (83) (455) (5) (38,528) (113) As at 30 June 2021 170,124 174 39,363 284 439 29 209,926 487 |
Drivers of loan impairment charge | Overview of management adjustments to models for impairment allowance 1 As at 30.06.21 As at 31.12.20 Management adjustments to impairment allowances Proportion of total impairment allowances Management adjustments to impairment allowances Proportion of total impairment allowances £m % £m % Home loans 83 17.5 131 24.3 Credit cards, unsecured loans and other retail lending 1,145 24.5 1,234 20.3 Wholesale loans 643 30.9 23 0.8 Total 1,871 25.9 1,388 14.8 Management adjustments to models for impairment allowance 1 Impairment allowance pre management adjustments 2 Economic uncertainty adjustments Other adjustments Total impairment allowance As at 30.06.21 £m £m £m £m Home loans 390 41 42 473 Credit cards, unsecured loans and other retail lending 3,534 1,398 (253) 4,679 Wholesale loans 1,435 651 (8) 2,078 Total 5,359 2,090 (219) 7,230 As at 31.12.20 Home loans 407 21 110 538 Credit cards, unsecured loans and other retail lending 4,849 1,625 (391) 6,083 Wholesale loans 2,755 421 (398) 2,778 Total 8,011 2,067 (679) 9,399 1 Positive values reflect an increase in impairment allowance. 2 Includes £4.3bn (December 2020: £6.8bn) of modelled ECL, £0.8bn (December 2020: £0.9bn) of individually assessed impairments and £0.3bn (December 2020: £0.3bn) ECL from non-modelled exposures. |
Macroeconomic variables used in the calculation of ECL and the respective scenario probability weighting | Baseline average macroeconomic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 4.9 5.6 2.3 UK unemployment 2 5.8 5.7 5.1 UK HPI 3 (0.5) 0.3 3.1 UK bank rate 0.1 0.2 0.4 US GDP 1 5.7 3.9 1.6 US unemployment 4 5.6 4.5 4.4 US HPI 5 3.9 3.5 3.5 US federal funds rate 0.3 0.3 0.7 As at 31.12.20 UK GDP 1 6.3 3.3 2.6 UK unemployment 2 6.7 6.4 5.8 UK HPI 3 2.4 2.3 5.0 UK bank rate — (0.1) — US GDP 1 3.9 3.1 2.9 US unemployment 4 6.9 5.7 5.6 US HPI 5 2.8 4.7 4.7 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Downside 2 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 (1.7) 2.0 5.2 UK unemployment 2 7.3 8.2 6.6 UK HPI 3 (5.8) (5.8) 0.2 UK bank rate 0.1 — — US GDP 1 1.5 1.4 2.0 US unemployment 4 8.7 11.0 9.3 US HPI 5 (4.9) (3.0) 1.1 US federal funds rate 0.3 0.3 0.3 As at 31.12.20 UK GDP 1 (3.9) 6.5 2.6 UK unemployment 2 8.0 9.3 7.8 UK HPI 3 (13.6) (10.8) 0.5 UK bank rate (0.2) (0.2) (0.1) US GDP 1 (2.4) 3.6 2.1 US unemployment 4 13.4 11.9 10.1 US HPI 5 (17.2) (0.7) 0.6 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA house price index, relative to prior year end. Downside 1 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 0.6 4.4 4.2 UK unemployment 2 6.4 6.6 5.6 UK HPI 3 (3.1) (2.7) 1.7 UK bank rate 0.1 0.1 0.2 US GDP 1 3.4 2.5 1.6 US unemployment 4 7.4 7.9 6.1 US HPI 5 (0.5) 0.2 2.3 US federal funds rate 0.3 0.3 0.3 As at 31.12.20 UK GDP 1 0.1 6.6 3.2 UK unemployment 2 7.3 8.0 6.9 UK HPI 3 (6.7) (3.5) 1.7 UK bank rate (0.1) (0.1) — US GDP 1 0.4 3.6 2.3 US unemployment 4 11.0 8.9 6.9 US HPI 5 (5.9) 1.8 2.6 US federal funds rate 0.3 0.3 0.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Upside 2 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 6.8 9.4 4.0 UK unemployment 2 5.5 4.9 4.4 UK HPI 3 4.6 9.9 11.3 UK bank rate 0.1 0.4 0.6 US GDP 1 6.5 8.2 3.4 US unemployment 4 5.3 3.8 3.8 US HPI 5 6.5 8.0 7.3 US federal funds rate 0.3 0.3 1.1 As at 31.12.20 UK GDP 1 12.2 5.3 3.9 UK unemployment 2 6.2 5.5 4.8 UK HPI 3 6.6 10.4 10.8 UK bank rate 0.1 0.3 0.3 US GDP 1 7.1 4.6 4.0 US unemployment 4 5.5 4.3 4.1 US HPI 5 8.8 9.1 8.9 US federal funds rate 0.3 0.4 0.6 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Upside 1 average economic variables used in the calculation of ECL 2021 2022 2023 As at 30.06.21 % % % UK GDP 1 5.9 7.3 3.0 UK unemployment 2 5.6 5.2 4.7 UK HPI 3 1.5 4.5 7.4 UK bank rate 0.1 0.2 0.6 US GDP 1 6.1 5.8 2.4 US unemployment 4 5.5 4.2 4.2 US HPI 5 6.2 6.8 5.7 US federal funds rate 0.3 0.3 0.9 As at 31.12.20 UK GDP 1 9.3 3.9 3.4 UK unemployment 2 6.4 6.0 5.2 UK HPI 3 4.6 6.1 6.1 UK bank rate 0.1 0.1 0.3 US GDP 1 5.5 4.0 3.7 US unemployment 4 6.0 4.8 4.6 US HPI 5 6.8 6.7 6.3 US federal funds rate 0.3 0.3 0.5 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in average yearly US HPI = FHFA House Price Index, relative to prior year end. Scenario probability weighting Upside 2 Upside 1 Baseline Downside 1 Downside 2 % % % % % As at 30.06.21 Scenario probability weighting 19.6 24.5 26.4 16.9 12.6 As at 31.12.20 Scenario probability weighting 20.2 24.2 24.7 15.5 15.4 Specific bases show the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to the start point in the 20 quarter period. Macroeconomic variables (specific bases) 1 Upside 2 Upside 1 Baseline Downside 1 Downside 2 As at 30.06.21 % % % % % UK GDP 2 25.9 20.2 3.3 (4.2) (8.1) UK unemployment 3 4.1 4.3 5.1 7.5 9.8 UK HPI 4 48.2 25.5 1.6 (5.8) (11.8) UK bank rate 3 0.1 0.1 0.4 0.3 0.1 US GDP 2 23.7 18.3 2.8 (0.2) (3.2) US unemployment 3 3.8 4.2 4.7 8.9 12.0 US HPI 4 41.2 32.6 3.6 (1.3) (7.9) US federal funds rate 3 0.3 0.3 0.8 1.5 0.8 As at 31.12.20 UK GDP 2 14.2 8.8 0.7 (22.1) (22.1) UK unemployment 3 4.0 4.0 5.7 8.4 10.1 UK HPI 4 48.2 30.8 3.6 (4.5) (18.3) UK bank rate 3 0.1 0.1 — 0.6 0.6 US GDP 2 15.7 12.8 1.6 (10.6) (10.6) US unemployment 3 3.8 3.8 6.4 13.0 13.7 US HPI 4 42.2 30.9 3.8 (3.7) (15.9) US federal funds rate 3 0.1 0.1 0.3 1.3 1.3 1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period starts from Q121 (2020: Q120). 2 Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year yearly average Compound Annual Growth Rate (CAGR) in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios. 3 Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter in 20 quarter period in Downside scenarios. 4 Maximum growth relative to Q420 (2020: Q419), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q420 (2020: Q419), based on 20 quarter period in Downside scenarios. Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively. Macroeconomic variables (5 year averages) 1 Upside 2 Upside 1 Baseline Downside 1 Downside 2 As at 30.06.21 % % % % % UK GDP 2 5.2 4.2 3.3 2.6 1.8 UK unemployment 3 4.6 4.8 5.1 5.7 6.5 UK HPI 4 8.2 4.7 1.6 — (1.6) UK bank rate 3 0.7 0.6 0.4 0.2 — US GDP 2 4.6 3.7 2.8 2.0 1.4 US unemployment 3 4.1 4.4 4.7 6.3 8.5 US HPI 4 7.1 5.8 3.6 1.6 (0.4) US federal funds rate 3 1.1 0.9 0.8 0.6 0.3 As at 31.12.20 UK GDP 2 2.5 1.6 0.7 0.1 (0.9) UK unemployment 3 5.0 5.3 5.7 6.5 7.2 UK HPI 4 8.2 5.5 3.6 (0.2) (3.6) UK bank rate 3 0.3 0.2 — — (0.1) US GDP 2 2.9 2.4 1.6 0.8 0.1 US unemployment 3 5.3 5.7 6.4 8.3 10.4 US HPI 4 7.3 5.5 3.8 0.8 (3.0) US federal funds rate 3 0.5 0.5 0.3 0.3 0.3 1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 2 5-year yearly average CAGR, starting 2020 (2020: 2019). 3 5-year average. Period based on 20 quarters from Q121 (2020: Q120). 4 5-year quarter end CAGR, starting Q420 (2020: Q419). |
ECL under 100% weighted scenarios for key principal portfolios | Scenarios As at 30.06.21 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2 Stage 1 Model Exposure (£m) Home loans 131,134 133,584 132,343 130,694 128,711 126,953 Credit cards, unsecured loans and other retail lending 44,014 45,185 44,809 44,307 42,383 39,252 Wholesale loans 160,174 162,762 162,201 160,564 158,614 152,164 Stage 1 Model ECL (£m) Home loans 4 2 3 4 6 8 Credit cards, unsecured loans and other retail lending 379 269 288 324 456 486 Wholesale loans 248 187 203 224 306 352 Stage 1 Coverage (%) Home loans — — — — — — Credit cards, unsecured loans and other retail lending 0.9 0.6 0.6 0.7 1.1 1.2 Wholesale loans 0.2 0.1 0.1 0.1 0.2 0.2 Stage 2 Model Exposure (£m) Home loans 24,345 21,895 23,136 24,785 26,769 28,526 Credit cards, unsecured loans and other retail lending 7,175 5,733 6,205 6,819 9,066 12,625 Wholesale loans 33,666 31,077 31,639 33,276 35,225 41,676 Stage 2 Model ECL (£m) Home loans 20 13 15 18 27 39 Credit cards, unsecured loans and other retail lending 1,076 733 841 976 1,544 2,517 Wholesale loans 773 594 646 709 939 1,342 Stage 2 Coverage (%) Home loans 0.1 0.1 0.1 0.1 0.1 0.1 Credit cards, unsecured loans and other retail lending 15.0 12.8 13.6 14.3 17.0 19.9 Wholesale loans 2.3 1.9 2.0 2.1 2.7 3.2 Stage 3 Model Exposure (£m) Home loans 1,829 1,829 1,829 1,829 1,829 1,829 Credit cards, unsecured loans and other retail lending 2,374 2,374 2,374 2,374 2,374 2,374 Wholesale loans 1 1,374 1,374 1,374 1,374 1,374 1,374 Stage 3 Model ECL (£m) Home loans 324 307 315 325 337 352 Credit cards, unsecured loans and other retail lending 1,878 1,850 1,864 1,875 1,905 1,920 Wholesale loans 1 67 65 66 67 69 72 Stage 3 Coverage (%) Home loans 17.7 16.8 17.2 17.8 18.4 19.2 Credit cards, unsecured loans and other retail lending 79.1 77.9 78.5 79.0 80.2 80.9 Wholesale loans 1 4.9 4.7 4.8 4.9 5.0 5.2 Total Model ECL (£m) Home loans 348 322 333 347 370 399 Credit cards, unsecured loans and other retail lending 3,333 2,852 2,993 3,175 3,905 4,923 Wholesale loans 1 1,088 846 915 1,000 1,314 1,766 Total Model ECL 4,769 4,020 4,241 4,522 5,589 7,088 1 Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £783m is reported as individually assessed impairments in the table below. Reconciliation to total ECL £m Total model ECL 4,769 ECL from individually assessed impairments on stage 3 loans 783 ECL from non-modelled and other management adjustments 1 1,678 Total ECL 7,230 1 Includes £1.9bn post-model adjustments of which £0.4bn is included as part of total model ECL and £0.2bn ECL from non-modelled exposures. The dispersion of results around the Baseline is an indication of uncertainty around the future projections. The disclosure highlights the results of the alternative scenarios enabling the reader to understand the extent of the impact on exposure and ECL from the upside/downside scenarios. Consequently, the use of five scenarios with associated weightings results in a total weighted ECL uplift from the Baseline ECL of 5.5%, largely driven by credit card losses which have more linear loss profiles than UK home loans and wholesale loan positions. Home loans: Total weighted ECL of £348m represents a 0.3% increase over the Baseline ECL (£347m), and coverage ratios remain steady across the Upside scenarios, Baseline and Downside 1 scenario. However, total ECL increases in the Downside 2 scenario to £399m, driven by a significant fall in UK HPI (11.8%) reflecting the non-linearity of the UK portfolio. Credit cards, unsecured loans and other retail lending: Total weighted ECL of £3,333m represents a 5% increase over the Baseline ECL (£3,175m) reflecting the range of economic scenarios used, mainly impacted by unemployment and other key retail variables. Total ECL increases to £4,923m under Downside 2 scenario, mainly driven by Stage 2, where coverage rates increase to 19.9% from a weighted scenario approach of 15% and circa £5.5bn increase in model exposure that meets the Significant Increase in Credit Risk criteria and transitions from Stage 1 to Stage 2. Wholesale loans: Total weighted ECL of £1,088m represents an 8.8% increase over the Baseline ECL (£1,000m) reflecting the range of economic scenarios used, with exposures in the Investment Bank particularly sensitive to the Downside 2 scenario. Scenarios As at 31.12.20 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2 Stage 1 Model Exposure (£m) Home loans 131,422 134,100 133,246 132,414 130,547 128,369 Credit cards, unsecured loans and other retail lending 51,952 53,271 52,932 51,995 50,168 48,717 Wholesale loans 149,099 155,812 154,578 152,141 144,646 131,415 Stage 1 Model ECL (£m) Home loans 6 4 5 6 14 42 Credit cards, unsecured loans and other retail lending 392 316 340 372 415 415 Wholesale loans 262 242 258 249 278 290 Stage 1 Coverage (%) Home loans — — — — — — Credit cards, unsecured loans and other retail lending 0.8 0.6 0.6 0.7 0.8 0.9 Wholesale loans 0.2 0.2 0.2 0.2 0.2 0.2 Stage 2 Model Exposure (£m) Home loans 19,180 16,502 17,356 18,188 20,055 22,233 Credit cards, unsecured loans and other retail lending 13,399 10,572 11,579 13,176 16,477 19,322 Wholesale loans 32,677 25,963 27,198 29,635 37,130 50,361 Stage 2 Model ECL (£m) Home loans 37 31 32 33 42 63 Credit cards, unsecured loans and other retail lending 2,207 1,618 1,837 2,138 2,865 3,564 Wholesale loans 1,410 952 1,047 1,223 1,771 2,911 Stage 2 Coverage (%) Home loans 0.2 0.2 0.2 0.2 0.2 0.3 Credit cards, unsecured loans and other retail lending 16.5 15.3 15.9 16.2 17.4 18.4 Wholesale loans 4.3 3.7 3.8 4.1 4.8 5.8 Stage 3 Model Exposure (£m) Home loans 1,778 1,778 1,778 1,778 1,778 1,778 Credit cards, unsecured loans and other retail lending 2,585 2,585 2,585 2,585 2,585 2,585 Wholesale loans 1 2,211 2,211 2,211 2,211 2,211 2,211 Stage 3 Model ECL (£m) Home loans 307 282 286 290 318 386 Credit cards, unsecured loans and other retail lending 2,003 1,947 1,972 2,001 2,055 2,078 Wholesale loans 1 146 128 134 141 157 184 Stage 3 Coverage (%) Home loans 17.3 15.9 16.1 16.3 17.9 21.7 Credit cards, unsecured loans and other retail lending 77.5 75.3 76.3 77.4 79.5 80.4 Wholesale loans 1 6.6 5.8 6.1 6.4 7.1 8.3 Total Model ECL (£m) Home loans 350 317 323 329 374 491 Credit cards, unsecured loans and other retail lending 4,602 3,881 4,149 4,511 5,335 6,057 Wholesale loans 1 1,818 1,322 1,439 1,613 2,206 3,385 Total Model ECL 6,770 5,520 5,911 6,453 7,915 9,933 1 Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £902m is reported as individually assessed impairments in the table below. Reconciliation to total ECL 1 £m Total model ECL 6,770 ECL from individually assessed impairments on stage 3 loans 902 ECL from non-modelled and other management adjustments 1,727 Total ECL 9,399 1 Includes £1.4bn of post-model adjustments and £0.3bn ECL from non-modelled exposures. |
Segmental reporting - Analysis
Segmental reporting - Analysis of results by business (Details) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | ||
Disclosure of operating segments [line items] | ||||
Total income | £ 11,315 | £ 11,621 | ||
Credit impairment releases/(charges) | 742 | (3,738) | £ (4,838) | |
Net operating income | 12,057 | 7,883 | ||
Operating expenses | (7,132) | (6,563) | ||
Litigation and conduct | (99) | (30) | ||
Total operating expenses | (7,231) | (6,593) | ||
Other net income/(expenses) | 153 | (18) | ||
Profit before tax | 4,979 | 1,272 | [1] | |
Total assets | 1,376,333 | 1,349,514 | ||
Operating segments | Barclays UK | ||||
Disclosure of operating segments [line items] | ||||
Total income | 3,199 | 3,171 | ||
Credit impairment releases/(charges) | 443 | (1,064) | ||
Net operating income | 3,642 | 2,107 | ||
Operating expenses | (2,114) | (2,041) | ||
Litigation and conduct | (22) | (11) | ||
Total operating expenses | (2,136) | (2,052) | ||
Other net income/(expenses) | 0 | 13 | ||
Profit before tax | 1,506 | 68 | ||
Total assets | 311,200 | 289,100 | ||
Operating segments | Barclays International | ||||
Disclosure of operating segments [line items] | ||||
Total income | 8,218 | 8,654 | ||
Credit impairment releases/(charges) | 293 | (2,619) | ||
Net operating income | 8,511 | 6,035 | ||
Operating expenses | (4,606) | (4,405) | ||
Litigation and conduct | (84) | (11) | ||
Total operating expenses | (4,690) | (4,416) | ||
Other net income/(expenses) | 22 | 10 | ||
Profit before tax | 3,843 | 1,629 | ||
Total assets | 1,046,800 | 1,041,800 | ||
Head Office | ||||
Disclosure of operating segments [line items] | ||||
Total income | (102) | (204) | ||
Credit impairment releases/(charges) | 6 | (55) | ||
Net operating income | (96) | (259) | ||
Operating expenses | (412) | (117) | ||
Litigation and conduct | 7 | (8) | ||
Total operating expenses | (405) | (125) | ||
Other net income/(expenses) | 131 | (41) | ||
Profit before tax | (370) | £ (425) | ||
Total assets | £ 18,300 | £ 18,600 | ||
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. |
Segmental reporting - Split of
Segmental reporting - Split of income by geographic region (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of operating segments [line items] | ||
Total income | £ 11,315 | £ 11,621 |
United Kingdom | ||
Disclosure of operating segments [line items] | ||
Total income | 5,895 | 5,989 |
Europe | ||
Disclosure of operating segments [line items] | ||
Total income | 1,222 | 1,199 |
Americas | ||
Disclosure of operating segments [line items] | ||
Total income | 3,608 | 3,776 |
Africa and Middle East | ||
Disclosure of operating segments [line items] | ||
Total income | 20 | 20 |
Asia | ||
Disclosure of operating segments [line items] | ||
Total income | £ 570 | £ 637 |
Net fee and commission income_2
Net fee and commission income (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | £ 4,620 | £ 4,339 |
Other non-contract fee income | 62 | 60 |
Fee and commission income | 4,682 | 4,399 |
Fee and commission expense | (976) | (1,090) |
Net fee and commission income | 3,706 | 3,309 |
Transactional | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1,589 | 1,543 |
Advisory | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 543 | 386 |
Brokerage and execution | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 662 | 787 |
Underwriting and syndication | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1,715 | 1,468 |
Other | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 111 | 155 |
Operating segments | Barclays UK | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 635 | 605 |
Other non-contract fee income | 0 | 0 |
Fee and commission income | 635 | 605 |
Fee and commission expense | (108) | (148) |
Net fee and commission income | 527 | 457 |
Operating segments | Barclays UK | Transactional | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 408 | 386 |
Operating segments | Barclays UK | Advisory | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 83 | 79 |
Operating segments | Barclays UK | Brokerage and execution | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 109 | 102 |
Operating segments | Barclays UK | Underwriting and syndication | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Operating segments | Barclays UK | Other | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 35 | 38 |
Operating segments | Barclays International | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 3,981 | 3,731 |
Other non-contract fee income | 62 | 60 |
Fee and commission income | 4,043 | 3,791 |
Fee and commission expense | (861) | (940) |
Net fee and commission income | 3,182 | 2,851 |
Operating segments | Barclays International | Transactional | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1,181 | 1,157 |
Operating segments | Barclays International | Advisory | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 459 | 306 |
Operating segments | Barclays International | Brokerage and execution | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 553 | 685 |
Operating segments | Barclays International | Underwriting and syndication | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1,715 | 1,468 |
Operating segments | Barclays International | Other | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 73 | 115 |
Head Office | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 4 | 3 |
Other non-contract fee income | 0 | 0 |
Fee and commission income | 4 | 3 |
Fee and commission expense | (7) | (2) |
Net fee and commission income | (3) | 1 |
Head Office | Transactional | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Head Office | Advisory | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 1 | 1 |
Head Office | Brokerage and execution | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Head Office | Underwriting and syndication | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | 0 | 0 |
Head Office | Other | ||
Disclosure of disaggregation of revenue from contracts with customers [line items] | ||
Total revenue from contracts with customers | £ 3 | £ 2 |
Staff costs (Details)
Staff costs (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Compensation costs | ||
Upfront bonus charge | £ 824 | £ 476 |
Deferred bonus charge | 262 | 269 |
Other incentives | 6 | 4 |
Performance costs | 1,092 | 749 |
Salaries | 2,117 | 2,153 |
Social security costs | 336 | 317 |
Post-retirement benefits | 275 | 268 |
Other compensation costs | 223 | 254 |
Total compensation costs | 4,043 | 3,741 |
Other resourcing costs | ||
Outsourcing | 171 | 175 |
Redundancy and restructuring | 23 | 39 |
Temporary staff costs | 55 | 58 |
Other | 42 | 40 |
Total other resourcing costs | 291 | 312 |
Total staff costs | £ 4,334 | £ 4,053 |
Barclays Group compensation costs as a % of total income | 35.70% | 32.20% |
Share-based payment arrangements | Fair value | Forward contract [member] | ||
Other resourcing costs | ||
Financial instruments designated as hedging instruments, at fair value | £ 158 |
Infrastructure, administratio_3
Infrastructure, administration and general expenses (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Infrastructure costs | ||
Property and equipment | £ 709 | £ 757 |
Depreciation and amortisation | 832 | 751 |
Lease payments | 20 | 26 |
Impairment of property, equipment and intangible assets | 304 | 32 |
Total infrastructure costs | 1,865 | 1,566 |
Administration and general expenses | ||
Consultancy, legal and professional fees | 262 | 270 |
Marketing and advertising | 163 | 158 |
Other administration and general expenses | 508 | 516 |
Total administration and general expenses | 933 | 944 |
Total infrastructure, administration and general expenses | £ 2,798 | £ 2,510 |
Tax (Narrative) (Details)
Tax (Narrative) (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax charge | £ 759 | £ 113 |
Effective tax rate | 15.20% | 8.90% |
Tax expense income excluding effect of tax rate change | £ 1,151 | |
Average effective tax rate excluding effect of tax rate change | 23.10% | |
AT1 Securities | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax charge | £ (104) | £ (112) |
UK | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Applicable tax rate | 19.00% | |
Increase (decrease) relating to tax rate changes or imposition of new taxes, deferred tax liability (asset) | £ (223) | |
Deferred tax expense (income) relating to tax rate changes or imposition of new taxes | 392 | |
Deferred tax expense (income) relating to tax rate changes or imposition of new taxes, other comprehensive income | £ 169 |
Tax - Deferred tax assets and l
Tax - Deferred tax assets and liabilities (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax assets | £ 3,771 | £ 3,444 |
Deferred tax liabilities | (8) | (15) |
Temporary differences | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax assets | 2,972 | 2,709 |
Tax losses | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax assets | 799 | 735 |
USA | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax assets | 1,908 | 2,049 |
UK | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax assets | 1,380 | 886 |
Other territories | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax assets | £ 483 | £ 509 |
Non-controlling interests (Deta
Non-controlling interests (Details) - GBP (£) £ in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | |
Profit attributable to non-controlling interests | £ 19 | £ 37 | |
Equity attributable to non-controlling interests | 1,064 | £ 1,085 | |
Other non-controlling interests | |||
Profit attributable to non-controlling interests | 3 | 0 | |
Equity attributable to non-controlling interests | 2 | 23 | |
Barclays Bank PLC | - Preference shares | |||
Profit attributable to non-controlling interests | 13 | 28 | |
Equity attributable to non-controlling interests | 529 | 529 | |
Barclays Bank PLC | - Upper T2 instruments | |||
Profit attributable to non-controlling interests | 3 | £ 9 | |
Equity attributable to non-controlling interests | £ 533 | £ 533 |
Earnings per share (Details)
Earnings per share (Details) - GBP (£) £ / shares in Units, £ in Millions, shares in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Earnings per share [abstract] | ||
Profit attributable to ordinary equity holders of the parent | £ 3,812 | £ 695 |
Basic weighted average number of shares in issue (in shares) | 17,140 | 17,294 |
Number of potential ordinary shares (in shares) | 467 | 319 |
Diluted weighted average number of shares (in shares) | 17,607 | 17,613 |
Basic earnings per ordinary share (in GBP per share) | £ 0.222 | £ 0.040 |
Diluted earnings per ordinary share (in GBP per share) | £ 0.217 | £ 0.039 |
Dividends on ordinary shares (D
Dividends on ordinary shares (Details) - GBP (£) £ / shares in Units, £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Dividends on ordinary shares [Abstract] | ||
Dividends paid, ordinary shares per share (in GBP per share) | £ 0.010 | £ 0 |
Dividends paid, ordinary shares | £ 173 | £ 0 |
Dividends on ordinary shares (N
Dividends on ordinary shares (Narrative) (Details) - GBP (£) £ / shares in Units, £ in Millions | 3 Months Ended | 6 Months Ended | |
Sep. 30, 2021 | Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of classes of share capital [line items] | |||
Repurchase of shares | £ (700) | ||
Share buyback | Maximum | |||
Disclosure of classes of share capital [line items] | |||
Repurchase of shares | £ 500 | ||
Ordinary share capital | |||
Disclosure of classes of share capital [line items] | |||
Interim dividends, per share | £ 0.020 | £ 0 | |
Number of shares comprising, one american depository share | 4 | ||
Repurchase of shares | £ (94) | ||
Qualifying American Despository Shares | |||
Disclosure of classes of share capital [line items] | |||
Interim dividends, per share | £ 0.080 |
Derivative financial instrume_3
Derivative financial instruments - Total recognised derivative assets/(liabilities) (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of detailed information about financial instruments [line items] | ||
Derivative assets | £ 256,636 | £ 302,446 |
Derivative liabilities | (247,034) | (300,775) |
Derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 46,203,824 | 43,359,755 |
Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative assets | 256,636 | 302,446 |
Derivative liabilities | (247,034) | (300,775) |
Derivatives in hedge accounting relationships | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 200,752 | 189,784 |
Derivatives in hedge accounting relationships | Derivatives designated as cash flow hedges | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 91,278 | 74,437 |
Derivatives in hedge accounting relationships | Derivatives designated as fair value hedges | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 107,879 | 114,556 |
Derivatives in hedge accounting relationships | Derivatives designated as hedges of net investments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 1,595 | 791 |
Derivatives in hedge accounting relationships | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative assets designated in hedge accounting relationships | 940 | 566 |
Derivative liabilities designated in hedge accounting relationships | (1,000) | (980) |
Derivatives in hedge accounting relationships | Fair value | Derivatives designated as cash flow hedges | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative assets designated in hedge accounting relationships | 806 | 386 |
Derivative liabilities designated in hedge accounting relationships | 0 | 0 |
Derivatives in hedge accounting relationships | Fair value | Derivatives designated as fair value hedges | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative assets designated in hedge accounting relationships | 128 | 155 |
Derivative liabilities designated in hedge accounting relationships | (993) | (980) |
Derivatives in hedge accounting relationships | Fair value | Derivatives designated as hedges of net investments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative assets designated in hedge accounting relationships | 6 | 25 |
Derivative liabilities designated in hedge accounting relationships | (7) | 0 |
Held for trading | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 46,003,072 | 43,169,971 |
Held for trading | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative financial assets held for trading | 255,696 | 301,880 |
Derivative financial liabilities held for trading | 246,034 | 299,795 |
Held for trading | Foreign exchange derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 5,654,026 | 5,554,037 |
Held for trading | Foreign exchange derivatives | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative financial assets held for trading | 66,963 | 84,739 |
Derivative financial liabilities held for trading | 64,194 | 84,381 |
Held for trading | Interest rate derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 37,888,009 | 35,257,371 |
Held for trading | Interest rate derivatives | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative financial assets held for trading | 134,734 | 172,144 |
Derivative financial liabilities held for trading | 123,436 | 162,402 |
Held for trading | Credit derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 920,030 | 847,845 |
Held for trading | Credit derivatives | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative financial assets held for trading | 5,469 | 4,605 |
Derivative financial liabilities held for trading | 5,960 | 5,004 |
Held for trading | Equity and stock index and commodity derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Contract notional amount | 1,541,007 | 1,510,718 |
Held for trading | Equity and stock index and commodity derivatives | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Derivative financial assets held for trading | 48,530 | 40,392 |
Derivative financial liabilities held for trading | £ 52,444 | £ 48,008 |
Derivative financial instrume_4
Derivative financial instruments, narrative (Details) - GBP (£) £ in Billions | 6 Months Ended | 12 Months Ended |
Jun. 30, 2021 | Dec. 31, 2020 | |
Derivative financial liabilities | ||
Disclosure of offsetting of financial assets [line items] | ||
Gross financial assets set off against financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements | £ 31 | £ 42 |
Derivative liability expsoures | 225 | 276 |
Non-cash assets pledged as collateral | 3 | 4 |
Cash collateral netted | Derivative financial liabilities | ||
Disclosure of offsetting of financial assets [line items] | ||
Gross financial assets set off against financial liabilities subject to offsetting, enforceable master netting arrangements or similar agreements | 5 | 7 |
Derivative liability expsoures | 31 | 43 |
Derivative financial assets | ||
Disclosure of offsetting of financial assets [line items] | ||
IFRS netting posted against derivative assets | 33 | 44 |
Derivative asset exposures | 230 | 276 |
Non-cash collateral | 5 | 5 |
Derivative financial assets | Cash collateral netted | ||
Disclosure of offsetting of financial assets [line items] | ||
IFRS netting posted against derivative assets | 4 | 5 |
Derivative asset exposures | £ 36 | £ 43 |
Fair value of financial instr_3
Fair value of financial instruments - Assets and liabilities held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | £ 147,239 | £ 127,950 |
Financial assets at fair value through the income statement | 194,421 | 175,151 |
Derivative financial instruments | 256,636 | 302,446 |
Financial assets at fair value through other comprehensive income | 73,260 | 78,688 |
Trading portfolio liabilities | (56,986) | (47,405) |
Financial liabilities designated at fair value | (264,164) | (249,765) |
Derivative financial instruments | (247,034) | (300,775) |
Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | 147,239 | 127,950 |
Financial assets at fair value through the income statement | 194,421 | 175,151 |
Derivative financial instruments | 256,636 | 302,446 |
Financial assets at fair value through other comprehensive income | 73,260 | 78,688 |
Investment property | 8 | 10 |
Total assets | 671,564 | 684,245 |
Trading portfolio liabilities | (56,986) | (47,405) |
Financial liabilities designated at fair value | (264,164) | (249,765) |
Derivative financial instruments | (247,034) | (300,775) |
Total liabilities | (568,184) | (597,945) |
(Level 1) | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | 73,405 | 60,671 |
Financial assets at fair value through the income statement | 1,229 | 4,503 |
Derivative financial instruments | 11,643 | 9,155 |
Financial assets at fair value through other comprehensive income | 21,375 | 19,792 |
Investment property | 0 | 0 |
Total assets | 107,652 | 94,121 |
Trading portfolio liabilities | (30,911) | (24,391) |
Financial liabilities designated at fair value | (142) | (159) |
Derivative financial instruments | (11,227) | (8,762) |
Total liabilities | (42,280) | (33,312) |
(Level 2) | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | 71,282 | 65,416 |
Financial assets at fair value through the income statement | 185,415 | 162,142 |
Derivative financial instruments | 241,336 | 288,822 |
Financial assets at fair value through other comprehensive income | 51,837 | 58,743 |
Investment property | 0 | 0 |
Total assets | 549,870 | 575,123 |
Trading portfolio liabilities | (26,058) | (22,986) |
Financial liabilities designated at fair value | (263,710) | (249,251) |
Derivative financial instruments | (230,207) | (285,774) |
Total liabilities | (519,975) | (558,011) |
(Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total assets | 14,042 | 15,001 |
Total liabilities | (5,929) | (6,622) |
(Level 3) | Fair value | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading portfolio assets | 2,552 | 1,863 |
Financial assets at fair value through the income statement | 7,777 | 8,506 |
Derivative financial instruments | 3,657 | 4,469 |
Financial assets at fair value through other comprehensive income | 48 | 153 |
Investment property | 8 | 10 |
Total assets | 14,042 | 15,001 |
Trading portfolio liabilities | (17) | (28) |
Financial liabilities designated at fair value | (312) | (355) |
Derivative financial instruments | (5,600) | (6,239) |
Total liabilities | £ (5,929) | £ (6,622) |
Fair value of financial instr_4
Fair value of financial instruments - Level 3 assets and liabilities held at fair value disaggregated by product type (Details) - (Level 3) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | £ 14,042 | £ 15,001 |
Financial liabilities, at fair value | (5,929) | (6,622) |
Asset backed securities | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 562 | 767 |
Financial liabilities, at fair value | 0 | (24) |
Corporate debt | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 981 | 698 |
Financial liabilities, at fair value | (38) | (3) |
Reverse repurchase and repurchase agreements | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 0 | 0 |
Financial liabilities, at fair value | (161) | (174) |
Non-asset backed loans | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 6,338 | 6,394 |
Financial liabilities, at fair value | 0 | 0 |
Equity cash products | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 402 | 542 |
Financial liabilities, at fair value | 0 | 0 |
Private equity investments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 979 | 873 |
Financial liabilities, at fair value | (16) | (14) |
Other | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 1,123 | 1,258 |
Financial liabilities, at fair value | (114) | (168) |
Interest rate derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 916 | 1,613 |
Financial liabilities, at fair value | (1,269) | (1,615) |
Foreign exchange derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 151 | 144 |
Financial liabilities, at fair value | (129) | (143) |
Credit derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 100 | 196 |
Financial liabilities, at fair value | (364) | (351) |
Equity derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 2,490 | 2,498 |
Financial liabilities, at fair value | (3,838) | (4,112) |
Commodity derivatives | ||
Disclosure of detailed information about financial instruments [line items] | ||
Financial assets, at fair value | 0 | 18 |
Financial liabilities, at fair value | £ 0 | £ (18) |
Fair value of financial instr_5
Fair value of financial instruments - Analysis of movements in Level 3 assets and liabilities (Details) - GBP (£) £ in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | |
Net assets (liabilities) [abstract] | |||
Derivative financial assets | £ 256,636 | £ 302,446 | |
Derivative financial liabilities | 247,034 | £ 300,775 | |
(Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 15,001 | ||
Ending balance, financial assets | 14,042 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (6,622) | ||
Ending balance, financial liabilities | (5,929) | ||
Recurring fair value measurement | (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, assets (liabilities) | 8,379 | £ 10,010 | |
Purchases, fair value measurement, assets (liabilities) net | 3,904 | 4,594 | |
Sales, fair value measurement, assets (liabilities) net | (3,407) | (3,252) | |
Issues, fair value measurement, assets (liabilities) net | 0 | (3) | |
Settlements, fair value measurement, assets (liabilities) net | (845) | (1,028) | |
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 2 | (4) | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 459 | 507 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 101 | (432) | |
Ending balance, assets (liabilities) | 8,113 | 10,934 | |
Derivative financial assets | 3,657 | 7,748 | |
Derivative financial liabilities | 5,600 | 8,932 | |
Recurring fair value measurement | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (591) | 548 | |
Recurring fair value measurement | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 111 | (6) | |
Recurring fair value measurement | Investment property | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 10 | 13 | |
Purchases, fair value measurement, assets | 0 | 0 | |
Sales, fair value measurement, assets | (2) | (1) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 2 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | (2) | |
Ending balance, financial assets | 8 | 10 | |
Recurring fair value measurement | Investment property | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Recurring fair value measurement | Investment property | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | (2) | |
Recurring fair value measurement | Net derivative financial instruments | (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, assets (liabilities) | (1,770) | (834) | |
Purchases, fair value measurement, assets (liabilities) net | (423) | (688) | |
Sales, fair value measurement, assets (liabilities) net | 1 | 10 | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | 54 | (361) | |
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 53 | 302 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 476 | (33) | |
Ending balance, assets (liabilities) | (1,943) | (1,184) | |
Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (336) | 418 | |
Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 2 | 2 | |
Trading portfolio liabilities | Recurring fair value measurement | (Level 3) | |||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (28) | 0 | |
Purchases, fair value measurement, liabilities | (3) | 0 | |
Sales, fair value measurement, liabilities | 14 | 0 | |
Issues, fair value measurement, liabilities | 0 | 0 | |
Settlements, fair value measurement, liabilities | 0 | 0 | |
Gains (losses) recognised in other comprehensive income including exchange differences, fair value measurement, liabilities | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, liabilities | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, liabilities | 7 | 0 | |
Ending balance, financial liabilities | (17) | 0 | |
Trading portfolio liabilities | Recurring fair value measurement | (Level 3) | Financial liabilities at fair value through profit or loss, category trading | |||
Categories of financial liabilities [abstract] | |||
Total gains and losses in the period recognised in the income statement, liabilities | (7) | 0 | |
Trading portfolio liabilities | Recurring fair value measurement | (Level 3) | Financial liabilities at fair value through profit or loss, category other income | |||
Categories of financial liabilities [abstract] | |||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | 0 | |
Financial liabilities designated at fair value | Recurring fair value measurement | (Level 3) | |||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (355) | (362) | |
Purchases, fair value measurement, liabilities | 0 | 0 | |
Sales, fair value measurement, liabilities | 0 | 1 | |
Issues, fair value measurement, liabilities | 0 | (3) | |
Settlements, fair value measurement, liabilities | 98 | 0 | |
Gains (losses) recognised in other comprehensive income including exchange differences, fair value measurement, liabilities | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, liabilities | (78) | (22) | |
Transfers out of Level 3 of fair value hierarchy, liabilities | 18 | 25 | |
Ending balance, financial liabilities | (312) | (369) | |
Financial liabilities designated at fair value | Recurring fair value measurement | (Level 3) | Financial liabilities at fair value through profit or loss, category trading | |||
Categories of financial liabilities [abstract] | |||
Total gains and losses in the period recognised in the income statement, liabilities | 7 | (10) | |
Financial liabilities designated at fair value | Recurring fair value measurement | (Level 3) | Financial liabilities at fair value through profit or loss, category other income | |||
Categories of financial liabilities [abstract] | |||
Total gains and losses in the period recognised in the income statement, liabilities | (2) | 2 | |
Asset backed securities | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 767 | ||
Ending balance, financial assets | 562 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (24) | ||
Ending balance, financial liabilities | 0 | ||
Interest rate derivatives | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 1,613 | ||
Ending balance, financial assets | 916 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (1,615) | ||
Ending balance, financial liabilities | (1,269) | ||
Interest rate derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, assets (liabilities) | (2) | (206) | |
Purchases, fair value measurement, assets (liabilities) net | 9 | 18 | |
Sales, fair value measurement, assets (liabilities) net | 0 | 0 | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | 33 | 10 | |
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 21 | 300 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | (297) | (10) | |
Ending balance, assets (liabilities) | (353) | 381 | |
Interest rate derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (121) | 268 | |
Interest rate derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 4 | 1 | |
Foreign exchange derivatives | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 144 | ||
Ending balance, financial assets | 151 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (143) | ||
Ending balance, financial liabilities | (129) | ||
Foreign exchange derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, assets (liabilities) | 1 | (7) | |
Purchases, fair value measurement, assets (liabilities) net | 0 | 0 | |
Sales, fair value measurement, assets (liabilities) net | 0 | 0 | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | 58 | (12) | |
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 3 | 5 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | (34) | (8) | |
Ending balance, assets (liabilities) | 22 | 67 | |
Foreign exchange derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (6) | 89 | |
Foreign exchange derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |
Credit derivatives | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 196 | ||
Ending balance, financial assets | 100 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (351) | ||
Ending balance, financial liabilities | (364) | ||
Credit derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, assets (liabilities) | (155) | 198 | |
Purchases, fair value measurement, assets (liabilities) net | (117) | (258) | |
Sales, fair value measurement, assets (liabilities) net | 2 | 11 | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | (5) | (376) | |
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 1 | 2 | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | (1) | 8 | |
Ending balance, assets (liabilities) | (264) | (263) | |
Credit derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 12 | 151 | |
Credit derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (1) | 1 | |
Equity derivatives | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 2,498 | ||
Ending balance, financial assets | 2,490 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (4,112) | ||
Ending balance, financial liabilities | (3,838) | ||
Equity derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | |||
Net assets (liabilities) [abstract] | |||
Beginning balance, assets (liabilities) | (1,614) | (819) | |
Purchases, fair value measurement, assets (liabilities) net | (315) | (448) | |
Sales, fair value measurement, assets (liabilities) net | (1) | (1) | |
Issues, fair value measurement, assets (liabilities) net | 0 | 0 | |
Settlements, fair value measurement, assets (liabilities) net | (32) | 17 | |
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 28 | (5) | |
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 808 | (23) | |
Ending balance, assets (liabilities) | (1,348) | (1,369) | |
Equity derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category trading income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (221) | (90) | |
Equity derivatives | Recurring fair value measurement | Net derivative financial instruments | (Level 3) | Net assets (liabilities) at fair value through profit or loss, category other income | |||
Net assets (liabilities) [abstract] | |||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (1) | 0 | |
Corporate debt | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 698 | ||
Ending balance, financial assets | 981 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (3) | ||
Ending balance, financial liabilities | (38) | ||
Non-asset backed loans | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 6,394 | ||
Ending balance, financial assets | 6,338 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | 0 | ||
Ending balance, financial liabilities | 0 | ||
Equity cash products | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 542 | ||
Ending balance, financial assets | 402 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | 0 | ||
Ending balance, financial liabilities | 0 | ||
Private equity investments | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 873 | ||
Ending balance, financial assets | 979 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (14) | ||
Ending balance, financial liabilities | (16) | ||
Other | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 1,258 | ||
Ending balance, financial assets | 1,123 | ||
Categories of financial liabilities [abstract] | |||
Beginning balance, financial liabilities | (168) | ||
Ending balance, financial liabilities | (114) | ||
Trading portfolio assets | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 1,863 | 2,264 | |
Purchases, fair value measurement, assets | 1,071 | 2,250 | |
Sales, fair value measurement, assets | (529) | (968) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (135) | (80) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 398 | 178 | |
Transfers out of Level 3 of fair value hierarchy, assets | (175) | (352) | |
Ending balance, financial assets | 2,552 | 3,078 | |
Trading portfolio assets | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 59 | (214) | |
Trading portfolio assets | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Asset backed securities | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 686 | 656 | |
Purchases, fair value measurement, assets | 112 | 249 | |
Sales, fair value measurement, assets | (294) | (224) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | (76) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 43 | 41 | |
Transfers out of Level 3 of fair value hierarchy, assets | (48) | (11) | |
Ending balance, financial assets | 489 | 623 | |
Trading portfolio assets | Asset backed securities | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | (10) | (12) | |
Trading portfolio assets | Asset backed securities | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Corporate debt | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 151 | 120 | |
Purchases, fair value measurement, assets | 305 | 25 | |
Sales, fair value measurement, assets | (87) | 0 | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 40 | 4 | |
Transfers out of Level 3 of fair value hierarchy, assets | (11) | (17) | |
Ending balance, financial assets | 423 | 106 | |
Trading portfolio assets | Corporate debt | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 25 | (26) | |
Trading portfolio assets | Corporate debt | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Non-asset backed loans | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 709 | 974 | |
Purchases, fair value measurement, assets | 620 | 1,926 | |
Sales, fair value measurement, assets | (131) | (740) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (84) | (4) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 124 | 97 | |
Transfers out of Level 3 of fair value hierarchy, assets | (106) | (320) | |
Ending balance, financial assets | 1,145 | 1,822 | |
Trading portfolio assets | Non-asset backed loans | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 13 | (111) | |
Trading portfolio assets | Non-asset backed loans | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Equity cash products | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 214 | 392 | |
Purchases, fair value measurement, assets | 13 | 2 | |
Sales, fair value measurement, assets | (17) | (4) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 29 | 28 | |
Transfers out of Level 3 of fair value hierarchy, assets | (9) | (4) | |
Ending balance, financial assets | 262 | 347 | |
Trading portfolio assets | Equity cash products | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 32 | (67) | |
Trading portfolio assets | Equity cash products | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Trading portfolio assets | Other | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 103 | 122 | |
Purchases, fair value measurement, assets | 21 | 48 | |
Sales, fair value measurement, assets | 0 | 0 | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (51) | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 162 | 8 | |
Transfers out of Level 3 of fair value hierarchy, assets | (1) | 0 | |
Ending balance, financial assets | 233 | 180 | |
Trading portfolio assets | Other | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | (1) | 2 | |
Trading portfolio assets | Other | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Financial assets at fair value through the income statement | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 8,506 | 8,500 | |
Purchases, fair value measurement, assets | 3,255 | 2,953 | |
Sales, fair value measurement, assets | (2,891) | (2,293) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (857) | (430) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 86 | 47 | |
Transfers out of Level 3 of fair value hierarchy, assets | (119) | (70) | |
Ending balance, financial assets | 7,777 | 9,052 | |
Financial assets at fair value through the income statement | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | (314) | 353 | |
Financial assets at fair value through the income statement | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 111 | (8) | |
Financial assets at fair value through the income statement | Non-asset backed loans | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 5,580 | 5,494 | |
Purchases, fair value measurement, assets | 698 | 1,050 | |
Sales, fair value measurement, assets | (299) | (270) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (687) | (410) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 69 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | (48) | (58) | |
Ending balance, financial assets | 5,194 | 6,187 | |
Financial assets at fair value through the income statement | Non-asset backed loans | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | (119) | 381 | |
Financial assets at fair value through the income statement | Non-asset backed loans | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Financial assets at fair value through the income statement | Equity cash products | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 326 | 835 | |
Purchases, fair value measurement, assets | 160 | 14 | |
Sales, fair value measurement, assets | (194) | 0 | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | 0 | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 1 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | 0 | |
Ending balance, financial assets | 140 | 799 | |
Financial assets at fair value through the income statement | Equity cash products | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | (171) | (22) | |
Financial assets at fair value through the income statement | Equity cash products | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 18 | (28) | |
Financial assets at fair value through the income statement | Private equity investments | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 874 | 900 | |
Purchases, fair value measurement, assets | 106 | 19 | |
Sales, fair value measurement, assets | (9) | (6) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (8) | (2) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 23 | |
Transfers out of Level 3 of fair value hierarchy, assets | (71) | (12) | |
Ending balance, financial assets | 979 | 880 | |
Financial assets at fair value through the income statement | Private equity investments | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | (5) | 2 | |
Financial assets at fair value through the income statement | Private equity investments | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 92 | (44) | |
Financial assets at fair value through the income statement | Other | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 1,726 | 1,271 | |
Purchases, fair value measurement, assets | 2,291 | 1,870 | |
Sales, fair value measurement, assets | (2,389) | (2,017) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (162) | (18) | |
Total gains or losses recognised in OCI, assets | 0 | 0 | |
Transfers into Level 3 of fair value hierarchy, assets | 16 | 24 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | 0 | |
Ending balance, financial assets | 1,464 | 1,186 | |
Financial assets at fair value through the income statement | Other | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | (19) | (8) | |
Financial assets at fair value through the income statement | Other | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 1 | 64 | |
Assets at fair value through other comprehensive income | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 153 | 429 | |
Purchases, fair value measurement, assets | 4 | 79 | |
Sales, fair value measurement, assets | 0 | (1) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (5) | (157) | |
Total gains or losses recognised in OCI, assets | 2 | (4) | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | (106) | 0 | |
Ending balance, financial assets | 48 | 347 | |
Assets at fair value through other comprehensive income | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 1 | |
Assets at fair value through other comprehensive income | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Assets at fair value through other comprehensive income | Asset backed securities | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 47 | 86 | |
Purchases, fair value measurement, assets | 4 | 0 | |
Sales, fair value measurement, assets | 0 | (1) | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | (5) | 0 | |
Total gains or losses recognised in OCI, assets | 2 | (1) | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | 0 | 0 | |
Ending balance, financial assets | 48 | 85 | |
Assets at fair value through other comprehensive income | Asset backed securities | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 1 | |
Assets at fair value through other comprehensive income | Asset backed securities | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Assets at fair value through other comprehensive income | Non-asset backed loans | Recurring fair value measurement | (Level 3) | |||
Categories of financial assets [abstract] | |||
Beginning balance, financial assets | 106 | 343 | |
Purchases, fair value measurement, assets | 0 | 79 | |
Sales, fair value measurement, assets | 0 | 0 | |
Issues, fair value measurement, assets | 0 | 0 | |
Settlements, fair value measurement, assets | 0 | (157) | |
Total gains or losses recognised in OCI, assets | 0 | (3) | |
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |
Transfers out of Level 3 of fair value hierarchy, assets | (106) | 0 | |
Ending balance, financial assets | 0 | 262 | |
Assets at fair value through other comprehensive income | Non-asset backed loans | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category trading | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |
Assets at fair value through other comprehensive income | Non-asset backed loans | Recurring fair value measurement | (Level 3) | Financial assets at fair value through profit or loss, category other income | |||
Categories of financial assets [abstract] | |||
Total gains and losses in the period recognised in the income statement, assets | £ 0 | £ 0 |
Fair value of financial instr_6
Fair value of financial instruments - Unrealised gains and losses recognised in the period on Level 3 assets and liabilities held at period end (Details) - GBP (£) £ in Millions | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | £ 3,482 | £ 4,198 |
Other income | 72 | 27 |
Other compre hensive income | (1,600) | 2,889 |
(Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | (532) | 452 |
Other income | 114 | (56) |
Other compre hensive income | 0 | (2) |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | (418) | 394 |
(Level 3) | Non-current assets/liabilities held for sale | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 0 | 0 |
Other income | 0 | 0 |
Other compre hensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | 0 | 0 |
(Level 3) | Investment properties | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 0 | 0 |
Other income | 0 | (2) |
Other compre hensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | 0 | (2) |
(Level 3) | Net derivative financial instruments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | (367) | 248 |
Other income | 0 | 0 |
Other compre hensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | (367) | 248 |
Trading portfolio liabilities | (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | (6) | 0 |
Other income | 0 | 0 |
Other compre hensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | (6) | 0 |
Financial liabilities designated at fair value | (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 7 | (16) |
Other income | 0 | (1) |
Other compre hensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | 7 | (17) |
Trading portfolio assets | (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 35 | (177) |
Other income | 0 | 0 |
Other compre hensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | 35 | (177) |
Financial assets at fair value through the income statement | (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | (201) | 397 |
Other income | 114 | (53) |
Other compre hensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | (87) | 344 |
Assets at fair value through other comprehensive income | (Level 3) | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 0 | 0 |
Other income | 0 | 0 |
Other compre hensive income | 0 | (2) |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | £ 0 | £ (2) |
Fair value of financial instr_7
Fair value of financial instruments - Sensitivity analysis of valuations using unobservable inputs (Details) - (Level 3) - Recurring fair value measurement - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | £ 893 | £ 903 |
Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 3 |
Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (993) | (1,171) |
Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | (3) |
Corporate debt | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 22 | 16 |
Corporate debt | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Corporate debt | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (16) | (14) |
Corporate debt | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Non-asset backed loans | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 202 | 190 |
Non-asset backed loans | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 3 |
Non-asset backed loans | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (310) | (409) |
Non-asset backed loans | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | (3) |
Equity cash products | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 130 | 158 |
Equity cash products | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Equity cash products | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (119) | (141) |
Equity cash products | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Private equity investments | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 223 | 199 |
Private equity investments | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Private equity investments | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (198) | (227) |
Private equity investments | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Other | Favourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 18 | 21 |
Other | Favourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Other | Unfavourable changes | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (18) | (21) |
Other | Unfavourable changes | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Interest rate derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 52 | 82 |
Interest rate derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Interest rate derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (83) | (123) |
Interest rate derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Foreign exchange derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 6 | 6 |
Foreign exchange derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Foreign exchange derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (10) | (11) |
Foreign exchange derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Credit derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 53 | 55 |
Credit derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Credit derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (44) | (44) |
Credit derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Equity derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 185 | 174 |
Equity derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Equity derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (193) | (179) |
Equity derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Commodity derivatives | Favourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 2 | 2 |
Commodity derivatives | Favourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | 0 | 0 |
Commodity derivatives | Unfavourable changes | Derivatives | Income statement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | (2) | (2) |
Commodity derivatives | Unfavourable changes | Derivatives | Equity | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions | £ 0 | £ 0 |
Fair value of financial instr_8
Fair value of financial instruments - Narrative (Details) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended |
Jun. 30, 2021 | Dec. 31, 2020 | |
Disclosure of detailed information about financial instruments [line items] | ||
Deposits at amortised cost | £ 500,895 | £ 481,036 |
Brokered certificates of deposit | ||
Disclosure of detailed information about financial instruments [line items] | ||
Deposits at amortised cost | 1,241 | 1,494 |
(Level 3) | Recurring fair value measurement | Favourable changes | ||
Disclosure of detailed information about financial instruments [line items] | ||
Increase in fair value measurement due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, assets (liabilities) | 893 | 906 |
(Level 3) | Recurring fair value measurement | Unfavourable changes | ||
Disclosure of detailed information about financial instruments [line items] | ||
Decrease in fair value measurement due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, assets (liabilities) | 993 | 1,174 |
Exit price adjustments derived from market bid-offer spreads | ||
Disclosure of detailed information about financial instruments [line items] | ||
(Increase) decrease in fair value adjustments of derivatives | 7 | |
Fair value adjustments | (500) | (493) |
Uncollateralised derivative funding | ||
Disclosure of detailed information about financial instruments [line items] | ||
(Increase) decrease in fair value adjustments of derivatives | 35 | |
Fair value adjustments | (80) | (115) |
Derivative credit valuation adjustments | ||
Disclosure of detailed information about financial instruments [line items] | ||
(Increase) decrease in fair value adjustments of derivatives | 58 | |
Fair value adjustments | (210) | (268) |
Derivative debit valuation adjustments | ||
Disclosure of detailed information about financial instruments [line items] | ||
(Increase) decrease in fair value adjustments of derivatives | 22 | |
Fair value adjustments | 91 | 113 |
Financial instruments at fair value, category | (Level 3) | Recurring fair value measurement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 126 | 116 |
Additions, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 32 | 27 |
Amortisation and releases, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 22 | 24 |
Financial instruments at amortised cost, category | (Level 3) | Recurring fair value measurement | ||
Disclosure of detailed information about financial instruments [line items] | ||
Aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 240 | 247 |
Additions, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 0 | 6 |
Amortisation and releases, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | £ 7 | £ 14 |
Fair value of financial instr_9
Fair value of financial instruments - Fair value adjustments (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Exit price adjustments derived from market bid-offer spreads | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | £ (500) | £ (493) |
Uncollateralised derivative funding | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | (80) | (115) |
Derivative credit valuation adjustments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | (210) | (268) |
Derivative debit valuation adjustments | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | £ 91 | £ 113 |
Fair value of financial inst_10
Fair value of financial instruments - Comparison of carrying amounts and fair values for assets and liabilities not held at fair value (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Categories of financial assets [abstract] | |||
Loans and advances at amortised cost | £ 348,549 | £ 342,632 | |
Reverse repurchase agreements and other similar secured lending | 4,459 | 9,031 | |
Categories of financial liabilities [abstract] | |||
Deposits at amortised cost | (500,895) | (481,036) | |
Repurchase agreements and other similar secured borrowing | (20,005) | (14,174) | |
Debt securities in issue | (90,733) | (75,796) | |
Subordinated liabilities | (12,839) | (16,341) | £ (18,156) |
Fair value | |||
Categories of financial assets [abstract] | |||
Loans and advances at amortised cost | 347,733 | 340,516 | |
Reverse repurchase agreements and other similar secured lending | 4,459 | 9,031 | |
Categories of financial liabilities [abstract] | |||
Deposits at amortised cost | (500,933) | (481,106) | |
Repurchase agreements and other similar secured borrowing | (20,005) | (14,174) | |
Debt securities in issue | (92,746) | (77,813) | |
Subordinated liabilities | (13,434) | (16,918) | |
Carrying amount | |||
Categories of financial assets [abstract] | |||
Loans and advances at amortised cost | 348,549 | 342,632 | |
Reverse repurchase agreements and other similar secured lending | 4,459 | 9,031 | |
Categories of financial liabilities [abstract] | |||
Deposits at amortised cost | (500,895) | (481,036) | |
Repurchase agreements and other similar secured borrowing | (20,005) | (14,174) | |
Debt securities in issue | (90,733) | (75,796) | |
Subordinated liabilities | £ (12,839) | £ (16,341) |
Loans and advances and deposi_3
Loans and advances and deposits at amortised cost (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Deposits | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total deposits at amortised cost | £ 500,895 | £ 481,036 |
Banks | Deposits | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total deposits at amortised cost | 17,165 | 17,343 |
Customers | Deposits | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total deposits at amortised cost | 483,730 | 463,693 |
Total loans and advances at amortised cost | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total loans and advances at amortised cost | 348,549 | 342,632 |
Total loans and advances at amortised cost | Banks | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total loans and advances at amortised cost | 11,032 | 8,900 |
Total loans and advances at amortised cost | Customers | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total loans and advances at amortised cost | 309,194 | 309,927 |
Debt securities at amortised cost | ||
Disclosure of detailed information about financial instruments [line items] | ||
Total loans and advances at amortised cost | £ 28,323 | £ 23,805 |
Goodwill and intangible asset_2
Goodwill and intangible assets (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of reconciliation of changes in intangible assets and goodwill [line items] | ||
Goodwill | £ 3,888 | £ 3,891 |
Intangibles | 4,308 | 4,057 |
Goodwill and intangible assets | 8,196 | 7,948 |
Head Office | ||
Disclosure of reconciliation of changes in intangible assets and goodwill [line items] | ||
Goodwill | 42 | 42 |
Intangibles | 3 | 4 |
Goodwill and intangible assets | 45 | 46 |
Barclays UK | ||
Disclosure of reconciliation of changes in intangible assets and goodwill [line items] | ||
Goodwill | 3,560 | 3,560 |
Intangibles | 1,570 | 1,618 |
Goodwill and intangible assets | 5,130 | 5,178 |
Barclays International | ||
Disclosure of reconciliation of changes in intangible assets and goodwill [line items] | ||
Goodwill | 286 | 289 |
Intangibles | 2,735 | 2,435 |
Goodwill and intangible assets | £ 3,021 | £ 2,724 |
Subordinated liabilities (Detai
Subordinated liabilities (Details) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended |
Jun. 30, 2021 | Dec. 31, 2020 | |
Subordinated liabilities [abstract] | ||
Opening balance as at 1 January | £ 16,341 | £ 18,156 |
Issuances | 1,734 | 1,438 |
Redemptions | (4,534) | (3,464) |
Other | (702) | 211 |
Closing balance | £ 12,839 | £ 16,341 |
Subordinated liabilities - Narr
Subordinated liabilities - Narrative (Details) € in Millions, £ in Millions | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2021GBP (£) | Jun. 30, 2021EUR (€) | Dec. 31, 2020GBP (£) | Dec. 31, 2021 | |
Disclosure of detailed information about borrowings [line items] | ||||
Issuances | £ 1,734 | £ 1,438 | ||
Redemption of subordinated debt | 4,534 | £ 3,464 | ||
ZAR Notes | Floating interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Issuances | 82 | |||
USD Notes | Fixed interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Redemption of subordinated debt | 73 | |||
USD Notes | Floating interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Issuances | £ 73 | |||
10% GBP Notes | Fixed interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Borrowings, interest rate | 10.00% | 10.00% | ||
Redemption of subordinated debt | £ 1,961 | |||
6% EUR Notes | Fixed interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Borrowings, interest rate | 6.00% | 6.00% | ||
Redemption of subordinated debt | £ 1,339 | |||
10.179% USD Notes | Fixed interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Borrowings, interest rate | 10.179% | |||
Redemption of subordinated debt | 1,075 | |||
EUR Notes | Floating interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Redemption of subordinated debt | £ 86 | |||
Barclays PLC | 1.125% Resetting callable notes | Fixed interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Issuances | € | € 855 | |||
Borrowings, interest rate | 1.125% | 1.125% | ||
Barclays PLC | 3.811% Resetting callable notes | Fixed interest rate | ||||
Disclosure of detailed information about borrowings [line items] | ||||
Issuances | £ 724 | |||
Borrowings, interest rate | 3.811% | 3.811% |
Provisions - Total Provisions (
Provisions - Total Provisions (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of other provisions [line items] | ||
Provisions | £ 1,772 | £ 2,304 |
Customer redress | ||
Disclosure of other provisions [line items] | ||
Provisions | 449 | 497 |
Legal, competition and regulatory matters | ||
Disclosure of other provisions [line items] | ||
Provisions | 223 | 268 |
Redundancy and restructuring | ||
Disclosure of other provisions [line items] | ||
Provisions | 88 | 158 |
Undrawn contractually committed facilities and guarantees | ||
Disclosure of other provisions [line items] | ||
Provisions | 713 | 1,064 |
Onerous contracts | ||
Disclosure of other provisions [line items] | ||
Provisions | 14 | 28 |
Sundry provisions | ||
Disclosure of other provisions [line items] | ||
Provisions | £ 285 | £ 289 |
Retirement benefits (Narrative)
Retirement benefits (Narrative) (Details) - GBP (£) £ in Billions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of fair value of plan assets [line items] | ||
Surplus (deficit) in plan | £ (2.4) | £ (1.5) |
Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | Pension defined benefit plans | United Kingdom | ||
Disclosure of fair value of plan assets [line items] | ||
Surplus (deficit) in plan | £ (2.6) | £ (1.8) |
Retirement benefits - UKRF fund
Retirement benefits - UKRF funding valuations (Details) - GBP (£) £ in Millions | 1 Months Ended | 6 Months Ended | ||
Apr. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2019 | |
Disclosure of fair value of plan assets [line items] | ||||
Surplus (deficit) in plan | £ (2,400) | £ (1,500) | ||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | ||||
Disclosure of fair value of plan assets [line items] | ||||
Surplus (deficit) in plan | (2,600) | £ (1,800) | ||
Employer contributions | £ 350 | 1,000 | ||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | Deficit contributions 30 September 2019 valuation | ||||
Disclosure of fair value of plan assets [line items] | ||||
Surplus (deficit) in plan | £ 2,300 | |||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | Deficit contributions valuation recovery plan 2020 | ||||
Disclosure of fair value of plan assets [line items] | ||||
Surplus (deficit) in plan | 900 | |||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | 2021 | Barclays Bank PLC | ||||
Disclosure of fair value of plan assets [line items] | ||||
Employer contributions | 700 | |||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | 2022 | Barclays Bank PLC | ||||
Disclosure of fair value of plan assets [line items] | ||||
Employer contributions | 294 | |||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | 2023 | Barclays Bank PLC | ||||
Disclosure of fair value of plan assets [line items] | ||||
Employer contributions | 286 | |||
Pension defined benefit plans | Defined benefit plans other than multi-employer plans, state plans and plans that share risks between entities under common control | United Kingdom | Later than one month and not later than three months | ||||
Disclosure of fair value of plan assets [line items] | ||||
Estimate of contributions expected to be paid to plan for next annual reporting period | £ 350 |
Called up share capital (Detail
Called up share capital (Details) - GBP (£) £ in Millions | 6 Months Ended | |||
Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | ||
Beginning Balance, equity | £ 66,882 | £ 69,541 | £ 65,660 | |
Issue of shares under employee share schemes | 314 | (283) | 629 | |
Repurchase of shares | (700) | |||
Ending Balance, equity | 68,116 | 66,882 | 69,541 | |
Share premium | ||||
Beginning Balance, equity | 297 | |||
Issue of shares under employee share schemes | 22 | |||
Ending Balance, equity | 319 | 297 | ||
Total share capital and share premium | ||||
Beginning Balance, equity | [1] | 4,637 | 4,620 | 4,594 |
Issue of shares under employee share schemes | [1] | 25 | 17 | 26 |
Repurchase of shares | [1] | (94) | ||
Ending Balance, equity | [1] | 4,568 | 4,637 | £ 4,620 |
Ordinary share capital | ||||
Beginning Balance, equity | 4,340 | |||
Issue of shares under employee share schemes | 3 | |||
Repurchase of shares | (94) | |||
Ending Balance, equity | £ 4,249 | £ 4,340 | ||
[1] | Details of share capital, other equity instruments and other reserves are shown on pages 84 to 85. |
Called up share capital (Narrat
Called up share capital (Narrative) (Details) - GBP (£) £ / shares in Units, £ in Millions, shares in Millions | 6 Months Ended | |
Jun. 30, 2021 | Dec. 31, 2020 | |
Repurchase of treasury shares (in shares) | 377 | |
Repurchase of shares | £ (700) | |
Ordinary share capital | ||
Number of shares issued (in shares) | 16,998 | 17,359 |
Par value per share (in GBP per share) | £ 0.25 | £ 0.25 |
Repurchase of shares | £ (94) |
Other equity instruments (Detai
Other equity instruments (Details) - GBP (£) £ in Millions | 6 Months Ended | 12 Months Ended | ||||
Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2020 | |||
Opening balance as at 1 January | £ 11,172 | £ 10,871 | £ 10,871 | |||
Securities held by the Group | (29) | £ (4) | £ 9 | |||
Closing balance | 11,167 | 11,172 | 11,172 | |||
Other equity instruments | ||||||
Issuances | 0 | 1,142 | ||||
Redemptions | 0 | (831) | ||||
Securities held by the Group | £ (5) | [1] | £ (10) | [1] | £ (10) | |
[1] | Details of share capital, other equity instruments and other reserves are shown on pages 84 to 85. |
Other equity instruments (Narra
Other equity instruments (Narrative) (Details) £ in Millions | Jun. 30, 2021GBP (£) | Dec. 31, 2020GBP (£) | Jun. 30, 2020GBP (£) | Dec. 31, 2019GBP (£) | |
Equity | £ 68,116 | £ 66,882 | £ 69,541 | £ 65,660 | |
Barclays PLC | |||||
Equity | 54,616 | 54,872 | |||
Other equity instruments | |||||
Equity | [1] | £ 11,167 | £ 11,172 | £ 10,871 | £ 10,871 |
AT1 Securities | Barclays PLC | |||||
Convertible instruments, conversion ratio minimum | 0.07 | ||||
[1] | Details of share capital, other equity instruments and other reserves are shown on pages 84 to 85. |
Other reserves (Details)
Other reserves (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of reserves within equity [line items] | ||
Other reserves | £ 2,856 | £ 4,461 |
Currency translation reserve | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | 2,376 | 2,871 |
Fair value through other comprehensive income reserve | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | (245) | 5 |
Cash flow hedging reserve | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | 664 | 1,575 |
Own credit reserve | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | (1,001) | (954) |
Other reserves and treasury shares | ||
Disclosure of reserves within equity [line items] | ||
Other reserves | £ 1,062 | £ 964 |
Other reserves - Narrative (Det
Other reserves - Narrative (Details) - GBP (£) £ in Millions, shares in Millions | 6 Months Ended | ||
Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | |
Disclosure of reserves within equity [line items] | |||
Reserves | £ (2,856) | £ (4,461) | |
Securities held by the Group | £ (29) | (4) | £ 9 |
Repurchase of treasury shares (in shares) | 377 | ||
Repurchase of shares | £ (700) | ||
Currency translation reserve | |||
Disclosure of reserves within equity [line items] | |||
Reserves | (2,376) | (2,871) | |
Movements | 495 | ||
Fair value through other comprehensive income reserve | Absa Group Limited | |||
Disclosure of reserves within equity [line items] | |||
Gains (losses) on financial assets measured at fair value through other comprehensive income, before tax | (325) | ||
Fair value through other comprehensive income reserve | |||
Disclosure of reserves within equity [line items] | |||
Reserves | 245 | (5) | |
Movements | (250) | ||
Reclassification adjustments on financial assets measured at fair value through other comprehensive income, before tax | 199 | ||
Tax | 168 | ||
Reversal of impairment loss recognised in other comprehensive income | 8 | ||
Fair value through other comprehensive income reserve | Loans to government | |||
Disclosure of reserves within equity [line items] | |||
Gains (losses) on financial assets measured at fair value through other comprehensive income, before tax | 114 | ||
Cash flow hedging reserve | |||
Disclosure of reserves within equity [line items] | |||
Reserves | (664) | (1,575) | |
Movements | 911 | ||
Gains (losses) on financial assets measured at fair value through other comprehensive income, before tax | 902 | ||
Reclassification adjustments on financial assets measured at fair value through other comprehensive income, before tax | 287 | ||
Tax | 282 | ||
Own credit reserve | |||
Disclosure of reserves within equity [line items] | |||
Reserves | 1,001 | 954 | |
Movements | 47 | ||
Tax | 115 | ||
Gains (losses) on change in value of foreign currency basis spreads, before tax | (266) | ||
Securities held by the Group | 100 | ||
Other reserves and treasury shares | |||
Disclosure of reserves within equity [line items] | |||
Reserves | (1,062) | £ (964) | |
Movements | 94 | ||
Treasury shares | |||
Disclosure of reserves within equity [line items] | |||
Movements | £ 4 |
Contingent liabilities and co_3
Contingent liabilities and commitments (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Contingent liabilities | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | £ 19,198 | £ 21,609 |
Commitments | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | 346,298 | 333,049 |
Guarantees and letters of credit pledged as collateral security | Contingent liabilities | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | 13,519 | 15,665 |
Performance guarantees, acceptances and endorsements | Contingent liabilities | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | 5,679 | 5,944 |
Documentary credits and other short-term trade related transactions | Commitments | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | 1,017 | 1,086 |
Standby facilities, credit lines and other commitments | Commitments | ||
Disclosure of contingent liabilities [line items] | ||
Notional amount | £ 345,281 | £ 331,963 |
Legal, competition and regula_2
Legal, competition and regulatory matters (Narrative) (Details) € in Millions, £ in Millions, SFr in Millions, $ in Millions | 1 Months Ended | 3 Months Ended | 5 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||
Jun. 30, 2021USD ($) | Apr. 30, 2021USD ($) | Jun. 30, 2019CHF (SFr)settlement | May 31, 2019EUR (€)settlement | Mar. 31, 2019GBP (£) | May 31, 2021USD ($) | Jun. 30, 2021GBP (£)lawsuitsplaintiffsettlementdefendant | Jun. 30, 2020GBP (£) | Dec. 31, 2020USD ($)defendantpensionFund | Dec. 31, 2018USD ($) | Dec. 31, 2016lawsuits | Dec. 31, 2015USD ($) | Dec. 31, 2013GBP (£) | Dec. 31, 2012USD ($)lawsuits | Dec. 31, 2008USD ($)agreement | Dec. 31, 2007lawsuits | Aug. 31, 2020GBP (£) | |
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | £ | £ 99 | £ 30 | |||||||||||||||
Government and agency securities civil actions and related matters | Barclays Capital Inc | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | $ | $ 87 | ||||||||||||||||
Civil actions in respect of the US Anti-Terrorism Act - EDNY | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of plaintiffs | plaintiff | 4,000 | ||||||||||||||||
Number of lawsuits dismissed | 3 | ||||||||||||||||
Number of lawsuits with specified damages sought | 6 | ||||||||||||||||
Number of lawsuits subject to appeal | 1 | ||||||||||||||||
Civil actions in respect of the US Anti-Terrorism Act - SDNY | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of lawsuits dismissed | 1 | ||||||||||||||||
Number of lawsuits with specified damages sought | 2 | ||||||||||||||||
HMRC assessments concerning UK VAT | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Loss contingency, damages sought, claimed amounts, value | £ | £ 181 | ||||||||||||||||
HMRC assessments concerning UK VAT | Barclays UK | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Loss contingency, damages sought, claimed amounts, value | £ | 128 | ||||||||||||||||
US residential and commercial mortgage-related activity and litigation | Legacy RMBS purchases | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Asset-backed debt instruments held | $ | $ 22 | ||||||||||||||||
Number of defendants | defendant | 6 | ||||||||||||||||
US residential and commercial mortgage-related activity and litigation | Legacy RMBS purchases | NEW MEXICO | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of retirement benefit funds | pensionFund | 2 | ||||||||||||||||
US residential and commercial mortgage-related activity and litigation | Originated and sold to third parties by Acquired Subsidiary | RMBS repurchase requests | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of lawsuits dismissed | settlement | 1 | ||||||||||||||||
Number of lawsuits with specified damages sought | 2 | 4 | |||||||||||||||
Number of settlements | settlement | 2 | ||||||||||||||||
Civil Actions In Respect Of VRDO - Private Plaintiffs | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of lawsuits with specified damages sought | 2 | ||||||||||||||||
Civil actions in respect of VRDO - SNDY | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of lawsuits with specified damages sought | 3 | ||||||||||||||||
Number of lawsuits consolidated | 2 | ||||||||||||||||
Foreign Exchange investigations | Securities and Exchange Commission | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | SFr | SFr 27 | ||||||||||||||||
Foreign Exchange investigations | Fines settlement | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | € | € 210 | ||||||||||||||||
Number of settlements | settlement | 2 | 2 | |||||||||||||||
USD LIBOR Cases in MDL Court | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of settlements | settlement | 2 | ||||||||||||||||
Sterling LIBOR Case in SDNY | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of lawsuits with specified damages sought | 2 | ||||||||||||||||
CFS remediation of ASL loans | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Expected reimbursement, other provisions | £ | £ 37 | ||||||||||||||||
Supranational, sovereign and agency bonds civil actions | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of lawsuits dismissed | 1 | ||||||||||||||||
Non-US forex civil actions | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of lawsuits with specified damages sought | 2 | ||||||||||||||||
LIBOR local authority civil action | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of defendants | defendant | 1 | ||||||||||||||||
Barclays Bank PLC | Government and agency securities civil actions and related matters | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | $ | $ 5.7 | ||||||||||||||||
Barclays Bank PLC | BDC Finance LLC | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Litigation settlements approved, value | $ | $ 3.3 | $ 298 | |||||||||||||||
Barclays Bank PLC | HMRC assessments concerning UK VAT | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Loss contingency, damages sought, claimed amounts, value | £ | £ 53 | ||||||||||||||||
Barclays Bank PLC | US residential and commercial mortgage-related activity and litigation | Originated and sold to third parties by Acquired Subsidiary | RMBS repurchase requests | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Original unpaid principal balance at time of sale | $ | $ 2,100 | ||||||||||||||||
Barclays Bank PLC | Foreign Exchange investigations | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | $ | $ 2,380 | ||||||||||||||||
Barclays Bank PLC | Consolidated FX Action | Barclays Capital Inc | Securities and Exchange Commission | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | $ | $ 384 | ||||||||||||||||
Barclays Bank PLC | USD LIBOR Cases in MDL Court | Lawsuits with specified damages sought | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of lawsuits with specified damages sought | 3 | ||||||||||||||||
Loss contingency, damages sought, claimed amounts, value | $ | $ 100 | ||||||||||||||||
Barclays Bank PLC | USD LIBOR Cases in MDL Court | Exchange-based class claims | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | $ | $ 7.5 | $ 7.1 | |||||||||||||||
Barclays Bank PLC | USD LIBOR Cases in MDL Court | Debt securities class claims | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Losses on litigation settlements | $ | $ 20 | ||||||||||||||||
Barclays Bank PLC | FCA Proceedings and other investigations | |||||||||||||||||
Disclosure of contingent liabilities [line items] | |||||||||||||||||
Number of advisory service agreements | agreement | 2 | ||||||||||||||||
Loss contingency, financial penalty warning | £ | £ 50 |
Barclays PLC parent company b_3
Barclays PLC parent company balance sheet (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2019 |
Assets | ||||
Loans and advances to subsidiaries | £ 348,549 | £ 342,632 | ||
Financial assets at fair value through the income statement | 194,421 | 175,151 | ||
Derivative financial instruments | 256,636 | 302,446 | ||
Other assets | 3,501 | 2,622 | ||
Total assets | 1,376,333 | 1,349,514 | ||
Liabilities | ||||
Deposits at amortised cost | 500,895 | 481,036 | ||
Cash collateral and settlement balances | 101,923 | 85,423 | ||
Debt securities in issue | 90,733 | 75,796 | ||
Subordinated Liabilities | 12,839 | 16,341 | £ 18,156 | |
Financial liabilities designated at fair value | 264,164 | 249,765 | ||
Other liabilities | 10,928 | 8,662 | ||
Total liabilities | 1,308,217 | 1,282,632 | ||
Equity | ||||
Other equity instruments | 11,167 | 11,172 | 10,871 | |
Other reserves | 2,856 | 4,461 | ||
Retained earnings | 48,461 | 45,527 | ||
Total equity | 68,116 | 66,882 | £ 69,541 | £ 65,660 |
Total equity and liabilities | 1,376,333 | 1,349,514 | ||
Barclays PLC | ||||
Assets | ||||
Investment in subsidiaries | 58,828 | 58,886 | ||
Loans and advances to subsidiaries | 23,295 | 24,710 | ||
Financial assets at fair value through the income statement | 21,046 | 17,521 | ||
Derivative financial instruments | 2 | 7 | ||
Other assets | 19 | 65 | ||
Total assets | 103,190 | 101,189 | ||
Liabilities | ||||
Deposits at amortised cost | 476 | 482 | ||
Cash collateral and settlement balances | 0 | 0 | ||
Debt securities in issue | 26,663 | 28,428 | ||
Subordinated Liabilities | 9,170 | 7,724 | ||
Financial liabilities designated at fair value | 12,130 | 9,507 | ||
Other liabilities | 135 | 176 | ||
Total liabilities | 48,574 | 46,317 | ||
Equity | ||||
Called up share capital | 4,249 | 4,340 | ||
Share premium account | 319 | 297 | ||
Other equity instruments | 11,169 | 11,169 | ||
Other reserves | 488 | 394 | ||
Retained earnings | 38,391 | 38,672 | ||
Total equity | 54,616 | 54,872 | ||
Total equity and liabilities | £ 103,190 | £ 101,189 |
Barclays PLC parent company b_4
Barclays PLC parent company balance sheet (Narrative) (Details) € in Millions, ¥ in Millions, £ in Millions, $ in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||
Mar. 31, 2020GBP (£) | Jun. 30, 2021GBP (£) | Jun. 30, 2021EUR (€) | Jun. 30, 2021USD ($) | Jun. 30, 2021AUD ($) | Jun. 30, 2021JPY (¥) | Jun. 30, 2020GBP (£) | [1] | Dec. 31, 2020GBP (£) | Dec. 31, 2019GBP (£) | |
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Financial liabilities designated at fair value | £ 264,164 | £ 249,765 | ||||||||
Issuance of subordinated debt | 1,734 | 1,438 | ||||||||
Financial assets at fair value through the income statement | 194,421 | 175,151 | ||||||||
Loans and advances to subsidiaries | 348,549 | 342,632 | ||||||||
Repurchase of shares | 700 | |||||||||
Subordinated Liabilities | 12,839 | 16,341 | £ 18,156 | |||||||
Debt securities in issue | 90,733 | 75,796 | ||||||||
Net increase in debt securities in issue | 13,041 | £ 24,183 | ||||||||
Other reserves | 2,856 | 4,461 | ||||||||
Barclays PLC | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Investment in subsidiaries | 58,828 | 58,886 | ||||||||
Financial liabilities designated at fair value | 12,130 | 9,507 | ||||||||
Financial assets at fair value through the income statement | 21,046 | 17,521 | ||||||||
Decrease in loans and advances to related parties | (1,415) | |||||||||
Foreign exchange gain (loss) | (500) | |||||||||
Loans and advances to subsidiaries | 23,295 | 24,710 | ||||||||
Repurchase of shares | £ 700 | |||||||||
Subordinated Liabilities | 9,170 | 7,724 | ||||||||
Debt securities in issue | 26,663 | 28,428 | ||||||||
Net increase in debt securities in issue | (2,200) | € (1,250) | ||||||||
Other reserves | 488 | 394 | ||||||||
Barclays PLC | Financial liabilities designated at fair value | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Financial liabilities designated at fair value | 12,130 | 9,507 | ||||||||
Barclays PLC | Barclays Bank PLC | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Dividends received | 776 | |||||||||
Barclays PLC | Barclays Bank PLC | AT1 Securities | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Investment in subsidiaries | 10,995 | £ 10,995 | ||||||||
Barclays PLC | Subordinated Notes | Financial liabilities designated at fair value | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Issuance of subordinated debt | $ | $ 750 | |||||||||
Barclays PLC | Subordinated Notes | Barclays Bank PLC | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Issuance of bonds and notes | 1,600 | |||||||||
Barclays PLC | Subordinated Notes | Fixed interest rate | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Issuance of subordinated debt | 1,000 | $ 1,000 | ||||||||
Barclays PLC | Senior Notes | Fixed interest rate | Financial liabilities designated at fair value | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Issuance of subordinated debt | € 1,000 | ¥ 77,000 | ||||||||
Barclays PLC | Senior Debt | Barclays Bank PLC | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Cash receipts from repayment of advances and loans made to related parties | £ 2,200 | |||||||||
Barclays PLC | Senior Debt | Floating interest rate | Financial liabilities designated at fair value | ||||||||||
Condensed Balance Sheet Statements, Captions [Line Items] | ||||||||||
Issuance of subordinated debt | $ | $ 600 | |||||||||
[1] | H120 comparative figures have been restated to make the condensed cash flow statement more relevant following a review of the disclosure and the accounting policies applied that was undertaken in H220. Amendments, which were first applied in the Barclays PLC Annual Report 2020, have been made to the classification of cash collateral reported within cash and cash equivalents and to the presentation of items within net cash flows from operating and investing activities. Footnotes 2 and 3 below quantify the impact of the changes to the respective cash flow categories in H120 and provide further detail. |
Credit Risk - Loans and advance
Credit Risk - Loans and advances at amortised cost by stage (Details) £ in Millions, $ in Billions | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2021GBP (£) | Jun. 30, 2020GBP (£) | Dec. 31, 2020GBP (£) | Dec. 31, 2020USD ($) | |
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 692,346 | £ 686,728 | ||
Coverage ratio | 0.010 | 0.014 | 0.014 | |
Loan impairment release | £ (742) | £ 3,738 | £ 4,838 | |
Loan loss rate | 0.0138 | |||
Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 699,576 | £ 696,127 | ||
Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (7,230) | (9,399) | ||
Financial assets at fair value, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Exposure to credit risk on loan commitments and financial guarantee contracts | £ 21,000 | £ 9,500 | ||
Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.002 | 0.002 | 0.002 | |
Stage 1 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 603,132 | £ 580,903 | ||
Stage 1 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (1,413) | £ (1,289) | ||
Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.030 | 0.042 | 0.042 | |
Lifetime expected credit losses | Stage 2 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 88,007 | £ 103,897 | ||
Lifetime expected credit losses | Stage 2 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (2,669) | £ (4,322) | ||
Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.373 | 0.334 | 0.334 | |
Lifetime expected credit losses | Stage 3 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 8,437 | £ 11,327 | ||
Lifetime expected credit losses | Stage 3 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (3,148) | (3,788) | ||
Total Barclays Group Wholesale | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 7,796 | 7,551 | ||
Head Office | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Loan impairment release | (6) | 55 | ||
Barclays UK | Operating segments | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Loan impairment release | (443) | 1,064 | ||
Barclays International | Operating segments | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Loan impairment release | (293) | £ 2,619 | ||
Total loans and advances at amortised cost | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 348,549 | £ 342,632 | ||
Coverage ratio | 0.018 | 0.024 | 0.024 | |
Loan impairment release | £ (382) | £ 3,909 | ||
Loan loss rate | 0.0111 | |||
Credit exposure | £ 5,000 | |||
Total loans and advances at amortised cost | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 355,066 | 350,967 | ||
Total loans and advances at amortised cost | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (6,517) | (8,335) | ||
Total loans and advances at amortised cost | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 303,797 | £ 289,931 | ||
Coverage ratio | 0.004 | 0.004 | 0.004 | |
Total loans and advances at amortised cost | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 304,982 | £ 290,964 | ||
Total loans and advances at amortised cost | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (1,185) | (1,033) | ||
Total loans and advances at amortised cost | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 40,078 | £ 47,442 | ||
Coverage ratio | 0.053 | 0.070 | 0.070 | |
Total loans and advances at amortised cost | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 42,311 | £ 51,006 | ||
Total loans and advances at amortised cost | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (2,233) | (3,564) | ||
Total loans and advances at amortised cost | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 4,674 | £ 5,259 | ||
Coverage ratio | 0.399 | 0.415 | 0.415 | |
Total loans and advances at amortised cost | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 7,773 | £ 8,997 | ||
Total loans and advances at amortised cost | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (3,099) | (3,738) | ||
Total loans and advances at amortised cost | Total Barclays Group retail | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 213,023 | £ 207,896 | ||
Coverage ratio | 0.023 | 0.030 | 0.030 | |
Loan impairment release | £ (284) | £ 2,841 | ||
Loan loss rate | 0.0133 | |||
Total loans and advances at amortised cost | Total Barclays Group retail | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 218,075 | £ 214,249 | ||
Total loans and advances at amortised cost | Total Barclays Group retail | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (5,052) | £ (6,353) | ||
Total loans and advances at amortised cost | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.005 | 0.004 | 0.004 | |
Total loans and advances at amortised cost | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 185,876 | £ 178,565 | ||
Total loans and advances at amortised cost | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (891) | £ (732) | ||
Total loans and advances at amortised cost | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.069 | 0.096 | 0.096 | |
Total loans and advances at amortised cost | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 26,964 | £ 30,116 | ||
Total loans and advances at amortised cost | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (1,855) | £ (2,889) | ||
Total loans and advances at amortised cost | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.440 | 0.491 | 0.491 | |
Total loans and advances at amortised cost | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 5,235 | £ 5,568 | ||
Total loans and advances at amortised cost | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (2,306) | (2,732) | ||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 135,526 | £ 134,736 | ||
Coverage ratio | 0.011 | 0.014 | 0.014 | |
Loan impairment release | £ (98) | £ 1,068 | ||
Loan loss rate | 0.0078 | |||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 136,991 | £ 136,718 | ||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (1,465) | £ (1,982) | ||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.002 | 0.003 | 0.003 | |
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 119,106 | £ 112,399 | ||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (294) | £ (301) | ||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.025 | 0.032 | 0.032 | |
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 15,347 | £ 20,890 | ||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (378) | £ (675) | ||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.312 | 0.293 | 0.293 | |
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 2,538 | £ 3,429 | ||
Total loans and advances at amortised cost | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (793) | (1,006) | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 4,865 | £ 5,396 | ||
Coverage ratio | 0.076 | 0.075 | 0.075 | |
Loan impairment release | £ (6) | £ 91 | ||
Loan loss rate | 0.0156 | |||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 5,265 | £ 5,831 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (400) | £ (435) | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.001 | 0.001 | 0.001 | |
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 4,003 | £ 4,267 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (3) | £ (4) | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.078 | 0.071 | 0.071 | |
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 502 | £ 720 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (39) | £ (51) | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.471 | 0.450 | 0.450 | |
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 760 | £ 844 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (358) | (380) | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 526 | £ 572 | ||
Coverage ratio | 0.056 | 0.051 | 0.051 | |
Loan impairment release | £ 0 | £ 0 | ||
Loan loss rate | 0 | |||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 557 | £ 603 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (31) | £ (31) | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0 | 0 | 0 | |
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 522 | £ 570 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 0 | £ 0 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0 | 0 | 0 | |
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 3 | £ 0 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 0 | £ 0 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.969 | 0.939 | 0.939 | |
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 32 | £ 33 | ||
Total loans and advances at amortised cost | Head Office | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (31) | (31) | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 182,586 | £ 176,890 | ||
Coverage ratio | 0.012 | 0.017 | 0.017 | |
Loan impairment release | £ (259) | £ 1,070 | ||
Loan loss rate | 0.0059 | |||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 184,878 | £ 179,878 | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (2,292) | £ (2,988) | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.002 | 0.002 | 0.002 | |
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 158,587 | £ 153,250 | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (313) | £ (332) | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.044 | 0.063 | 0.063 | |
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 23,576 | £ 23,896 | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (1,035) | £ (1,509) | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.348 | 0.420 | 0.420 | |
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 2,715 | £ 2,732 | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (944) | (1,147) | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 38,676 | £ 37,111 | ||
Coverage ratio | 0.005 | 0.007 | 0.007 | |
Loan impairment release | £ (23) | £ 154 | ||
Loan loss rate | 0.0041 | |||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 38,877 | £ 37,369 | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (201) | £ (258) | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.002 | 0 | 0 | |
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 36,069 | £ 31,918 | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (63) | £ (13) | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.028 | 0.030 | 0.030 | |
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 1,727 | £ 4,325 | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (49) | £ (129) | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.082 | 0.103 | 0.103 | |
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 1,081 | £ 1,126 | ||
Total loans and advances at amortised cost | Barclays UK | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (89) | (116) | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 25,572 | £ 25,610 | ||
Coverage ratio | 0.084 | 0.103 | 0.103 | |
Loan impairment release | £ (19) | £ 1,680 | ||
Loan loss rate | 0.0589 | |||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 27,932 | £ 28,540 | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (2,360) | £ (2,930) | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.025 | 0.019 | 0.019 | |
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 23,286 | £ 21,048 | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (575) | £ (396) | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.271 | 0.242 | 0.242 | |
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 2,886 | £ 5,500 | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (781) | £ (1,329) | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.570 | 0.605 | 0.605 | |
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 1,760 | £ 1,992 | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group retail | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (1,004) | (1,205) | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 96,324 | £ 97,053 | ||
Coverage ratio | 0.013 | 0.017 | 0.017 | |
Loan impairment release | £ (75) | £ 914 | ||
Loan loss rate | 0.0093 | |||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 97,557 | £ 98,746 | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (1,233) | £ (1,693) | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.003 | 0.004 | 0.004 | |
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 82,515 | £ 79,911 | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Stage 1 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (231) | £ (288) | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.024 | 0.033 | 0.033 | |
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 13,617 | £ 16,565 | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (329) | £ (546) | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.472 | 0.378 | 0.378 | |
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 1,425 | £ 2,270 | ||
Total loans and advances at amortised cost | Barclays International | Operating segments | Total Barclays Group Wholesale | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (673) | (859) | ||
Off balance sheet loan commitments and financial guarantee contracts | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 343,797 | £ 344,096 | ||
Coverage ratio | 0.002 | 0.003 | 0.003 | |
Loan impairment release | £ (343) | £ 776 | ||
Off balance sheet loan commitments and financial guarantee contracts | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 344,510 | 345,160 | ||
Off balance sheet loan commitments and financial guarantee contracts | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (713) | £ (1,064) | ||
Off balance sheet loan commitments and financial guarantee contracts | Stage 1 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.001 | 0.001 | 0.001 | |
Off balance sheet loan commitments and financial guarantee contracts | Stage 1 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 298,150 | £ 289,939 | ||
Off balance sheet loan commitments and financial guarantee contracts | Stage 1 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (228) | £ (256) | ||
Off balance sheet loan commitments and financial guarantee contracts | Lifetime expected credit losses | Stage 2 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.010 | 0.014 | 0.014 | |
Off balance sheet loan commitments and financial guarantee contracts | Lifetime expected credit losses | Stage 2 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 45,696 | £ 52,891 | ||
Off balance sheet loan commitments and financial guarantee contracts | Lifetime expected credit losses | Stage 2 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (436) | £ (758) | ||
Off balance sheet loan commitments and financial guarantee contracts | Lifetime expected credit losses | Stage 3 | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Coverage ratio | 0.074 | 0.021 | 0.021 | |
Off balance sheet loan commitments and financial guarantee contracts | Lifetime expected credit losses | Stage 3 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ 664 | £ 2,330 | ||
Off balance sheet loan commitments and financial guarantee contracts | Lifetime expected credit losses | Stage 3 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (49) | (50) | ||
Impairment charge on other financial assets | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Loan impairment release | (17) | 153 | ||
Impairment charge on other financial assets | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 186,000 | 180,300 | ||
Impairment charge on other financial assets | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (114) | (165) | ||
Impairment charge on other financial assets | Stage 1 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 185,800 | 175,700 | ||
Impairment charge on other financial assets | Stage 1 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (9) | (11) | ||
Financial assets at fair value through other comprehensive income | Lifetime expected credit losses | Stage 2 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 58 | 4,400 | $ (4.4) | |
Financial assets at fair value through other comprehensive income | Lifetime expected credit losses | Stage 2 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | (3) | (9) | ||
Other assets | Lifetime expected credit losses | Stage 3 | Gross exposure | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | 109 | 154 | ||
Other assets | Lifetime expected credit losses | Stage 3 | Impairment allowance | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Total impairment allowance | £ (102) | £ (145) |
Credit Risk - Loans and advan_2
Credit Risk - Loans and advances at amortised cost by product (Details) £ in Millions | Jun. 30, 2021GBP (£) | Dec. 31, 2020GBP (£) |
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 692,346 | £ 686,728 |
Coverage ratio | 0.010 | 0.014 |
Gross exposure | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 699,576 | £ 696,127 |
Impairment allowance | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (7,230) | (9,399) |
Financial assets at amortised cost, class | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 348,549 | £ 342,632 |
Coverage ratio | 0.018 | 0.024 |
Financial assets at amortised cost, class | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 166,345 | £ 159,647 |
Coverage ratio | 0.003 | 0.003 |
Financial assets at amortised cost, class | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 39,008 | £ 40,813 |
Coverage ratio | 0.102 | 0.123 |
Financial assets at amortised cost, class | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 143,196 | £ 142,172 |
Coverage ratio | 0.011 | 0.015 |
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 355,066 | £ 350,967 |
Financial assets at amortised cost, class | Gross exposure | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 166,818 | 160,185 |
Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 43,461 | 46,513 |
Financial assets at amortised cost, class | Gross exposure | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 144,787 | 144,269 |
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (6,517) | (8,335) |
Financial assets at amortised cost, class | Impairment allowance | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (473) | (538) |
Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (4,453) | (5,700) |
Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ (1,591) | £ (2,097) |
Stage 1 | ||
Disclosure of financial assets [line items] | ||
Coverage ratio | 0.002 | 0.002 |
Stage 1 | Gross exposure | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 603,132 | £ 580,903 |
Stage 1 | Impairment allowance | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (1,413) | (1,289) |
Stage 1 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 303,797 | £ 289,931 |
Coverage ratio | 0.004 | 0.004 |
Stage 1 | Financial assets at amortised cost, class | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 144,088 | £ 138,606 |
Coverage ratio | 0 | 0 |
Stage 1 | Financial assets at amortised cost, class | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 33,703 | £ 32,341 |
Coverage ratio | 0.024 | 0.021 |
Stage 1 | Financial assets at amortised cost, class | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 126,006 | £ 118,984 |
Coverage ratio | 0.003 | 0.003 |
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 304,982 | £ 290,964 |
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 144,103 | 138,639 |
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 34,537 | 33,021 |
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 126,342 | 119,304 |
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (1,185) | (1,033) |
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (15) | (33) |
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (834) | (680) |
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ (336) | £ (320) |
Lifetime expected credit losses | Stage 2 | ||
Disclosure of financial assets [line items] | ||
Coverage ratio | 0.030 | 0.042 |
Lifetime expected credit losses | Stage 2 | Gross exposure | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 88,007 | £ 103,897 |
Lifetime expected credit losses | Stage 2 | Impairment allowance | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (2,669) | (4,322) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 40,078 | £ 47,442 |
Coverage ratio | 0.053 | 0.070 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 20,411 | £ 19,228 |
Coverage ratio | 0.003 | 0.004 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 4,384 | £ 7,551 |
Coverage ratio | 0.287 | 0.268 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 15,283 | £ 20,663 |
Coverage ratio | 0.025 | 0.033 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Not past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 36,409 | £ 42,533 |
Coverage ratio | 0.052 | 0.068 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Not past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 17,935 | £ 16,594 |
Coverage ratio | 0.003 | 0.003 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Not past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 4,095 | £ 7,088 |
Coverage ratio | 0.274 | 0.252 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Not past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 14,379 | £ 18,851 |
Coverage ratio | 0.026 | 0.033 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Less than or equal to 30 days past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 2,384 | £ 3,183 |
Coverage ratio | 0.044 | 0.071 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Less than or equal to 30 days past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 1,660 | £ 1,772 |
Coverage ratio | 0.004 | 0.007 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Less than or equal to 30 days past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 200 | £ 364 |
Coverage ratio | 0.333 | 0.331 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Less than or equal to 30 days past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 524 | £ 1,047 |
Coverage ratio | 0.009 | 0.046 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | >30 days past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 1,285 | £ 1,726 |
Coverage ratio | 0.097 | 0.118 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | >30 days past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 816 | £ 862 |
Coverage ratio | 0.009 | 0.016 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | >30 days past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 89 | £ 99 |
Coverage ratio | 0.574 | 0.676 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | >30 days past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 380 | £ 765 |
Coverage ratio | 0.028 | 0.014 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 42,311 | £ 51,006 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 20,480 | 19,312 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 6,151 | 10,320 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 15,680 | 21,374 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Not past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 38,393 | 45,622 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Not past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 17,991 | 16,651 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Not past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 5,642 | 9,470 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Not past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 14,760 | 19,501 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Less than or equal to 30 days past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 2,495 | 3,426 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Less than or equal to 30 days past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 1,666 | 1,785 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Less than or equal to 30 days past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 300 | 544 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Less than or equal to 30 days past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 529 | 1,097 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | >30 days past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 1,423 | 1,958 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | >30 days past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 823 | 876 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | >30 days past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 209 | 306 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | >30 days past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 391 | 776 |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (2,233) | (3,564) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (69) | (84) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (1,767) | (2,769) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (397) | (711) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Not past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (1,984) | (3,089) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Not past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (56) | (57) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Not past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (1,547) | (2,382) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Not past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (381) | (650) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Less than or equal to 30 days past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (111) | (243) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Less than or equal to 30 days past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (6) | (13) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Less than or equal to 30 days past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (100) | (180) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Less than or equal to 30 days past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (5) | (50) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | >30 days past due | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (138) | (232) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | >30 days past due | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (7) | (14) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | >30 days past due | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (120) | (207) |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | >30 days past due | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ (11) | £ (11) |
Lifetime expected credit losses | Stage 3 | ||
Disclosure of financial assets [line items] | ||
Coverage ratio | 0.373 | 0.334 |
Lifetime expected credit losses | Stage 3 | Gross exposure | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 8,437 | £ 11,327 |
Lifetime expected credit losses | Stage 3 | Impairment allowance | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (3,148) | (3,788) |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 4,674 | £ 5,259 |
Coverage ratio | 0.399 | 0.415 |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 1,846 | £ 1,813 |
Coverage ratio | 0.174 | 0.188 |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 921 | £ 921 |
Coverage ratio | 0.668 | 0.710 |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 1,907 | £ 2,525 |
Coverage ratio | 0.310 | 0.297 |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ 7,773 | £ 8,997 |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 2,235 | 2,234 |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 2,773 | 3,172 |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | 2,765 | 3,591 |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (3,099) | (3,738) |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Home loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (389) | (421) |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | (1,852) | (2,251) |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Total impairment allowance | £ (858) | £ (1,066) |
Credit Risk - Loans and advan_3
Credit Risk - Loans and advances at amortised cost by selected sectors (Details) £ in Millions, $ in Billions | Dec. 31, 2021GBP (£) | Jun. 30, 2021GBP (£) | Jun. 30, 2021USD ($) | Dec. 31, 2020GBP (£) | Dec. 31, 2020USD ($) |
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 692,346 | £ 686,728 | |||
Coverage ratio | 0.010 | 0.010 | 0.014 | 0.014 | |
Gross exposure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 699,576 | £ 696,127 | |||
Impairment allowance | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (7,230) | (9,399) | |||
Financial assets at amortised cost, class | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 348,549 | £ 342,632 | |||
Coverage ratio | 0.018 | 0.018 | 0.024 | 0.024 | |
Financial assets at amortised cost, class | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Coverage ratio | 0.034 | 0.034 | 0.045 | 0.045 | |
Financial assets at amortised cost, class | Total loans and advances at amortised cost | UK Commercial real estate | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | $ | $ 9.4 | $ 10 | |||
Coverage ratio | 0.0061 | 0.0061 | 0.0098 | 0.0098 | |
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 355,066 | £ 350,967 | |||
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 17,395 | £ 18,739 | |||
Total of Wholesale exposures | 12.00% | 12.00% | 13.00% | 13.00% | |
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Air travel | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 648 | £ 948 | |||
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Hospitality and leisure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 6,224 | 7,140 | |||
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Oil and gas | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 2,576 | 3,073 | |||
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Retail | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 5,199 | 5,343 | |||
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Shipping | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 717 | 709 | |||
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Transportation | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 2,031 | 1,526 | |||
Financial assets at amortised cost, class | Impairment allowance | Undrawn loans and receivables | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (100) | (100) | |||
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (6,517) | (8,335) | |||
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (591) | £ (842) | |||
Total of Wholesale exposures | 37.00% | 37.00% | 40.00% | 40.00% | |
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Air travel | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (34) | £ (59) | |||
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Hospitality and leisure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (165) | (229) | |||
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Oil and gas | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (154) | (198) | |||
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Retail | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (137) | (237) | |||
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Shipping | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (40) | (33) | |||
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Transportation | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (61) | £ (86) | |||
Stage 1 | |||||
Disclosure of financial assets [line items] | |||||
Coverage ratio | 0.002 | 0.002 | 0.002 | 0.002 | |
Stage 1 | Gross exposure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 603,132 | £ 580,903 | |||
Stage 1 | Impairment allowance | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (1,413) | (1,289) | |||
Stage 1 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 303,797 | £ 289,931 | |||
Coverage ratio | 0.004 | 0.004 | 0.004 | 0.004 | |
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 304,982 | £ 290,964 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 12,543 | £ 11,924 | |||
Total of Wholesale exposures | 10.00% | 10.00% | 10.00% | 10.00% | |
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Air travel | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 305 | £ 367 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Hospitality and leisure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 4,019 | 4,440 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Oil and gas | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 1,877 | 1,754 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Retail | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 4,089 | 3,907 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Shipping | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 485 | 308 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Transportation | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 1,768 | 1,148 | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (1,185) | (1,033) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (153) | £ (192) | |||
Total of Wholesale exposures | 45.00% | 45.00% | 60.00% | 60.00% | |
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Air travel | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (3) | £ (9) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Hospitality and leisure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (48) | (53) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Oil and gas | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (14) | (31) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Retail | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (63) | (78) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Shipping | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (5) | (2) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Transportation | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (20) | £ (19) | |||
Lifetime expected credit losses | Stage 2 | |||||
Disclosure of financial assets [line items] | |||||
Coverage ratio | 0.030 | 0.030 | 0.042 | 0.042 | |
Lifetime expected credit losses | Stage 2 | Gross exposure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 88,007 | £ 103,897 | |||
Lifetime expected credit losses | Stage 2 | Impairment allowance | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (2,669) | (4,322) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 40,078 | £ 47,442 | |||
Coverage ratio | 0.053 | 0.053 | 0.070 | 0.070 | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 42,311 | £ 51,006 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 4,037 | £ 5,561 | |||
Total of Wholesale exposures | 26.00% | 26.00% | 26.00% | 26.00% | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Air travel | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 322 | £ 525 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Hospitality and leisure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 1,907 | 2,387 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Oil and gas | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 465 | 854 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Retail | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 962 | 1,153 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Shipping | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 220 | 389 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Transportation | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 161 | 253 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (2,233) | (3,564) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (162) | £ (260) | |||
Total of Wholesale exposures | 41.00% | 41.00% | 37.00% | 37.00% | |
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Air travel | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (13) | £ (27) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Hospitality and leisure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (68) | (115) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Oil and gas | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (12) | (27) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Retail | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (30) | (51) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Shipping | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (35) | (30) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Transportation | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (4) | £ (10) | |||
Lifetime expected credit losses | Stage 3 | |||||
Disclosure of financial assets [line items] | |||||
Coverage ratio | 0.373 | 0.373 | 0.334 | 0.334 | |
Lifetime expected credit losses | Stage 3 | Gross exposure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 8,437 | £ 11,327 | |||
Lifetime expected credit losses | Stage 3 | Impairment allowance | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (3,148) | (3,788) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 4,674 | £ 5,259 | |||
Coverage ratio | 0.399 | 0.399 | 0.415 | 0.415 | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 7,773 | £ 8,997 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 815 | £ 1,254 | |||
Total of Wholesale exposures | 29.00% | 29.00% | 35.00% | 35.00% | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Air travel | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ 21 | £ 56 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Hospitality and leisure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 298 | 313 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Oil and gas | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 234 | 465 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Retail | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 148 | 283 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Shipping | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 12 | 12 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | Transportation | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 102 | 125 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (3,099) | (3,738) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Selected sectors | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (276) | £ (390) | |||
Total of Wholesale exposures | 32.00% | 32.00% | 37.00% | 37.00% | |
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Air travel | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (18) | £ (23) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Hospitality and leisure | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (49) | (61) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Oil and gas | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (128) | (140) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Retail | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | (44) | (108) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Shipping | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | 0 | (1) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | Transportation | |||||
Disclosure of financial assets [line items] | |||||
Total impairment allowance | £ (37) | £ (57) |
Credit Risk - Movement in gross
Credit Risk - Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees (Details) £ in Millions, $ in Billions | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2021GBP (£) | Jun. 30, 2020GBP (£) | Dec. 31, 2020GBP (£) | Dec. 31, 2020USD ($) | |
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Income statement release for the period | £ (742) | £ 3,738 | £ 4,838 | |
Total impairment allowance | (692,346) | (686,728) | ||
Financial guarantee contracts | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Post write-off recoveries | 31 | 15 | ||
Net releasein ECL | 216 | 279 | ||
Total loans and advances at amortised cost | ||||
Loans and advances at amortised cost | ||||
Opening balance | 9,399 | |||
Closing balance | 7,230 | 9,399 | ||
Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 538 | |||
Closing balance | 473 | 538 | ||
Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 6,083 | |||
Closing balance | 4,679 | 6,083 | ||
Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 2,778 | |||
Closing balance | 2,078 | 2,778 | ||
Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Income statement release for the period | (343) | 776 | ||
Total impairment allowance | (343,797) | (344,096) | ||
Impairment charge on other financial assets | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Income statement release for the period | (17) | 153 | ||
Gross exposure | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (699,576) | (696,127) | ||
Gross exposure | Home loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (7,416) | |||
Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (1,139) | |||
Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,255 | |||
Gross exposure | Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (344,510) | (345,160) | ||
Gross exposure | Impairment charge on other financial assets | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (186,000) | (180,300) | ||
Impairment allowance | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 7,230 | 9,399 | ||
Impairment allowance | Home loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (148) | |||
Impairment allowance | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (207) | |||
Impairment allowance | Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 713 | 1,064 | ||
Impairment allowance | Impairment charge on other financial assets | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 114 | 165 | ||
Financial assets at amortised cost, class | Total loans and advances at amortised cost | ||||
Loans and advances at amortised cost | ||||
Write-offs | 1,001 | 953 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Income statement release for the period | (382) | 3,909 | ||
Post write-off recoveries | 31 | 15 | ||
Net write-offs | 970 | £ 938 | ||
Total impairment allowance | (348,549) | (342,632) | ||
Financial assets at amortised cost, class | Home loans | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (166,345) | (159,647) | ||
Financial assets at amortised cost, class | Credit cards, unsecured loans and other retail lending | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (39,008) | (40,813) | ||
Financial assets at amortised cost, class | Wholesale loans | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (143,196) | (142,172) | ||
Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (355,066) | (350,967) | ||
Financial assets at amortised cost, class | Gross exposure | Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 160,185 | |||
Business activity in the year | 19,611 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (5,461) | |||
Final repayments | 7,505 | |||
Disposals | 0 | |||
Write-offs | 12 | |||
Closing balance | 166,818 | 160,185 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (166,818) | (160,185) | ||
Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 46,513 | |||
Business activity in the year | 3,944 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (4,065) | |||
Final repayments | 1,996 | |||
Disposals | 101 | |||
Write-offs | 834 | |||
Closing balance | 43,461 | 46,513 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (43,461) | (46,513) | ||
Transfers out of Level 2 into Level 1 of fair value hierarchy, assets held at end of reporting period | 2,200 | |||
Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 144,269 | |||
Business activity in the year | 24,638 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (151) | |||
Final repayments | 22,099 | |||
Disposals | 1,715 | |||
Write-offs | 155 | |||
Closing balance | 144,787 | 144,269 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (144,787) | (144,269) | ||
Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Barclays Asset Finance | ||||
Loans and advances at amortised cost | ||||
Disposals | 1,000 | |||
Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
ECL movement excluding assets derecognised due to disposals and write-offs | (699) | |||
Recoveries and reimbursements | 185 | |||
Exchange and other adjustments | 132 | |||
Total impairment allowance | 6,517 | 8,335 | ||
Financial assets at amortised cost, class | Impairment allowance | Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 538 | |||
Business activity in the year | 3 | |||
Changes to models used for calculation | 34 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (79) | |||
Final repayments | (11) | |||
Disposals | 0 | |||
Write-offs | (12) | |||
Closing balance | 473 | 538 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
ECL movement excluding assets derecognised due to disposals and write-offs | (53) | |||
Total impairment allowance | 473 | 538 | ||
Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 5,700 | |||
Business activity in the year | 72 | |||
Changes to models used for calculation | (24) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (274) | |||
Final repayments | (113) | |||
Disposals | (74) | |||
Write-offs | (834) | |||
Closing balance | 4,453 | 5,700 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
ECL movement excluding assets derecognised due to disposals and write-offs | (339) | |||
Total impairment allowance | 4,453 | 5,700 | ||
Net releasein ECL | 300 | |||
Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 2,097 | |||
Business activity in the year | 87 | |||
Changes to models used for calculation | (36) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (191) | |||
Final repayments | (167) | |||
Disposals | (44) | |||
Write-offs | (155) | |||
Closing balance | 1,591 | 2,097 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
ECL movement excluding assets derecognised due to disposals and write-offs | (307) | |||
Total impairment allowance | 1,591 | 2,097 | ||
Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Debt securities at amortised cost | Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Disposals | 700 | |||
Stage 1 | Gross exposure | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (603,132) | (580,903) | ||
Stage 1 | Gross exposure | Home loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (7,397) | |||
Stage 1 | Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (1,005) | |||
Stage 1 | Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,603 | |||
Stage 1 | Gross exposure | Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (298,150) | (289,939) | ||
Stage 1 | Gross exposure | Impairment charge on other financial assets | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (185,800) | (175,700) | ||
Stage 1 | Impairment allowance | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 1,413 | 1,289 | ||
Stage 1 | Impairment allowance | Home loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Stage 1 | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (215) | |||
Stage 1 | Impairment allowance | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (146) | |||
Stage 1 | Impairment allowance | Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 228 | 256 | ||
Stage 1 | Impairment allowance | Impairment charge on other financial assets | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 9 | 11 | ||
Stage 1 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (303,797) | (289,931) | ||
Stage 1 | Financial assets at amortised cost, class | Home loans | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (144,088) | (138,606) | ||
Stage 1 | Financial assets at amortised cost, class | Credit cards, unsecured loans and other retail lending | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (33,703) | (32,341) | ||
Stage 1 | Financial assets at amortised cost, class | Wholesale loans | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (126,006) | (118,984) | ||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (304,982) | (290,964) | ||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 138,639 | |||
Business activity in the year | 19,231 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (4,670) | |||
Final repayments | 6,204 | |||
Disposals | 0 | |||
Write-offs | 0 | |||
Closing balance | 144,103 | 138,639 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (144,103) | (138,639) | ||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (6,369) | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 3,615 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (160) | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 21 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 33,021 | |||
Business activity in the year | 3,855 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (3,134) | |||
Final repayments | 1,757 | |||
Disposals | 0 | |||
Write-offs | 0 | |||
Closing balance | 34,537 | 33,021 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (34,537) | (33,021) | ||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (1,590) | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 4,376 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (264) | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 30 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 119,304 | |||
Business activity in the year | 23,266 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 81 | |||
Final repayments | 18,854 | |||
Disposals | 1,495 | |||
Write-offs | 0 | |||
Closing balance | 126,342 | 119,304 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (126,342) | (119,304) | ||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (4,636) | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 8,410 | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (249) | |||
Stage 1 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 515 | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 1,185 | 1,033 | ||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 33 | |||
Business activity in the year | 2 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (38) | |||
Final repayments | (1) | |||
Disposals | 0 | |||
Write-offs | 0 | |||
Closing balance | 15 | 33 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 15 | 33 | ||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (2) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 21 | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 680 | |||
Business activity in the year | 50 | |||
Changes to models used for calculation | (5) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (866) | |||
Final repayments | (46) | |||
Disposals | 0 | |||
Write-offs | 0 | |||
Closing balance | 834 | 680 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 834 | 680 | ||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (72) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 1,080 | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (12) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 25 | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 320 | |||
Business activity in the year | 35 | |||
Changes to models used for calculation | (7) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (153) | |||
Final repayments | (39) | |||
Disposals | (8) | |||
Write-offs | 0 | |||
Closing balance | 336 | 320 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 336 | 320 | ||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (12) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 188 | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (2) | |||
Stage 1 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 14 | |||
Lifetime expected credit losses | Stage 2 | Gross exposure | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (88,007) | (103,897) | ||
Lifetime expected credit losses | Stage 2 | Gross exposure | Home loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (17) | |||
Lifetime expected credit losses | Stage 2 | Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 114 | |||
Lifetime expected credit losses | Stage 2 | Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 680 | |||
Lifetime expected credit losses | Stage 2 | Gross exposure | Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (45,696) | (52,891) | ||
Lifetime expected credit losses | Stage 2 | Gross exposure | Financial assets at fair value through other comprehensive income | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (58) | (4,400) | $ 4.4 | |
Lifetime expected credit losses | Stage 2 | Impairment allowance | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 2,669 | 4,322 | ||
Lifetime expected credit losses | Stage 2 | Impairment allowance | Home loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Lifetime expected credit losses | Stage 2 | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 63 | |||
Lifetime expected credit losses | Stage 2 | Impairment allowance | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (63) | |||
Lifetime expected credit losses | Stage 2 | Impairment allowance | Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 436 | 758 | ||
Lifetime expected credit losses | Stage 2 | Impairment allowance | Financial assets at fair value through other comprehensive income | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 3 | 9 | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (40,078) | (47,442) | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Home loans | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (20,411) | (19,228) | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Credit cards, unsecured loans and other retail lending | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (4,384) | (7,551) | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Wholesale loans | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (15,283) | (20,663) | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (42,311) | (51,006) | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 19,312 | |||
Business activity in the year | 380 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (667) | |||
Final repayments | 1,081 | |||
Disposals | 0 | |||
Write-offs | 0 | |||
Closing balance | 20,480 | 19,312 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (20,480) | (19,312) | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 6,369 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (3,615) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (337) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 119 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 10,320 | |||
Business activity in the year | 58 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (808) | |||
Final repayments | 99 | |||
Disposals | 0 | |||
Write-offs | 0 | |||
Closing balance | 6,151 | 10,320 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (6,151) | (10,320) | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 1,590 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (4,376) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (572) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 38 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 21,374 | |||
Business activity in the year | 1,181 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (47) | |||
Final repayments | 3,042 | |||
Disposals | 162 | |||
Write-offs | 0 | |||
Closing balance | 15,680 | 21,374 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (15,680) | (21,374) | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 4,636 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (8,410) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (226) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 376 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 2,233 | 3,564 | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 84 | |||
Business activity in the year | 1 | |||
Changes to models used for calculation | (4) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 13 | |||
Final repayments | (2) | |||
Disposals | 0 | |||
Write-offs | 0 | |||
Closing balance | 69 | 84 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 69 | 84 | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 2 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (21) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (7) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 3 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 2,769 | |||
Business activity in the year | 14 | |||
Changes to models used for calculation | (33) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 310 | |||
Final repayments | (17) | |||
Disposals | 0 | |||
Write-offs | 0 | |||
Closing balance | 1,767 | 2,769 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 1,767 | 2,769 | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 72 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (1,080) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (282) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 14 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 711 | |||
Business activity in the year | 30 | |||
Changes to models used for calculation | (29) | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (37) | |||
Final repayments | (95) | |||
Disposals | (3) | |||
Write-offs | 0 | |||
Closing balance | 397 | 711 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 397 | 711 | ||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 12 | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (188) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (17) | |||
Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 13 | |||
Lifetime expected credit losses | Stage 3 | Gross exposure | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (8,437) | (11,327) | ||
Lifetime expected credit losses | Stage 3 | Gross exposure | Home loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (2) | |||
Lifetime expected credit losses | Stage 3 | Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (248) | |||
Lifetime expected credit losses | Stage 3 | Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (28) | |||
Lifetime expected credit losses | Stage 3 | Gross exposure | Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (664) | (2,330) | ||
Lifetime expected credit losses | Stage 3 | Gross exposure | Other assets | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (109) | (154) | ||
Lifetime expected credit losses | Stage 3 | Impairment allowance | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 3,148 | 3,788 | ||
Lifetime expected credit losses | Stage 3 | Impairment allowance | Home loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 | |||
Lifetime expected credit losses | Stage 3 | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 4 | |||
Lifetime expected credit losses | Stage 3 | Impairment allowance | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2 | |||
Lifetime expected credit losses | Stage 3 | Impairment allowance | Impairment charge on loan commitments and other financial guarantees | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 49 | 50 | ||
Lifetime expected credit losses | Stage 3 | Impairment allowance | Other assets | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 102 | 145 | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (4,674) | (5,259) | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Home loans | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (1,846) | (1,813) | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Credit cards, unsecured loans and other retail lending | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (921) | (921) | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Wholesale loans | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (1,907) | (2,525) | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (7,773) | (8,997) | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 2,234 | |||
Business activity in the year | 0 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (124) | |||
Final repayments | 220 | |||
Disposals | 0 | |||
Write-offs | 12 | |||
Closing balance | 2,235 | 2,234 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (2,235) | (2,234) | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 497 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Home loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (140) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 3,172 | |||
Business activity in the year | 31 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (123) | |||
Final repayments | 140 | |||
Disposals | 101 | |||
Write-offs | 834 | |||
Closing balance | 2,773 | 3,172 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (2,773) | (3,172) | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 836 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (68) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 3,591 | |||
Business activity in the year | 191 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (185) | |||
Final repayments | 203 | |||
Disposals | 58 | |||
Write-offs | 155 | |||
Closing balance | 2,765 | 3,591 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | (2,765) | (3,591) | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 475 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Gross exposure | Wholesale loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (891) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Total loans and advances at amortised cost | ||||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 3,099 | 3,738 | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Home loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 421 | |||
Business activity in the year | 0 | |||
Changes to models used for calculation | 38 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (54) | |||
Final repayments | (8) | |||
Disposals | 0 | |||
Write-offs | (12) | |||
Closing balance | 389 | 421 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 389 | 421 | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 7 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Home loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (3) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | ||||
Loans and advances at amortised cost | ||||
Opening balance | 2,251 | |||
Business activity in the year | 8 | |||
Changes to models used for calculation | 14 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 282 | |||
Final repayments | (50) | |||
Disposals | (74) | |||
Write-offs | (834) | |||
Closing balance | 1,852 | 2,251 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 1,852 | 2,251 | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 294 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Credit cards, unsecured loans and other retail lending | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | (39) | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | ||||
Loans and advances at amortised cost | ||||
Opening balance | 1,066 | |||
Business activity in the year | 22 | |||
Changes to models used for calculation | 0 | |||
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (1) | |||
Final repayments | (33) | |||
Disposals | (33) | |||
Write-offs | (155) | |||
Closing balance | 858 | 1,066 | ||
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost | ||||
Total impairment allowance | 858 | £ 1,066 | ||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 1 to Stage 2 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 2 to Stage 1 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 0 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers to Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | 19 | |||
Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost, class | Impairment allowance | Wholesale loans | Transfers from Stage 3 | ||||
Loans and advances at amortised cost | ||||
Increase (decrease) through transfers, financial assets | £ (27) |
Credit Risk - Movement in gro_2
Credit Risk - Movement in gross exposure for loan commitment and financial guarantees (Details) £ in Millions | 6 Months Ended |
Jun. 30, 2021GBP (£) | |
Gross exposure | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | £ 12,382 |
Net transfers between stages | 0 |
Business activity in the year | 6,288 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (7,416) |
Limit management and final repayments | (263) |
Ending balance | 10,991 |
Gross exposure | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 126,717 |
Net transfers between stages | 0 |
Business activity in the year | 3,411 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (1,139) |
Limit management and final repayments | (5,396) |
Ending balance | 123,593 |
Gross exposure | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 206,061 |
Net transfers between stages | 0 |
Business activity in the year | 40,138 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2,255 |
Limit management and final repayments | (38,528) |
Ending balance | 209,926 |
Impairment allowance | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 0 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 0 |
Impairment allowance | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 383 |
Net transfers between stages | 0 |
Business activity in the year | 3 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (148) |
Limit management and final repayments | (12) |
Ending balance | 226 |
Impairment allowance | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 681 |
Net transfers between stages | 0 |
Business activity in the year | 126 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (207) |
Limit management and final repayments | (113) |
Ending balance | 487 |
Stage 1 | Gross exposure | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 11,861 |
Net transfers between stages | (74) |
Business activity in the year | 6,287 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (7,397) |
Limit management and final repayments | (238) |
Ending balance | 10,439 |
Stage 1 | Gross exposure | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 114,371 |
Net transfers between stages | 5,784 |
Business activity in the year | 3,378 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (1,005) |
Limit management and final repayments | (4,941) |
Ending balance | 117,587 |
Stage 1 | Gross exposure | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 163,707 |
Net transfers between stages | 682 |
Business activity in the year | 37,211 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 1,603 |
Limit management and final repayments | (33,079) |
Ending balance | 170,124 |
Stage 1 | Impairment allowance | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 0 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 0 |
Stage 1 | Impairment allowance | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 55 |
Net transfers between stages | 217 |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (215) |
Limit management and final repayments | (4) |
Ending balance | 54 |
Stage 1 | Impairment allowance | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 201 |
Net transfers between stages | 116 |
Business activity in the year | 28 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (146) |
Limit management and final repayments | (25) |
Ending balance | 174 |
Lifetime expected credit losses | Stage 2 | Gross exposure | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 516 |
Net transfers between stages | 71 |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (17) |
Limit management and final repayments | (22) |
Ending balance | 549 |
Lifetime expected credit losses | Stage 2 | Gross exposure | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 12,117 |
Net transfers between stages | (6,081) |
Business activity in the year | 32 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 114 |
Limit management and final repayments | (398) |
Ending balance | 5,784 |
Lifetime expected credit losses | Stage 2 | Gross exposure | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 40,258 |
Net transfers between stages | 504 |
Business activity in the year | 2,915 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 680 |
Limit management and final repayments | (4,994) |
Ending balance | 39,363 |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 0 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 0 |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 305 |
Net transfers between stages | (212) |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 63 |
Limit management and final repayments | (5) |
Ending balance | 152 |
Lifetime expected credit losses | Stage 2 | Impairment allowance | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 453 |
Net transfers between stages | (112) |
Business activity in the year | 89 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (63) |
Limit management and final repayments | (83) |
Ending balance | 284 |
Lifetime expected credit losses | Stage 3 | Gross exposure | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 5 |
Net transfers between stages | 3 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (2) |
Limit management and final repayments | (3) |
Ending balance | 3 |
Lifetime expected credit losses | Stage 3 | Gross exposure | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 229 |
Net transfers between stages | 297 |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (248) |
Limit management and final repayments | (57) |
Ending balance | 222 |
Lifetime expected credit losses | Stage 3 | Gross exposure | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 2,096 |
Net transfers between stages | (1,186) |
Business activity in the year | 12 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | (28) |
Limit management and final repayments | (455) |
Ending balance | 439 |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Home loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 0 |
Net transfers between stages | 0 |
Business activity in the year | 0 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 0 |
Limit management and final repayments | 0 |
Ending balance | 0 |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Credit cards, unsecured loans and other retail lending | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 23 |
Net transfers between stages | (5) |
Business activity in the year | 1 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 4 |
Limit management and final repayments | (3) |
Ending balance | 20 |
Lifetime expected credit losses | Stage 3 | Impairment allowance | Wholesale loans | |
Increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts [abstract] | |
Opening balance | 27 |
Net transfers between stages | (4) |
Business activity in the year | 9 |
Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes | 2 |
Limit management and final repayments | (5) |
Ending balance | £ 29 |
Credit Risk - Management adjust
Credit Risk - Management adjustments to models for impairment (Details) - GBP (£) £ in Millions | Jun. 30, 2021 | Dec. 31, 2020 |
Disclosure of financial assets [line items] | ||
Management adjustments to impairment allowances | £ 1,871 | £ 1,388 |
Proportion of total impairment allowances | 25.90% | 14.80% |
Total loans and advances at amortised cost | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets, Before adjustments | £ 5,359 | £ 8,011 |
Allowance account for credit losses of financial assets | 7,230 | 9,399 |
Total loans and advances at amortised cost | Economic uncertainty adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 2,090 | 2,067 |
Total loans and advances at amortised cost | Other adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | (219) | (679) |
Total loans and advances at amortised cost | Modelled ECL | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets, Before adjustments | 4,300 | 6,800 |
Allowance account for credit losses of financial assets | 400 | |
Total loans and advances at amortised cost | ECL from individually assessed impairments on stage 3 loans | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets, Before adjustments | 800 | 900 |
Total loans and advances at amortised cost | ECL from non-modelled and other management adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets, Before adjustments | 300 | 300 |
Allowance account for credit losses of financial assets | (200) | (300) |
Home loans | ||
Disclosure of financial assets [line items] | ||
Management adjustments to impairment allowances | £ 83 | £ 131 |
Proportion of total impairment allowances | 17.50% | 24.30% |
Allowance account for credit losses of financial assets, Before adjustments | £ 390 | £ 407 |
Allowance account for credit losses of financial assets | 473 | 538 |
Home loans | Economic uncertainty adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 41 | 21 |
Home loans | Other adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 42 | 110 |
Credit cards, unsecured loans and other retail lending | ||
Disclosure of financial assets [line items] | ||
Management adjustments to impairment allowances | £ 1,145 | £ 1,234 |
Proportion of total impairment allowances | 24.50% | 20.30% |
Allowance account for credit losses of financial assets, Before adjustments | £ 3,534 | £ 4,849 |
Allowance account for credit losses of financial assets | 4,679 | 6,083 |
Credit cards, unsecured loans and other retail lending | Economic uncertainty adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 1,398 | 1,625 |
Credit cards, unsecured loans and other retail lending | Other adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | (253) | (391) |
Wholesale loans | ||
Disclosure of financial assets [line items] | ||
Management adjustments to impairment allowances | £ 643 | £ 23 |
Proportion of total impairment allowances | 30.90% | 0.80% |
Allowance account for credit losses of financial assets, Before adjustments | £ 1,435 | £ 2,755 |
Allowance account for credit losses of financial assets | 2,078 | 2,778 |
Wholesale loans | Economic uncertainty adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | 651 | 421 |
Wholesale loans | Other adjustments | ||
Disclosure of financial assets [line items] | ||
Allowance account for credit losses of financial assets | £ (8) | £ (398) |
Credit Risk - Economic uncertai
Credit Risk - Economic uncertainty adjustments (Details) £ in Millions | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2021GBP (£)method | Dec. 31, 2020GBP (£) | Dec. 31, 2019 | Dec. 31, 2021GBP (£) | |
Covid-19 related uncertainty adjustments | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | £ 2,100 | £ 2,100 | ||
Number Of Methods To Determine Uncertainty Adjustments | method | 2 | |||
Credit cards, unsecured loans and other retail lending | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | £ 4,679 | 6,083 | ||
Credit cards, unsecured loans and other retail lending | Covid-19 related uncertainty adjustments | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | 900 | |||
Credit cards, unsecured loans and other retail lending | Economic uncertainty adjustments | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | 1,398 | 1,625 | ||
Total loans and advances at amortised cost | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | 7,230 | 9,399 | ||
Total loans and advances at amortised cost | Covid-19 related uncertainty adjustments | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | £ 1,200 | |||
Total loans and advances at amortised cost | Covid-19 related uncertainty adjustments | Guarantees | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | 100 | |||
Total loans and advances at amortised cost | Covid-19 related uncertainty adjustments | Customers | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | 500 | 700 | ||
Total loans and advances at amortised cost | Covid-19 related uncertainty adjustments | Specific bases | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | £ 500 | 1,200 | ||
Unemployment rate | 7.20% | |||
Total loans and advances at amortised cost | Economic uncertainty adjustments | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | £ 2,090 | 2,067 | ||
Wholesale loans | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | 2,078 | 2,778 | ||
Wholesale loans | Covid-19 related uncertainty adjustments | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | 300 | |||
Wholesale loans | Economic uncertainty adjustments | ||||
Disclosure of financial assets [line items] | ||||
Allowance account for credit losses of financial assets | £ 651 | £ 421 | ||
Financial assets at amortised cost, class | ||||
Disclosure of financial assets [line items] | ||||
Arrears collection period | 30 days | |||
Financial assets at amortised cost, class | USA | Credit cards, unsecured loans and other retail lending | ||||
Disclosure of financial assets [line items] | ||||
Decrease in arrears collection rate | (1.60%) | |||
Arrears collection rate | 2.50% | 2.70% | ||
Financial assets at amortised cost, class | UK | Credit cards, unsecured loans and other retail lending | ||||
Disclosure of financial assets [line items] | ||||
Decrease in arrears collection rate | (1.40%) | (1.70%) | (1.70%) |
Credit Risk - Measurement uncer
Credit Risk - Measurement uncertainty, narrative (Details) £ in Millions | 6 Months Ended | |
Jun. 30, 2021GBP (£)economic_scenario | Dec. 31, 2020GBP (£) | |
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Number of economic scenarios to calculate ECL | 5 | |
Management adjustments to impairment allowances | £ | £ 1,871 | £ 1,388 |
Credit risk | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Number of economic scenarios to calculate ECL | 5 | |
Number of economic variables to calculate ECL | 8 | |
Stress horizon period, ECL | 5 years | |
Term at which scenario converges to steady state | 8 years | |
Calculation period for ECL estimates | 3 years | |
Credit risk | Downside Scenario | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Number of economic scenarios to calculate ECL | 2 | |
Credit risk | Upside Scenario | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Number of economic scenarios to calculate ECL | 2 | |
Baseline | UK | Later than three months and not later than six months | Unemployment | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 6.00% | |
Downside 2 | UK | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 9.80% | |
Downside 2 | UK | Later than one month and not later than three months | Unemployment | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 10.00% | |
Downside 2 | USA | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 12.00% | |
Downside 2 | USA | Later than one month and not later than three months | Unemployment | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 12.00% | |
Upside 2 | UK | Later than one year [member] | Unemployment | Maximum | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 5.00% | |
Upside 2 | USA | Later than one year [member] | Unemployment | Maximum | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 4.00% |
Credit Risk - Measurement unc_2
Credit Risk - Measurement uncertainty - Baseline average macroeconomic variables used in the calculation of ECL (Details) | Jun. 30, 2021 | Dec. 31, 2020 |
Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 26.40% | 24.70% |
Baseline | GDP | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.90% | 6.30% |
Baseline | GDP | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.60% | 3.30% |
Baseline | GDP | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.30% | 2.60% |
Baseline | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.70% | 3.90% |
Baseline | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.90% | 3.10% |
Baseline | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 2.90% |
Baseline | Unemployment | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.80% | 6.70% |
Baseline | Unemployment | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.70% | 6.40% |
Baseline | Unemployment | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.10% | 5.80% |
Baseline | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.60% | 6.90% |
Baseline | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.50% | 5.70% |
Baseline | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.40% | 5.60% |
Baseline | HPI | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (0.50%) | 2.40% |
Baseline | HPI | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 2.30% |
Baseline | HPI | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.10% | 5.00% |
Baseline | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.90% | 2.80% |
Baseline | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.50% | 4.70% |
Baseline | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.50% | 4.70% |
Baseline | UK bank rate | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.00% |
Baseline | UK bank rate | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | (0.10%) |
Baseline | UK bank rate | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.40% | 0.00% |
Baseline | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Baseline | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Baseline | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.70% | 0.30% |
Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.60% | 15.40% |
Downside 2 | GDP | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (1.70%) | (3.90%) |
Downside 2 | GDP | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.00% | 6.50% |
Downside 2 | GDP | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.20% | 2.60% |
Downside 2 | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.50% | (2.40%) |
Downside 2 | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.40% | 3.60% |
Downside 2 | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.00% | 2.10% |
Downside 2 | Unemployment | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.30% | 8.00% |
Downside 2 | Unemployment | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.20% | 9.30% |
Downside 2 | Unemployment | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.60% | 7.80% |
Downside 2 | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.70% | 13.40% |
Downside 2 | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 11.00% | 11.90% |
Downside 2 | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 9.30% | 10.10% |
Downside 2 | HPI | UK | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 11.80% | |
Downside 2 | HPI | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (5.80%) | (13.60%) |
Downside 2 | HPI | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (5.80%) | (10.80%) |
Downside 2 | HPI | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 0.50% |
Downside 2 | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (4.90%) | (17.20%) |
Downside 2 | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (3.00%) | (0.70%) |
Downside 2 | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.10% | 0.60% |
Downside 2 | UK bank rate | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | (0.20%) |
Downside 2 | UK bank rate | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.00% | (0.20%) |
Downside 2 | UK bank rate | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.00% | (0.10%) |
Downside 2 | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 2 | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 2 | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 16.90% | 15.50% |
Downside 1 | GDP | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.10% |
Downside 1 | GDP | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.40% | 6.60% |
Downside 1 | GDP | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 3.20% |
Downside 1 | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.40% | 0.40% |
Downside 1 | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.50% | 3.60% |
Downside 1 | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 2.30% |
Downside 1 | Unemployment | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.40% | 7.30% |
Downside 1 | Unemployment | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.60% | 8.00% |
Downside 1 | Unemployment | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.60% | 6.90% |
Downside 1 | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.40% | 11.00% |
Downside 1 | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.90% | 8.90% |
Downside 1 | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.10% | 6.90% |
Downside 1 | HPI | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (3.10%) | (6.70%) |
Downside 1 | HPI | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (2.70%) | (3.50%) |
Downside 1 | HPI | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.70% | 1.70% |
Downside 1 | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (0.50%) | (5.90%) |
Downside 1 | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 1.80% |
Downside 1 | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.30% | 2.60% |
Downside 1 | UK bank rate | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | (0.10%) |
Downside 1 | UK bank rate | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | (0.10%) |
Downside 1 | UK bank rate | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 0.00% |
Downside 1 | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 1 | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Downside 1 | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Upside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 19.60% | 20.20% |
Upside 2 | GDP | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.80% | 12.20% |
Upside 2 | GDP | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 9.40% | 5.30% |
Upside 2 | GDP | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.00% | 3.90% |
Upside 2 | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.50% | 7.10% |
Upside 2 | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.20% | 4.60% |
Upside 2 | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.40% | 4.00% |
Upside 2 | Unemployment | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.50% | 6.20% |
Upside 2 | Unemployment | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.90% | 5.50% |
Upside 2 | Unemployment | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.40% | 4.80% |
Upside 2 | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.30% | 5.50% |
Upside 2 | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.80% | 4.30% |
Upside 2 | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.80% | 4.10% |
Upside 2 | HPI | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.60% | 6.60% |
Upside 2 | HPI | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 9.90% | 10.40% |
Upside 2 | HPI | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 11.30% | 10.80% |
Upside 2 | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.50% | 8.80% |
Upside 2 | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.00% | 9.10% |
Upside 2 | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.30% | 8.90% |
Upside 2 | UK bank rate | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.10% |
Upside 2 | UK bank rate | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.40% | 0.30% |
Upside 2 | UK bank rate | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.30% |
Upside 2 | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Upside 2 | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.40% |
Upside 2 | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.10% | 0.60% |
Upside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 24.50% | 24.20% |
Upside 1 | GDP | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.90% | 9.30% |
Upside 1 | GDP | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.30% | 3.90% |
Upside 1 | GDP | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.00% | 3.40% |
Upside 1 | GDP | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.10% | 5.50% |
Upside 1 | GDP | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.80% | 4.00% |
Upside 1 | GDP | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.40% | 3.70% |
Upside 1 | Unemployment | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.60% | 6.40% |
Upside 1 | Unemployment | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.20% | 6.00% |
Upside 1 | Unemployment | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.70% | 5.20% |
Upside 1 | Unemployment | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.50% | 6.00% |
Upside 1 | Unemployment | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 4.80% |
Upside 1 | Unemployment | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 4.60% |
Upside 1 | HPI | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.50% | 4.60% |
Upside 1 | HPI | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.50% | 6.10% |
Upside 1 | HPI | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.40% | 6.10% |
Upside 1 | HPI | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.20% | 6.80% |
Upside 1 | HPI | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.80% | 6.70% |
Upside 1 | HPI | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.70% | 6.30% |
Upside 1 | UK bank rate | UK | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.10% |
Upside 1 | UK bank rate | UK | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 0.10% |
Upside 1 | UK bank rate | UK | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.30% |
Upside 1 | US federal funds rate | USA | 2021 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Upside 1 | US federal funds rate | USA | 2022 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Upside 1 | US federal funds rate | USA | 2023 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.90% | 0.50% |
Credit Risk - Measurement unc_3
Credit Risk - Measurement uncertainty - Scenario probability weighting (Details) | Jun. 30, 2021 | Dec. 31, 2020 |
Upside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 19.60% | 20.20% |
Upside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 24.50% | 24.20% |
Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 26.40% | 24.70% |
Downside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 16.90% | 15.50% |
Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.60% | 15.40% |
Credit Risk - Measurement unc_4
Credit Risk - Measurement uncertainty - Macroeconomic variables (specific bases and 5-year averages) (Details) | Jun. 30, 2021 | Dec. 31, 2020 |
Upside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 19.60% | 20.20% |
Upside 2 | GDP | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 25.90% | 14.20% |
Upside 2 | GDP | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.20% | 2.50% |
Upside 2 | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 23.70% | 15.70% |
Upside 2 | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.60% | 2.90% |
Upside 2 | Unemployment | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.10% | 4.00% |
Upside 2 | Unemployment | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.60% | 5.00% |
Upside 2 | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.80% | 3.80% |
Upside 2 | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.10% | 5.30% |
Upside 2 | HPI | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 48.20% | 48.20% |
Upside 2 | HPI | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.20% | 8.20% |
Upside 2 | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 41.20% | 42.20% |
Upside 2 | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.10% | 7.30% |
Upside 2 | UK bank rate | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.10% |
Upside 2 | UK bank rate | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.70% | 0.30% |
Upside 2 | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.10% |
Upside 2 | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.10% | 0.50% |
Upside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 24.50% | 24.20% |
Upside 1 | GDP | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 20.20% | 8.80% |
Upside 1 | GDP | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 1.60% |
Upside 1 | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 18.30% | 12.80% |
Upside 1 | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.70% | 2.40% |
Upside 1 | Unemployment | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.30% | 4.00% |
Upside 1 | Unemployment | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.80% | 5.30% |
Upside 1 | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.20% | 3.80% |
Upside 1 | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.40% | 5.70% |
Upside 1 | HPI | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 25.50% | 30.80% |
Upside 1 | HPI | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.70% | 5.50% |
Upside 1 | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 32.60% | 30.90% |
Upside 1 | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.80% | 5.50% |
Upside 1 | UK bank rate | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.10% |
Upside 1 | UK bank rate | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.20% |
Upside 1 | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.10% |
Upside 1 | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.90% | 0.50% |
Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 26.40% | 24.70% |
Baseline | GDP | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.30% | 0.70% |
Baseline | GDP | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.30% | 0.70% |
Baseline | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.80% | 1.60% |
Baseline | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.80% | 1.60% |
Baseline | Unemployment | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.10% | 5.70% |
Baseline | Unemployment | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.10% | 5.70% |
Baseline | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.70% | 6.40% |
Baseline | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 4.70% | 6.40% |
Baseline | HPI | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 3.60% |
Baseline | HPI | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 3.60% |
Baseline | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.60% | 3.80% |
Baseline | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 3.60% | 3.80% |
Baseline | UK bank rate | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.40% | 0.00% |
Baseline | UK bank rate | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.40% | 0.00% |
Baseline | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.80% | 0.30% |
Baseline | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.80% | 0.30% |
Downside 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 16.90% | 15.50% |
Downside 1 | GDP | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (4.20%) | (22.10%) |
Downside 1 | GDP | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.60% | 0.10% |
Downside 1 | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (0.20%) | (10.60%) |
Downside 1 | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 2.00% | 0.80% |
Downside 1 | Unemployment | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 7.50% | 8.40% |
Downside 1 | Unemployment | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 5.70% | 6.50% |
Downside 1 | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.90% | 13.00% |
Downside 1 | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.30% | 8.30% |
Downside 1 | HPI | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (5.80%) | (4.50%) |
Downside 1 | HPI | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.00% | (0.20%) |
Downside 1 | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (1.30%) | (3.70%) |
Downside 1 | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.60% | 0.80% |
Downside 1 | UK bank rate | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.60% |
Downside 1 | UK bank rate | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.20% | 0.00% |
Downside 1 | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.50% | 1.30% |
Downside 1 | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.60% | 0.30% |
Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.60% | 15.40% |
Downside 2 | GDP | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (8.10%) | (22.10%) |
Downside 2 | GDP | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.80% | (0.90%) |
Downside 2 | GDP | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (3.20%) | (10.60%) |
Downside 2 | GDP | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 1.40% | 0.10% |
Downside 2 | Unemployment | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 9.80% | 10.10% |
Downside 2 | Unemployment | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 6.50% | 7.20% |
Downside 2 | Unemployment | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.00% | 13.70% |
Downside 2 | Unemployment | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 8.50% | 10.40% |
Downside 2 | HPI | UK | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 11.80% | |
Downside 2 | HPI | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (11.80%) | 18.30% |
Downside 2 | HPI | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (1.60%) | (3.60%) |
Downside 2 | HPI | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (7.90%) | (15.90%) |
Downside 2 | HPI | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | (0.40%) | (3.00%) |
Downside 2 | UK bank rate | UK | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.10% | 0.60% |
Downside 2 | UK bank rate | UK | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.00% | (0.10%) |
Downside 2 | US federal funds rate | USA | Specific bases | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.80% | 1.30% |
Downside 2 | US federal funds rate | USA | 5-year averages | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 0.30% | 0.30% |
Credit Risk - Measurement unc_5
Credit Risk - Measurement uncertainty - ECL under 100% weighted scenarios for modelled portfolios, narrative (Details) £ in Millions | 6 Months Ended | |
Jun. 30, 2021GBP (£)economic_scenario | Dec. 31, 2020GBP (£) | |
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Weighted expected credit loss, uplift percentage | 100.00% | |
Average EAD period | 12 months | |
Treasury Assets ECL | £ 4 | |
Number of economic scenarios to calculate ECL | economic_scenario | 5 | |
Total impairment allowance | £ 692,346 | £ 686,728 |
Coverage ratio | 0.010 | 0.014 |
Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Transfers into Stage 2 | £ 18,000 | |
Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.030 | 0.042 |
Credit risk | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Number of economic scenarios to calculate ECL | economic_scenario | 5 | |
Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Weighted expected credit loss, uplift percentage | 5.50% | |
Scenario probability weighting | 26.40% | 24.70% |
Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 12.60% | 15.40% |
Total loans and advances at amortised cost | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 348,549 | £ 342,632 |
Coverage ratio | 0.018 | 0.024 |
Total loans and advances at amortised cost | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 40,078 | £ 47,442 |
Coverage ratio | 0.053 | 0.070 |
Home loans | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 166,345 | £ 159,647 |
Coverage ratio | 0.003 | 0.003 |
Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 20,411 | £ 19,228 |
Coverage ratio | 0.003 | 0.004 |
Home loans | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Home loans | Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Weighted expected credit loss, uplift percentage | 0.30% | |
Home loans | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Home loans | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.003 |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 39,008 | £ 40,813 |
Coverage ratio | 0.102 | 0.123 |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 4,384 | £ 7,551 |
Coverage ratio | 0.287 | 0.268 |
Credit cards, unsecured loans and other retail lending | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.15 | 0.165 |
Credit cards, unsecured loans and other retail lending | Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Weighted expected credit loss, uplift percentage | 5.00% | |
Credit cards, unsecured loans and other retail lending | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.143 | 0.162 |
Credit cards, unsecured loans and other retail lending | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.199 | 0.184 |
Wholesale loans | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 143,196 | £ 142,172 |
Coverage ratio | 0.011 | 0.015 |
Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 15,283 | £ 20,663 |
Coverage ratio | 0.025 | 0.033 |
Wholesale loans | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.023 | 0.043 |
Wholesale loans | Baseline | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Weighted expected credit loss, uplift percentage | 8.80% | |
Wholesale loans | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.021 | 0.041 |
Wholesale loans | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.032 | 0.058 |
UK | Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 9.80% | |
UK | Downside 2 | HPI | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Scenario probability weighting | 11.80% | |
USA | Downside 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Unemployment rate | 12.00% | |
Impairment allowance | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (7,230) | £ (9,399) |
Impairment allowance | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2,669) | (4,322) |
Impairment allowance | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4,769) | (6,770) |
Impairment allowance | Total loans and advances at amortised cost | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (6,517) | (8,335) |
Increase (decrease) in financial assets | (699) | |
Impairment allowance | Total loans and advances at amortised cost | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2,233) | (3,564) |
Impairment allowance | Total loans and advances at amortised cost | Credit risk | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4,769) | (6,770) |
Impairment allowance | Total loans and advances at amortised cost | Baseline | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4,522) | (6,453) |
Impairment allowance | Total loans and advances at amortised cost | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (7,088) | (9,933) |
Impairment allowance | Home loans | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (473) | (538) |
Increase (decrease) in financial assets | (53) | |
Impairment allowance | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (69) | (84) |
Impairment allowance | Home loans | Credit risk | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (348) | (350) |
Impairment allowance | Home loans | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (20) | (37) |
Impairment allowance | Home loans | Baseline | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (347) | (329) |
Impairment allowance | Home loans | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (18) | (33) |
Impairment allowance | Home loans | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (399) | (491) |
Impairment allowance | Home loans | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (39) | (63) |
Impairment allowance | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4,453) | (5,700) |
Increase (decrease) in financial assets | (339) | |
Impairment allowance | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,767) | (2,769) |
Impairment allowance | Credit cards, unsecured loans and other retail lending | Credit risk | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (3,333) | (4,602) |
Impairment allowance | Credit cards, unsecured loans and other retail lending | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,076) | (2,207) |
Impairment allowance | Credit cards, unsecured loans and other retail lending | Baseline | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (3,175) | (4,511) |
Impairment allowance | Credit cards, unsecured loans and other retail lending | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (976) | (2,138) |
Impairment allowance | Credit cards, unsecured loans and other retail lending | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4,923) | (6,057) |
Impairment allowance | Credit cards, unsecured loans and other retail lending | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2,517) | (3,564) |
Impairment allowance | Wholesale loans | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,591) | (2,097) |
Increase (decrease) in financial assets | (307) | |
Impairment allowance | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (397) | (711) |
Impairment allowance | Wholesale loans | Credit risk | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,088) | (1,818) |
Impairment allowance | Wholesale loans | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (773) | (1,410) |
Impairment allowance | Wholesale loans | Baseline | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,000) | (1,613) |
Impairment allowance | Wholesale loans | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (709) | (1,223) |
Impairment allowance | Wholesale loans | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,766) | (3,385) |
Impairment allowance | Wholesale loans | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,342) | (2,911) |
Gross exposure | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 699,576 | 696,127 |
Gross exposure | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 88,007 | 103,897 |
Gross exposure | Total loans and advances at amortised cost | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 355,066 | 350,967 |
Gross exposure | Total loans and advances at amortised cost | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 42,311 | 51,006 |
Gross exposure | Home loans | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 166,818 | 160,185 |
Gross exposure | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 20,480 | 19,312 |
Gross exposure | Home loans | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 24,345 | 19,180 |
Gross exposure | Home loans | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 24,785 | 18,188 |
Gross exposure | Home loans | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 28,526 | 22,233 |
Gross exposure | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 43,461 | 46,513 |
Gross exposure | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 6,151 | 10,320 |
Gross exposure | Credit cards, unsecured loans and other retail lending | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 7,175 | 13,399 |
Increase (decrease) in financial assets | 5,500 | |
Gross exposure | Credit cards, unsecured loans and other retail lending | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 6,819 | 13,176 |
Gross exposure | Credit cards, unsecured loans and other retail lending | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 12,625 | 19,322 |
Gross exposure | Wholesale loans | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 144,787 | 144,269 |
Gross exposure | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 15,680 | 21,374 |
Gross exposure | Wholesale loans | Credit risk | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 33,666 | 32,677 |
Gross exposure | Wholesale loans | Baseline | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 33,276 | 29,635 |
Gross exposure | Wholesale loans | Downside 2 | Financial assets at amortised cost, class | Modelled ECL | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 41,676 | £ 50,361 |
Credit Risk - Measurement unc_6
Credit Risk - Measurement uncertainty - ECL under 100% weighted scenarios for modelled portfolios (Details) £ in Millions | Jun. 30, 2021GBP (£) | Dec. 31, 2020GBP (£) |
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 692,346 | £ 686,728 |
Coverage ratio | 0.010 | 0.014 |
Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.002 | 0.002 |
Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.030 | 0.042 |
Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.373 | 0.334 |
Gross exposure | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 699,576 | £ 696,127 |
Gross exposure | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 603,132 | 580,903 |
Gross exposure | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 88,007 | 103,897 |
Gross exposure | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 8,437 | 11,327 |
Impairment allowance | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (7,230) | (9,399) |
Impairment allowance | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4,769) | (6,770) |
Impairment allowance | ECL from individually assessed impairments on stage 3 loans | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (783) | (902) |
Impairment allowance | ECL from non-modelled and other management adjustments | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,678) | (1,727) |
Impairment allowance | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,413) | (1,289) |
Impairment allowance | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2,669) | (4,322) |
Impairment allowance | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (3,148) | (3,788) |
Total loans and advances at amortised cost | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | (7,230) | (9,399) |
Total loans and advances at amortised cost | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | (400) | |
Total loans and advances at amortised cost | ECL from post-model adjustments | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | 1,900 | 1,400 |
Total loans and advances at amortised cost | ECL from non-modelled and other management adjustments | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | 200 | 300 |
Total loans and advances at amortised cost | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 348,549 | £ 342,632 |
Coverage ratio | 0.018 | 0.024 |
Total loans and advances at amortised cost | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 303,797 | £ 289,931 |
Coverage ratio | 0.004 | 0.004 |
Total loans and advances at amortised cost | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 40,078 | £ 47,442 |
Coverage ratio | 0.053 | 0.070 |
Total loans and advances at amortised cost | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 4,674 | £ 5,259 |
Coverage ratio | 0.399 | 0.415 |
Total loans and advances at amortised cost | Gross exposure | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 355,066 | £ 350,967 |
Total loans and advances at amortised cost | Gross exposure | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 304,982 | 290,964 |
Total loans and advances at amortised cost | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 42,311 | 51,006 |
Total loans and advances at amortised cost | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 7,773 | 8,997 |
Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (6,517) | (8,335) |
Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,185) | (1,033) |
Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2,233) | (3,564) |
Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (3,099) | (3,738) |
Home loans | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | (473) | (538) |
Home loans | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 166,345 | £ 159,647 |
Coverage ratio | 0.003 | 0.003 |
Home loans | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 144,088 | £ 138,606 |
Coverage ratio | 0 | 0 |
Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 20,411 | £ 19,228 |
Coverage ratio | 0.003 | 0.004 |
Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 1,846 | £ 1,813 |
Coverage ratio | 0.174 | 0.188 |
Home loans | Gross exposure | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 166,818 | £ 160,185 |
Allowance account for credit losses of financial assets | (166,818) | (160,185) |
Home loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 144,103 | 138,639 |
Allowance account for credit losses of financial assets | (144,103) | (138,639) |
Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 20,480 | 19,312 |
Allowance account for credit losses of financial assets | (20,480) | (19,312) |
Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,235 | 2,234 |
Allowance account for credit losses of financial assets | (2,235) | (2,234) |
Home loans | Impairment allowance | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (473) | (538) |
Allowance account for credit losses of financial assets | (473) | (538) |
Home loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (15) | (33) |
Allowance account for credit losses of financial assets | (15) | (33) |
Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (69) | (84) |
Allowance account for credit losses of financial assets | (69) | (84) |
Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (389) | (421) |
Allowance account for credit losses of financial assets | (389) | (421) |
Credit cards, unsecured loans and other retail lending | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | (4,679) | (6,083) |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 39,008 | £ 40,813 |
Coverage ratio | 0.102 | 0.123 |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 33,703 | £ 32,341 |
Coverage ratio | 0.024 | 0.021 |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 4,384 | £ 7,551 |
Coverage ratio | 0.287 | 0.268 |
Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 921 | £ 921 |
Coverage ratio | 0.668 | 0.710 |
Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 43,461 | £ 46,513 |
Allowance account for credit losses of financial assets | (43,461) | (46,513) |
Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 34,537 | 33,021 |
Allowance account for credit losses of financial assets | (34,537) | (33,021) |
Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 6,151 | 10,320 |
Allowance account for credit losses of financial assets | (6,151) | (10,320) |
Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,773 | 3,172 |
Allowance account for credit losses of financial assets | (2,773) | (3,172) |
Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4,453) | (5,700) |
Allowance account for credit losses of financial assets | (4,453) | (5,700) |
Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (834) | (680) |
Allowance account for credit losses of financial assets | (834) | (680) |
Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,767) | (2,769) |
Allowance account for credit losses of financial assets | (1,767) | (2,769) |
Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,852) | (2,251) |
Allowance account for credit losses of financial assets | (1,852) | (2,251) |
Wholesale loans | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Allowance account for credit losses of financial assets | (2,078) | (2,778) |
Wholesale loans | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 143,196 | £ 142,172 |
Coverage ratio | 0.011 | 0.015 |
Wholesale loans | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 126,006 | £ 118,984 |
Coverage ratio | 0.003 | 0.003 |
Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 15,283 | £ 20,663 |
Coverage ratio | 0.025 | 0.033 |
Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 1,907 | £ 2,525 |
Coverage ratio | 0.310 | 0.297 |
Wholesale loans | Gross exposure | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 144,787 | £ 144,269 |
Allowance account for credit losses of financial assets | (144,787) | (144,269) |
Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 126,342 | 119,304 |
Allowance account for credit losses of financial assets | (126,342) | (119,304) |
Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 15,680 | 21,374 |
Allowance account for credit losses of financial assets | (15,680) | (21,374) |
Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,765 | 3,591 |
Allowance account for credit losses of financial assets | (2,765) | (3,591) |
Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,591) | (2,097) |
Allowance account for credit losses of financial assets | (1,591) | (2,097) |
Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (336) | (320) |
Allowance account for credit losses of financial assets | (336) | (320) |
Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (397) | (711) |
Allowance account for credit losses of financial assets | (397) | (711) |
Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (858) | (1,066) |
Allowance account for credit losses of financial assets | (858) | (1,066) |
Credit risk | Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (4,769) | £ (6,770) |
Credit risk | Home loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0 | 0 |
Credit risk | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Credit risk | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.177 | 0.173 |
Credit risk | Home loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 131,134 | £ 131,422 |
Credit risk | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 24,345 | 19,180 |
Credit risk | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,829 | 1,778 |
Credit risk | Home loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (348) | (350) |
Credit risk | Home loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4) | (6) |
Credit risk | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (20) | (37) |
Credit risk | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (324) | £ (307) |
Credit risk | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.009 | 0.008 |
Credit risk | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.15 | 0.165 |
Credit risk | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.791 | 0.775 |
Credit risk | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 44,014 | £ 51,952 |
Credit risk | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 7,175 | 13,399 |
Credit risk | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,374 | 2,585 |
Credit risk | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (3,333) | (4,602) |
Credit risk | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (379) | (392) |
Credit risk | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,076) | (2,207) |
Credit risk | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (1,878) | £ (2,003) |
Credit risk | Wholesale loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.002 | 0.002 |
Credit risk | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.023 | 0.043 |
Credit risk | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.049 | 0.066 |
Credit risk | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 160,174 | £ 149,099 |
Credit risk | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 33,666 | 32,677 |
Credit risk | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,374 | 2,211 |
Credit risk | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,088) | (1,818) |
Credit risk | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (248) | (262) |
Credit risk | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (773) | (1,410) |
Credit risk | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (67) | (146) |
Upside 2 | Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (4,020) | £ (5,520) |
Upside 2 | Home loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0 | 0 |
Upside 2 | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Upside 2 | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.168 | 0.159 |
Upside 2 | Home loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 133,584 | £ 134,100 |
Upside 2 | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 21,895 | 16,502 |
Upside 2 | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,829 | 1,778 |
Upside 2 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (322) | (317) |
Upside 2 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2) | (4) |
Upside 2 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (13) | (31) |
Upside 2 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (307) | £ (282) |
Upside 2 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.006 | 0.006 |
Upside 2 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.128 | 0.153 |
Upside 2 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.779 | 0.753 |
Upside 2 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 45,185 | £ 53,271 |
Upside 2 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 5,733 | 10,572 |
Upside 2 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,374 | 2,585 |
Upside 2 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2,852) | (3,881) |
Upside 2 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (269) | (316) |
Upside 2 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (733) | (1,618) |
Upside 2 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (1,850) | £ (1,947) |
Upside 2 | Wholesale loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Upside 2 | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.019 | 0.037 |
Upside 2 | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.047 | 0.058 |
Upside 2 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 162,762 | £ 155,812 |
Upside 2 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 31,077 | 25,963 |
Upside 2 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,374 | 2,211 |
Upside 2 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (846) | (1,322) |
Upside 2 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (187) | (242) |
Upside 2 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (594) | (952) |
Upside 2 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (65) | (128) |
Upside 1 | Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (4,241) | £ (5,911) |
Upside 1 | Home loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0 | 0 |
Upside 1 | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Upside 1 | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.172 | 0.161 |
Upside 1 | Home loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 132,343 | £ 133,246 |
Upside 1 | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 23,136 | 17,356 |
Upside 1 | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,829 | 1,778 |
Upside 1 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (333) | (323) |
Upside 1 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (3) | (5) |
Upside 1 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (15) | (32) |
Upside 1 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (315) | £ (286) |
Upside 1 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.006 | 0.006 |
Upside 1 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.136 | 0.159 |
Upside 1 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.785 | 0.763 |
Upside 1 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 44,809 | £ 52,932 |
Upside 1 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 6,205 | 11,579 |
Upside 1 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,374 | 2,585 |
Upside 1 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2,993) | (4,149) |
Upside 1 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (288) | (340) |
Upside 1 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (841) | (1,837) |
Upside 1 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (1,864) | £ (1,972) |
Upside 1 | Wholesale loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Upside 1 | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.020 | 0.038 |
Upside 1 | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.048 | 0.061 |
Upside 1 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 162,201 | £ 154,578 |
Upside 1 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 31,639 | 27,198 |
Upside 1 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,374 | 2,211 |
Upside 1 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (915) | (1,439) |
Upside 1 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (203) | (258) |
Upside 1 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (646) | (1,047) |
Upside 1 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (66) | (134) |
Baseline | Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (4,522) | £ (6,453) |
Baseline | Home loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0 | 0 |
Baseline | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Baseline | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.178 | 0.163 |
Baseline | Home loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 130,694 | £ 132,414 |
Baseline | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 24,785 | 18,188 |
Baseline | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,829 | 1,778 |
Baseline | Home loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (347) | (329) |
Baseline | Home loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4) | (6) |
Baseline | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (18) | (33) |
Baseline | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (325) | £ (290) |
Baseline | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.007 | 0.007 |
Baseline | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.143 | 0.162 |
Baseline | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.790 | 0.774 |
Baseline | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 44,307 | £ 51,995 |
Baseline | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 6,819 | 13,176 |
Baseline | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,374 | 2,585 |
Baseline | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (3,175) | (4,511) |
Baseline | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (324) | (372) |
Baseline | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (976) | (2,138) |
Baseline | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (1,875) | £ (2,001) |
Baseline | Wholesale loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Baseline | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.021 | 0.041 |
Baseline | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.049 | 0.064 |
Baseline | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 160,564 | £ 152,141 |
Baseline | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 33,276 | 29,635 |
Baseline | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,374 | 2,211 |
Baseline | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,000) | (1,613) |
Baseline | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (224) | (249) |
Baseline | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (709) | (1,223) |
Baseline | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (67) | (141) |
Downside 1 | Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (5,589) | £ (7,915) |
Downside 1 | Home loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0 | 0 |
Downside 1 | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.002 |
Downside 1 | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.184 | 0.179 |
Downside 1 | Home loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 128,711 | £ 130,547 |
Downside 1 | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 26,769 | 20,055 |
Downside 1 | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,829 | 1,778 |
Downside 1 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (370) | (374) |
Downside 1 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (6) | (14) |
Downside 1 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (27) | (42) |
Downside 1 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (337) | £ (318) |
Downside 1 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.011 | 0.008 |
Downside 1 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.170 | 0.174 |
Downside 1 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.802 | 0.795 |
Downside 1 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 42,383 | £ 50,168 |
Downside 1 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 9,066 | 16,477 |
Downside 1 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,374 | 2,585 |
Downside 1 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (3,905) | (5,335) |
Downside 1 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (456) | (415) |
Downside 1 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,544) | (2,865) |
Downside 1 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (1,905) | £ (2,055) |
Downside 1 | Wholesale loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.002 | 0.002 |
Downside 1 | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.027 | 0.048 |
Downside 1 | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.050 | 0.071 |
Downside 1 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 158,614 | £ 144,646 |
Downside 1 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 35,225 | 37,130 |
Downside 1 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,374 | 2,211 |
Downside 1 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,314) | (2,206) |
Downside 1 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (306) | (278) |
Downside 1 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (939) | (1,771) |
Downside 1 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (69) | (157) |
Downside 2 | Total loans and advances at amortised cost | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (7,088) | £ (9,933) |
Downside 2 | Home loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0 | 0 |
Downside 2 | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.001 | 0.003 |
Downside 2 | Home loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.192 | 0.217 |
Downside 2 | Home loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 126,953 | £ 128,369 |
Downside 2 | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 28,526 | 22,233 |
Downside 2 | Home loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,829 | 1,778 |
Downside 2 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (399) | (491) |
Downside 2 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (8) | (42) |
Downside 2 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (39) | (63) |
Downside 2 | Home loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (352) | £ (386) |
Downside 2 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.012 | 0.009 |
Downside 2 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.199 | 0.184 |
Downside 2 | Credit cards, unsecured loans and other retail lending | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.809 | 0.804 |
Downside 2 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 39,252 | £ 48,717 |
Downside 2 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 12,625 | 19,322 |
Downside 2 | Credit cards, unsecured loans and other retail lending | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 2,374 | 2,585 |
Downside 2 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (4,923) | (6,057) |
Downside 2 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (486) | (415) |
Downside 2 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (2,517) | (3,564) |
Downside 2 | Credit cards, unsecured loans and other retail lending | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (1,920) | £ (2,078) |
Downside 2 | Wholesale loans | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.002 | 0.002 |
Downside 2 | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.032 | 0.058 |
Downside 2 | Wholesale loans | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Coverage ratio | 0.052 | 0.083 |
Downside 2 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ 152,164 | £ 131,415 |
Downside 2 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 41,676 | 50,361 |
Downside 2 | Wholesale loans | Gross exposure | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | 1,374 | 2,211 |
Downside 2 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,766) | (3,385) |
Downside 2 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Stage 1 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (352) | (290) |
Downside 2 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 2 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | (1,342) | (2,911) |
Downside 2 | Wholesale loans | Impairment allowance | Financial assets at amortised cost, class | Lifetime expected credit losses | Stage 3 | Modelled ECL | ||
Disclosure of nature and extent of risks arising from financial instruments [line items] | ||
Total impairment allowance | £ (72) | £ (184) |